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ABSTRACT 
Background 
The muscles of the trunk are essential for an individual’s ability to perform normal functional 
activities such as standing or walking and are involved in the control of balance and posture. 
Decreased trunk proprioception, muscle imbalance and functional decline of these muscles all 
have the potential to alter posture and balance, leading to an increase in the risk of falls and 
deterioration in physical function and quality of life. The trunk muscles investigated in this study 
are the rectus abdominis, transversus abdominis, internal oblique, external oblique and the 
lumbar multifidus (MF) muscles. The external and internal abdominal oblique muscles are 
torque producers of the trunk, while the transversus abdominis and MF muscles are tonically 
active during weight-bearing activities. While peripheral skeletal muscle mass and strength 
deteriorate with age (sarcopenia), the effect of ageing or pathology on muscles of the trunk, and 
the potential effects these changes have on physical function and quality of life are not fully 
understood.  
Aims 
 This thesis aimed to: 
1. Summarise the evidence in older adults for:
i. changes in function, composition and morphology of the abdominal and MF
muscles and the effects of these changes on physical function.
ii. validity and reliability of electromyographic and imaging measurements of
abdominal and multifidus muscles among adults aged 50 years and older.
2. Determine the test-retest reliability of ultrasound imaging (USI) for the assessment of
abdominal and MF muscle thickness and CSA at the L2 - L5 vertebral levels in older
adults. These results will determine the appropriateness of using these measures in  cross-
sectional and longitudinal studies (aims 3 and 4), particularly as outcomes for randomised
controlled trials (RCT)
3. Determine the effect of 12 months of vitamin D supplementation, on morphology and
function of the abdominal and MF muscles of adults aged 50 to 79 years with low serum
25(OH)D levels.
4. Determine the associations between abdominal and MF muscle size and function and
measures of physical activity, physical function and quality of life among older adults.
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Methods 
The first part of this thesis provides a comprehensive and systematic assessment of the current 
literature investigating abdominal and multifidus muscle in older adults (Study 1). This study 
helped to inform the studies in the second part of this thesis (Studies 2 – 4) that aimed to fill 
some of the gaps in the literature identified in the systematic review. Studies 2 - 4 used data from 
an ultrasound imaging sub-study (n=217) of the Vitamin D Effect on Osteoarthritis (VIDEO) 
clinical trial, conducted between June 2010 and December 2013. The participants were 
community-dwelling adults aged 50-79 years with ongoing symptoms of knee osteoarthritis and 
serum 25(OH)D levels between 12.5 and 60 nmol/L.  
Key findings  
The key findings and evidence gaps identified by the systematic review (Study 1) were: 
 Research on abdominal and MF muscles in older adults was limited
 There was limited evidence that imaging modalities were reliable tools for the assessment
of abdominal and MF muscles of older adults
 There was no evidence for the reliability of test-retest measures of abdominal or MF
muscles using ultrasound imaging in older adults
 There was limited evidence for an age-related decrease in abdominal and MF muscle size
and an increase in intramuscular fat infiltrations that had the potential to affect physical
function of older adults
 There was limited, but consistent evidence of detrimental effects on abdominal and MF
muscles by conditions that affect physical function such as various spinal conditions and
low back pain (LBP)
 There was limited or no evidence on the effect of other conditions such as stroke or
vitamin D deficiency on abdominal or MF muscles
 There were no studies in healthy, older adults investigating associations between trunk
muscle measures and any aspect of physical activity or physical function nor identifying
modifiable factors that could mitigate age-related changes in abdominal or MF muscles
Study 2 determined the test-retest reliability for measurements of abdominal and MF muscle 
thickness and CSA. The estimates of reliability were as follows: 
 Substantial (ICC 0.87-0.98) for all measurements of abdominal muscles, except for the
right internal oblique muscle in the contracted state which was moderate (ICC 0.75)
 Substantial (ICC 0.84-0.91) for all measurements of MF muscle CSA
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 Fair to moderate (ICC 0.55-0.74) for all measurements of MF muscle thickness
Establishing the test-retest reliability of USI for assessing abdominal and lumbar multifidus 
muscles confirmed the appropriateness of using these measures in longitudinal studies and 
particularly as outcomes for randomised controlled trials (RCT)  
We used this technique to assess muscle outcomes in the VIDEO RCT.  Twelve months of 
vitamin D supplementation in vitamin D deficient older adults with knee osteoarthritis alone was 
not an effective means to improve or maintain abdominal or MF muscle size of active, 
community dwelling adults aged 50-79 years (Study 3). 
Given the lack of effect of vitamin D on muscle size, we proceeded to investigate another 
important gap in the literature described in section 1.4 of the introduction of this thesis and also 
identified the systematic review, namely a paucity of studies investigating associations between 
trunk muscle measures and any aspect of physical function in healthy older adults. This cross-
sectional analysis  revealed no cross-sectional correlations between abdominal or MF muscle 
size or function (assessed by changes in muscle thickness on contraction) and measures of 
physical activity (International Physical Activity Questionnaire and pedometer), physical 
function ( functional deficit subscale of the Western Ontario and McMaster Universities Arthritis 
Index  and quality of life (Assessment of Quality of Life instrument) in healthy, active, 
community-dwelling adults with knee osteoarthritis (Study 4). However, such effects cannot be 
ruled out due to the limitations in the measures used to assess muscle function, physical activity 
and physical function available in VIDEO. 
Conclusion 
Age and various spinal conditions have detrimental effects on abdominal and MF muscle size, 
strength, activation and muscle quality, reflected in an increase in intramuscular fat infiltrations. 
However, how these detrimental factors affect physical function and healthy ageing are not 
clearly understood. The findings in this thesis have contributed to fill some of the identified gaps 
in the literature.  
Particularly important are the finding of the RCT on the effect of vitamin D supplementation on 
abdominal and MF muscles suggesting that vitamin D supplementation alone is not an effective 
therapy to improve or preserve the size or ability to contract of postural muscle of the trunk. A 
question that was not investigated in this study and remains unanswered is the effect of vitamin 
D supplementation on other aspects of trunk muscle function such as strength, power or physical 
function.  
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Study 4 contributed to a limited body of evidence on the associations between abdominal and 
MF muscle size and measures of physical function. Although our negative results are consistent 
with findings in the systematic review published in 2017 and some of the studies in the 
systematic review update in this thesis, the evidence is not robust enough to rule out associations 
between abdominal and MF muscle size and measures of physical function in older adults. Given 
that the evidence base remains limited, further research is definitely required, to further address 
important persisting gaps in the literature. These include: 
 what other factors affect trunk muscles of older adults?
 what are the long-term effects of declines in muscle size on physical activity, physical
function and quality of life of older adults?
 what strategies can be implemented to mitigate the effect of age-related changes on these
muscles?
Finally, the literature in the systematic review update suggest that abdominal and MF muscle 
strength and muscle quality are important determinants of physical function in older adults. 
Therefore, these two areas of research would also appear to be promising for future research 
investigating the effect of age-related changes in abdominal and MF muscles on physical 
function and quality of life of older adults. 
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Overview 
By 2050, the global population of people aged 60 years and over will double, and the number of 
people over 80 years will triple (1). This will have profound consequences on social-support 
systems and health budgets (2). The Australian government spent an estimated $45 billion on 
patients admitted to hospitals between 2012 and 2013 and approximately $17 billion in aged care 
between 2015 and 2016 (3). The largest growth in population over the period between 2005 and 
2013 was among people over 60 years of age, which was the group that accounted for the 
greatest growth in health expenditure (4).   
Physical capacity, skeletal muscle mass and strength (5) deteriorate with age, increasing the risk 
of falls that could lead to an increase in hospital admissions and health expenditure. Therefore, it 
is important to focus on this ageing population to identify and develop cost-effective 
interventions to address both the increase in age-related injuries and the rising costs of health 
care  (6, 7). The muscles of the trunk have the potential to play a key role in maintaining people’s 
physical capacity due to the complex role these muscles play in load transfer from the upper 
limbs to the pelvis, force dissipation, control of balance and posture, and movement of the trunk 
and pelvis (6, 8, 9). Decreased trunk proprioception (10), muscle imbalance or functional declines of 
these muscles have the potential to alter posture and balance, increasing the risk of falls that 
could lead to deterioration in physical function and quality of life (11-15). 
Therefore, this thesis examines the effects of ageing on trunk muscles and the implications of 
this for healthy ageing. It also explores potential factors that might slow age-related changes in 
these muscles, namely physical activity and vitamin D supplementation.  
This chapter discusses 
1. Sarcopenia: the age-related process of decline in neuromuscular function and physical
performance characterised by a progressive and generalised decrease in lean muscle
mass, peripheral muscle size and the consequent loss of muscle strength and muscle
function.
2. Muscles of the trunk: . The trunk provides proximal stability for the distal mobility and
function of the limbs and its muscles are anti-gravity muscles, crucial for people to be
able to perform fundamental functional activities of daily living due to the complex role
they play in body load transfer, force dissipation, control of balance and posture, and
movement of the trunk and pelvis. The movement producing elements of the trunk
Chapter 1 - Introduction  3 
include the muscles of the back, the small intersegmental muscles that provide stability 
of the spine, the muscles of the thorax that include muscles of respiration and upper limb 
movement, as well as the muscles of the abdomen and pelvis that produce intra-
abdominal pressure.  
3. Vitamin D: Vitamin D plays an important role in muscle metabolism, development and
growth. vitamin D and its effect on skeletal muscle will be discussed.
1.1 SARCOPENIA 
1.1.2 Introduction 
Sarcopenia is an age-related process of decline in neuromuscular function and physical 
performance characterised by a progressive and generalised decrease in skeletal lean muscle 
mass, appendicular muscle size and the consequent loss of muscle strength and muscle function 
(16-18). This is associated with deterioration in physical activity, physical function and quality of 
life in older adults (11, 12, 17, 19, 20). Sarcopenia has been described as a key contributor to the risk of 
falls, frailty, loss of independence and disability in older adults (16, 21-27).  
1.1.3 Definition of sarcopenia 
Historically, sarcopenia was defined as an appendicular skeletal muscle mass divided by height 
in square meters that is more than two standard deviations less than the normal mean in younger 
persons (28, 29). However, following ongoing criticism (20, 28-33) and in order to provide a better 
definition and to provide general guidance on the subject, a number of working groups on 
sarcopenia have been formed around the world (22, 34-37).  
Currently, there are three main approaches for definition and diagnosis of sarcopenia: 
1- The European Working Group on Sarcopenia (EWGSOP2) (2018) (38) recently reviewed
their position based on current literature and proposed the following operational
definition for the diagnosis of sarcopenia in older individuals following three criteria:
a. Low muscle strength
 Grip strength: <27 kg for men and <16 kg for women
 Chair stand: >15 seconds for five rises
b. Low muscle quantity or quality
Chapter 1 - Introduction  4 
 Appendicular skeletal muscle mass: <20 kg for men and <15 kg for women
 Skeletal muscle mass index: <7.0 kg/m2 for men and <6.0 kg/m2 for women
c. Low physical performance
 Gait speed: ≤0.8m/s
 Short physical performance battery: ≤0.8 m/s
 Timed up and go test: ≥20 seconds
 400 m walk test: non-completion or ≥6 min for completion
2- The International Working Group on Sarcopenia (IWGS) (2011) (36) proposed a
diagnosis of sarcopenia as having a low whole body or appendicular fat-free mass
together with poor physical functioning:
a- Low lean mass < 20th percentile of measurement of younger adults. Objective cut
points for lean mass in men ≤7.23 kg/m2 and in women ≤5.67 kg/m2.
b- Poor physical functioning includes patients who are bedridden, non-ambulatory or
unable to rise from a chair unaided. If patients are ambulatory, a gait speed of <1m/s
is considered a positive finding.
3- The Foundation for the National Institutes of Health Sarcopenia Project (35) proposed the
following operational definitions of sarcopenia:
a- Weakness and low lean mass: grip strength < 26 kg in men and <16 kg in women.
Lean mass in men <0.789 ALM/BMI and in women <0.512 ALM/BMI.
b- Slowness with weakness and low lean mass: gate speed ≤ 0.8 m/s. Grip strength < 26
kg in men and <16 kg in women. Lean mass in men <0.789 ALM/BMI and in women
<0.512 ALM/BMI.
4- In 2018, the EWGSOP (22) definition of sarcopenia was adopted for use in Australia and
New Zealand by researchers and clinicians (39)
1.1.4 Prevalence of sarcopenia 
The different approaches used to define sarcopenia, differences in the populations studied, and 
methods used to measure lean muscle mass, strength and physical performance have resulted in 
broad variations in estimates of prevalence for sarcopenia. A study by Baumgartner et al. (28) was 
one of the first epidemiological studies on the prevalence of sarcopenia. Using data from the 
New Mexico Elder Health survey and lean muscle mass alone to define sarcopenia, Baumgartner 
et al. (28) reported rates of sarcopenia between 13.5% - 36.4% in Hispanic and non-Hispanic 
individuals under the age of 70 years and a much larger prevalence of up to 60% in people older 
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than 80 years (28). In a systematic review published in 2014 that included 18 prevalence studies, 
the prevalence of EWGSOP-defined sarcopenia ranged from 1 – 29% for community-dwelling 
older adults, 14 – 33% for people in long-term care institutions and was 10% for people in acute 
hospital care (34).  
1.1.5 Aetiology of Sarcopenia 
The process by which loss of lean muscle mass occurs is complex and results from the 
accumulation of several factors associated with ageing (5, 40, 41). Potential mechanisms include 
decreased neurological input to muscle (loss of Alpha- motor neurones input to muscle that 
occurs with ageing) (33), age-related body composition changes  (11), systemic low-level 
inflammation and a decline in endocrine function (16, 42), decreases in food and protein intake (43) 
and decreased physical activity either due to inactivity or disability (20). These potential 
mechanisms are discussed in more detail in the next sections 
1.1.5.1 Decreased neurological input 
The decrease in strength seen with ageing may be due to impairment of the regeneration 
capabilities of muscle fibres or an alteration to neural input (17, 44). An age-related decrease in 
functional motor neurones innervating muscle (45) leads to a decrease in co-ordinated muscle 
function (31, 43). Roubenoff (20) proposed that the continuous loss of alpha motor neurones through 
life causes motor units to be bigger and have decreased neural input to muscle. Neural input is 
essential for normal muscle function and age-related neuronal death leads to atrophy, loss of 
muscle mass and decreased muscle force in older adults (20, 33, 45), which are critical features of 
sarcopenia (17, 42). 
1.1.5.2 Age-related changes in skeletal muscle composition 
Although the composition of skeletal muscle varies greatly depending on age, obesity and 
presence or absence of disease (46), a typical muscle is composed of water (79%), collagenous 
protein fraction (15%), collagen (3.4%), lipids (2%), other factors (0.6%) (47). Upper and lower 
limb skeletal muscle mass peaks in early adulthood (11, 19) and gradually declines by 30% 
between the ages of 20 and 80 years (48). Age-related decreases in muscle mass are often 
associated with increased accumulation of intramuscular fatty infiltrations in skeletal muscle and 
have been associated with decreases in muscle strength (17, 46). Decreases in slow twitch, fatigue 
resistant, Type I and accelerated loss of  fast twitch, Type II muscle fibres with ageing have been 
linked to changes in muscle function associated with decreases in the capacity of older adults to 
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perform activities such as rising from a chair, climbing stairs and impaired balance (20, 31, 49). 
1.1.5.3 Systemic low-level inflammation and endocrine dysfunction  
Skeletal muscle mass is maintained by a dynamic balance between muscle protein synthesis from 
amino acids and muscle protein breakdown (31, 50). Ageing is associated with both a decline in 
expression of hormonal factors that stimulate protein synthesis and a rise in the expression of 
endocrine and inflammatory factors that promote protein breakdown (31). Similar decreases in 
protein synthesis and increase in protein degradation are seen in acute illness and chronic 
inflammatory conditions such as cachexia and human immunodeficiency virus (HIV), which has 
led to the theory that ageing is associated with a subclinical inflammatory state which increases 
the production of inflammatory cytokines that in turn increases the rate of muscle catabolism 
leading to sarcopenia (20, 31). Declines in growth hormone (GH), testosterone and oestrogen seen 
with ageing (40) have the potential to affect muscle mass and function leading to sarcopenia (42). A 
progressive decline in GH begins in the fourth decade and has been proposed as an important 
mechanism for the loss of lean muscle mass and muscle function (31, 42).  
1.1.5.4 Decreases in food and protein intake 
There is an age-related decrease in food intake in the general population and in healthy older 
adults (51). The reasons for this decline in food consumption are complex and include early 
satiation due to the inability of the gastric fundus to relax and adapt to food intake, and increased 
release of cholecystokinin and leptin that are associated with decreased food and protein intake 
(43, 51). Decreased protein intake often precedes weight loss in the elderly, leading to a loss of 
both fat and lean muscle mass. In some instances, it causes loss of lean muscle mass only, 
leading to fat-frailty or sarcopenic obesity (16, 43, 52).  
1.1.5.5 Vitamin D deficiency 
The association between vitamin D deficiency and the development of sarcopenia has not been 
clearly established. However, the age-related decline in muscle mass, muscle strength and 
physical performance coincide with an age-related decrease in the skeletal muscle vitamin D 
receptor expression. Common clinical symptoms of vitamin D deficiency in older adults include 
symmetrical proximal muscle weakness, easy fatigability, decreased physical function and 
increased postural sway (53-61), which is positively associated with balance and risk of falling (62). 
Previous reports indicating that higher serum vitamin D levels are associated with greater muscle 
mass and predictive of increased muscle strength and function in older adults (63), suggest 
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vitamin D could play a part in the occurrence and progression of sarcopenia (63). Vitamin D and 
its effect on skeletal muscle will be discussed in more detail in the third section of this chapter. 
1.1.5.6 Decreased physical activity 
There is a trend in developed societies towards a decrease in physical activity with increasing 
age (20). Various studies have found a correlation between decreased physical activity and the 
development of sarcopenia (11-15). Reduced physical activity may lead to increased accumulation 
of intramuscular fat (41, 64, 65), as well as greater muscle loss compared with physically active 
adults (20). There are significant associations between decreased physical activity in older people 
and increases in body fat measures (66), as well as decreases in lean muscle mass (17, 20, 28, 67). 
Along with decreased physical activity with ageing, there is an increase in sedentary behaviour 
(SB), defined as waking activities with an energy expenditure of ≤1.5 metabolic equivalent of 
task (MET), while sitting or reclining (68). In older adults, SB has been associated with decreased 
or loss of physical function and increased difficulty performing activities of daily life (ADL) (69-
72).  
1.1.5.7 Muscles investigated to determine sarcopenia 
Given that sarcopenia is associated with deterioration in physical activity, physical function and 
quality of life in older adults (11, 12, 17, 19, 20), muscles of the upper (grip strength) and lower 
(quadriceps and calves) limbs have been used to quantify loss of strength, muscle mass and 
physical impediments (38). Assessments of these muscles have been shown to be valid, reliable 
and apart from imaging tests, they are easy to use in clinical practice (38). Assessment of muscles 
of the trunk or quantification of their qualities are not part of any of the current guidelines for the 
diagnosis of sarcopenia, despite these muscles playing a key role in body load transfer, force 
dissipation, control of balance and posture, and movement of the trunk and pelvis. A possible 
explanation for the omission of the muscles of the trunk in the overall picture of sarcopenia may 
be that, as is the case for the psoas muscle (38), these muscles have been considered minor 
muscles and not representative of an overall picture of sarcopenia. The increase use of ultrasound 
imaging (USI) in clinical practice may facilitate the inclusion of these muscles in the diagnosis 
of sarcopenia, but studies are needed to ascertain the viability of using this assessment method 
and the framework it will operate in.  
1.1.6 Concluding Comments  
This section described sarcopenia as an age-related process characterised by a generalised 
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decrease in lean muscle mass, appendicular muscle size and the consequent loss of muscle 
strength and muscle function (16-18). It also discussed its prevalence and aetiology which include 
neurological, body composition, endocrine, decreased nutrition and physical activity factors 
associated with ageing (11, 16, 20, 33, 42, 43).  
In the next section, the muscle of the trunk will be described and the essential role these muscles 
play in an individual’s ability to perform normal functional activities will be discussed. 
1.2 THE MUSCLES OF THE TRUNK 
1.2.1 Introduction 
Topographical anatomy divides the human body into segments and focuses its study on specific 
parts or regions, exploring the organisation and systemic structures within the segment (73). These 
segments include the head, neck, upper and lower limbs and the trunk. The trunk provides 
proximal stability for the distal mobility and function of the limbs (74), and plays a fundamental 
role in a person’s ability to perform activities of daily living through its involvement in load 
transfer, force dissipation, control of balance and posture, and trunk and pelvic movement (6, 8, 9). 
The trunk is subdivided into thorax, abdomen, back and pelvis (73). The structural 
musculoskeletal elements of the trunk include the spine, pelvis and the thoracic cage (74) and the 
connecting soft tissue surrounding these structures. The movement-producing elements of the 
trunk include the muscles of the back, the small intersegmental muscles that provide stability of 
the spine, the muscles of the thorax that include muscles of respiration and upper limb 
movement, as well as the muscles of the abdomen and pelvis that produce intra-abdominal 
pressure (75-77). 
1.2.2 Classification of trunk muscles 
For the purpose of mechanical modelling of the spine, Bergmark (9) proposed the concept of local 
and global systems composed of muscles and intra-abdominal pressure. He defined the muscles 
with origin or insertion at the vertebra, except for the psoas, as belonging to the local system. 
The muscles which transfer loads between the thoracic cage and the pelvis and function 
primarily as movement producers, he assigned to the global system (9). Even though this 
classification has been extensively used by researchers and clinicians to describe these muscles, 
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and various adaptations have been made to this classification (9, 74, 78-83), it does not include some 
important muscles of the trunk. 
In this thesis, the current anatomical classification of the muscles of the trunk will be followed 
(73, 84). The muscles of the back are arranged in layers that divide them into intrinsic and extrinsic 
muscles. The extrinsic (superficial) muscles of the back (trapezius, latissimus dorsi, levator 
scapulae and rhomboids) connect the upper limb to the axial skeleton and almost all are 
innervated by the ventral rami of cervical spinal nerves (73, 84). Although these muscles are 
located in the back, the primary functions of these muscles are the production and control of 
movements of the upper limb, and therefore these muscles are instead described as upper limb 
muscles instead (73, 84). The serratus posterior muscles, also part of the extrinsic back muscles, are 
accessory respiratory muscles (73, 84).  The intrinsic or “muscles of the back proper” (73) are the 
deep muscles of the back that are further divided into superficial, intermediate and deep layers. 
These muscles are innervated by the dorsal rami of the spinal nerves and their primary function 
is to maintain posture and produce and control movement of the vertebral column (73). The terms 
“trunk muscles” and “muscles of the trunk” will be used interchangeably throughout this thesis 
and the muscles being referred to here will be the abdominal muscles and the muscles of the 
intermediate and deep layers of the intrinsic back muscles. The term excludes the extrinsic 
muscles of the back, the pectoral and intercostal muscles.  
1.2.3 Muscles of the abdominal wall 
The rectus abdominis muscle (RA) (Figure 1.1) extends along the entire length of the anterior 
abdominal wall. The paired muscles are separated in the middle by the linea alba (Figure 1.1). 
The RA muscle arises from tendons extending from the pubis and inserts as three slips of muscle 
into the fifth, sixth and seventh costal cartilages and in some instances to the third, fourth and 
fifth ribs (73, 85, 86). The RA muscle is fundamentally a trunk flexor (87), and contributes little to 
spinal compression in lifting and quiet breathing (88). The RA muscle has phasic electrical 
activity that is detected before major activity of the back muscles, and exerts stabilising flexion 
forces to the trunk during walking (89) 
Photographs of dissected cadavers from page 
10-23 have been removed from the publicly 
available version at the request of the author, 
for sensitivity reasons.
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Figure 1.1. The rectus abdominis muscle 
A 
Images of the anterior abdominal wall. A: on the right, the aponeurosis where the upper and middle 
fibres of the external oblique muscle insert is labelled. On the left, is the rectus sheath. B: on the right, 
are the different sections of the rectus abdominis muscle separated by tendinous intersections. (Ethics 
reference number H0017462)
The external abdominal oblique (EO) muscle (Figure 1.2) is the largest and the most superficial 
of the abdominal wall muscles. It arises from the external surfaces and the inferior border of the 
lower eight ribs and curves around the lateral and anterior aspects of the abdomen. The middle 
and upper fibres insert in the anterior aponeurosis. The inguinal ligament is formed by the 
margins of the aponeurosis of EO extending between the anterior superior iliac spine (ASIS) and 
the pubic tubercle (73, 85, 86).  The main action of EO is torque production, especially trunk rotation 
and flexion (90).  
B 
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Figure 1.2. The external oblique muscle 
Image of the lateral abdominal wall. Labelled is the most superficial of the lateral abdominal muscles, 
the external oblique and inferiorly where it forms the inguinal ligament. Note the orientation of the 
muscle fibres. (Ethics reference number H0017462) 
The internal abdominal oblique (IO) muscle (Figure 1.3) is the middle layer of the lateral 
abdominal muscles. It arises from the inguinal ligament, the iliac crest, and posteriorly the 
thoracolumbar fascia (TLF) (85, 86, 91, 92). It inserts into the inferior borders of the lower three or 
four ribs and anterior aponeurosis. The IO muscle is both a postural muscle because it fires 
together with the transversus abdominis muscle in anticipation of movement, during changes in 
posture and during expiration (93, 94), and a torque-producing muscle because it is involved in 
trunk flexion and rotation (95) and compression of the sacroiliac joint (96, 97).      
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Figure 1.3. The internal oblique muscle. 
The image shows muscles of the lateral abdominal wall with cut edges of the external oblique muscle 
reflected upwards and downwards, revealing the internal oblique muscle. Note the difference in 
orientation of the muscle fibres compared with the external oblique (Figure 1.2). (Ethics reference 
number H0017462) 
The transversus abdominis (TrA) muscle (Figure 1.4) is the deepest of the lateral abdominal 
muscles. Its name is derived from the direction of its fibres. It arises from the inguinal ligament, 
the iliac crest, the cartilages of the lower six ribs, the diaphragm and from the thoracolumbar 
fascia (85, 86, 91, 98). The lower fibres of the TrA fuse together with the lower fibres of the IO 
muscle to form the inguinal aponeurotic flax or conjoint tendon (73, 85, 86, 91, 92, 96).  Throughout the 
rest of its extent, the aponeurosis passes horizontally and inserts into the linea alba. The TrA 
muscle has been described as sometimes being fused with the IO muscle or on rare occasions 
absent altogether (85). Between the inner surface of the TrA and the extraperitoneal fat there is a 
thin layer of connective tissue, the transversalis fascia. The transversalis fascia is continuous 
with the anterior layer of the thoracolumbar fascia posteriorly, the iliac and pelvic fasciae 
inferiorly and the fascia covering the inferior surface of the diaphragm superiorly (84) 
The TrA is an important muscle of respiration. The activity of the TrA and IO muscle increases 
with increased physical demand 
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Figure 1.4. The transversus abdominis muscle. 
A 
B 
Image A: shows the three layers of the lateral abdominal muscle group (from superficial to deep: external 
oblique, internal oblique and transversus abdominis. Image B: shows the transversus abdominis muscle 
with the external and internal abdominal oblique muscles removed. Note the difference in orientation of 
the muscle fibres compared with external abdominal oblique (Figure 1.2) and internal abdominal oblique 
muscles (Figure 1.3). (Ethics reference number H0017462) 
The quadratus lumborum (QL) (Figure 1.5) is a large, generally thin, quadrilateral muscle 
located on the posterior abdominal wall with a combination of various oblique and longitudinal 
fibres that connect the lumbar transverse processes, the ilium and the 12th rib (85, 86, 98). The QL 
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muscle divides into three components (inferior oblique, superior oblique and longitudinal) 
named after the orientation of its fibres.  The longitudinal and oblique fibres attach laterally to 
the 12th rib and are thought to stabilise the 12th rib during respiration. The remaining fibres attach 
to the ilium and the upper four lumbar transverse processes and are thought to be weak lateral 
flexors of the lumbar spine.  
Figure 1.5. The quadratus lumborum, iliacus and psoas major muscles
A B
Anterior view of the posterior abdominal wall. Labelled from lateral to medial the iliacus, quadratus 
lumborum and psoas major muscles. (Ethics reference number H0017462) 
1.2.4 The intrinsic muscles of the back 
The intrinsic muscles of the back are comprised of three layers: superficial, intermediate and 
deep. 
1.2.4.1 The superficial layer 
The splenius muscles are the thick, flat muscles on the lateral and posterior aspects of the neck. 
The splenius capitus takes origin from the mastoid process and occipital bone and insert into the 
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spinous processes of the seventh and upper three or four thoracic vertebrae (73, 84). The splenius 
cervicis arises from the atlas and axis and inserts into the spinous processes of the third to sixth 
thoracic vertebrae. These muscles cover and keep in place the deep muscles of the neck. 
Unilaterally, they rotate the upper cervical vertebrae and head and together they extend the upper 
cervical spine (73, 84) 
1.2.4.2 The intermediate layer: The erector spinae muscles 
The erector spinae (ES) (Figure 1.6) is a large musculotendinous mass that varies in size and 
structure at different parts of the vertebral column (84). The ES is divided into three muscular 
columns, each one defined by the superior attachment of their fascicles and the regional areas 
they traverse. They are named from medial to lateral: the spinalis (thoracis, cervicis and capitus), 
longissimus (capitis, cervicis, thoracis and lumborum) and iliocostalis (cervicis, thoracis and 
lumborum) muscles. The erector spinae muscle arises from the iliac crest and sacrum and the 
different columns may insert into the spine, the ribs or mastoid process of the temporal bone. 
The three muscular columns are clearly defined in the thoracic region (Figure 1.6), with the 
spinalis muscle also having fascicles that attach to the first two lumbar vertebrae   (73, 84).  
 Figure 1.6. The erector spinae muscles 
Image of the intrinsic, intermediate layer of muscles of the back. Labelled are the three components of the 
erector spinae muscle at different spinal levels – Iliocostalis lumborum, longissimus thoracis and spinalis 
muscles. (Ethics reference number H0017462) 
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The lumbar erector spinae (LES) is a large muscle mass located lateral to the multifidus muscle 
and is covered by the erector spinae aponeurosis. The muscle mass is divided mainly into lateral 
(iliocostalis lumborum pars lumborum and iliocostalis lumborum pars thoracis) and medial 
(longissimus thoracis pars lumborum and longissimus lumborum pars lumborum) divisions by 
the erector spinae aponeurosis and an intramuscular aponeurosis (99). In the lumbar region, the 
spinalis muscle has spindles that attach to the first two lumbar vertebrae, but it is irregular and 
poorly developed in this area (84).  
The main actions of the thoracic and lumbar sections of the ES muscle are to extend the vertebral 
column, contribute to the movement of the lumbar spine via their pelvic attachments and control 
the rate of flexion against gravity (85, 86, 98, 100, 101). The majority of muscles fibres in the ES 
muscles are slow twitch, fatigue resistant type I muscle fibres, making these muscles suited for 
one of its main actions of working tonically to maintain the upright posture (102). Unilaterally the 
ES muscles are involved in lateral flexion of the trunk (73). The LES muscles specifically, 
balance, stabilise and control shear forces on the lumbar spine during axial rotation movements 
(103)
1.2.4.2 The deep layer: The transversospinalis muscle group 
The transversospinalis group consists of three muscles, the rotatores, semispinalis and multifidus 
muscles. The rotatores (Figure 1.7) and semispinalis muscles originate from the transverse 
processes of the vertebrae and insert into the spinous processes of the vertebrae above (73). The 
rotatores muscle consists of cervicis, thoracis and lumborum segments, named depending on 
their superior attachment. They are small muscles spanning 1-2 vertebral segments and are 
thought to contribute minimally to momentum, but rather act as proprioceptive transducers 
providing feedback to influence the actions of surrounding muscles (98, 104). The semispinalis 
muscle has the longest fascicles of this group of muscles and consists of capitis, cervicis and 
thoracis segments. They span 4-6 vertebral segments and are involved in the extension of the 
head and cervical and thoracic spine (73, 84) 
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 Figure 1.7. The rotatores muscles 
The image shows the rotatores and levatores muscles. The rotatores muscles are the deepest of the 
transversospinalis muscle group. (Ethics reference number H0017462) 
The multifidus (MF) muscle (Figure 1.8) extends the length of the vertebral column and is 
formed by several triangular fleshy and tendinous fasciculi that are thickest in the lumbar region 
(73). This muscle has traditionally been described as part of the transversospinalis group of 
muscles (73, 85). In the lumbar spine however, studies have demonstrated that the MF muscle has a 
spino-transverse arrangement instead, with the muscle dividing into five bands (L1-L5) that are 
innervated segmentally (105, 106). Each band arises from a tubercle at the tip of the spinous 
process, its lateral surface and the lamina. The bands further divide into several fascicles with a 
caudal insertion that varies from level to level, but the typical arrangement is fascicles arising 
from the lamina (deep fibres) insert into the mamillary process 2 vertebrae below. The fascicles 
from the lateral surface of the spinous process (intermediate fibres – absent at L5) insert 3 
vertebrae below and the fascicles arising from the tubercle (superficial fibres) insert into the 
mamillary process 4-5 vertebrae below, the sacrum or the ilium (105, 106). The lumbar multifidus 
muscle contributes to extension of the lumbar spine (107) and has a dual role as stabiliser of the 
spine, controlling intersegmental motion via its deep muscle fibres and generating trunk 
extension and control of spine orientation via its superficial fibres (105, 107-109). 
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Figure 1.8 The lumbar multifidus muscle 
A 
B
Image A: posterior longitudinal view of the muscles of the back. Labelled are the lumbar multifidus 
muscles, the erector spinae muscle and the gluteus maximus muscles. Image B: posterior lateral view of 
the same muscles. Note the increase in the size of the lumbar multifidus muscle from L2 to S1 spinal 
levels. (Ethics reference number H0017462) 
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1.2.4.2.2 Interspinales and intertransverserii and levatores costarum 
The interspinales, intertransversii and levatores costarum muscles are part of the minor deep 
layer of muscles of the back (73). The levatores costarum muscles elevate the ribs and assist in 
respiration. The interspinales and intertransversii muscles are small muscles that are located 
between the superior and inferior aspects of the spinous and transverse process of the spine, 
respectively. These muscles are not prime movers of the spine. Instead, they are rich in muscle 
spindles and are described as proprioceptive muscles for control of the position of the spine and 
its movements (84) 
1.2.5 Other important muscles and anatomical structures of the trunk 
1.2.5.1 The iliacus and psoas major (iliopsoas) muscle 
The Psoas major (Figure 1.5) is a long muscle that arises from the anterolateral surfaces of all 
lumbar vertebrae. It descends into the upper part of the anterior compartment of the thigh and 
inserts into the lesser trochanter of the femur together with the iliacus muscle to form the 
iliopsoas muscle (85, 86, 110, 111). The iliopsoas muscle is primarily a hip flexor although ipsilateral 
lateral flexion of the trunk has also been described as one of its functions (85). However, as the 
only muscle group in the body with direct attachment to the spine, pelvis and femur (112) iliopsoas 
can potentially generate compression forces which increase spinal stiffness (98, 113, 114) and control 
shear forces of the lumbar joints (101). 
1.2.5.2 Diaphragm and pelvic floor (PF) muscles 
The diaphragm and pelvic floor muscles are muscles of respiration and continence, respectively. 
However, they act together with the abdominal muscles to create and regulate intra-abdominal 
pressure and therefore they play an essential role in the function of the muscles of the trunk (75,
115). The musculotendinous diaphragm seals the inferior thoracic aperture and serves as the roof 
of the abdominal muscular complex (104). The pelvic diaphragm, the perineal membrane and the 
deep perineal pouch muscles form the pelvic floor. Increased intra-abdominal pressure is thought 
to be beneficial in all everyday activities by producing extensor torque and spinal unloading (76,
115).  
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 Figure 1.9. The pelvic floor muscles 
Model of the pelvis showing the pelvic floor muscles 
1.2.5.3 The thoracolumbar fascia 
The lumbosacral spine is essential for the postural stability of the human body, but on its own is 
unable to withstand the loads it is exposed to on a daily basis (116). The thoracolumbar fascia 
(TLF) (Figure 1.10) is a myofascial and aponeurotic band that covers the posterior trunk, and is 
continuous with the paraspinal fascia of the sacral, lumbar, thoracic and cervical regions (116). 
The TLF consists of three layers of fascia (anterior, middle and posterior) that envelop the deep 
muscles of the back and trunk, separating them into three components (85, 98). The anterior layer 
of the TLF is thin and covers the anterior surface of quadratus lumborum. The middle layer lies 
behind quadratus lumborum and attaches medially to the tips of the lumbar transverse processes 
and intertransverse ligaments (85, 86, 98, 117). The posterior layer is the thickest of the three layers 
and it divides into two laminae that cover the muscles of the back (91, 98, 118) and provide 
attachment for muscles of the shoulder girdle and anterolateral abdominal wall (91, 98, 104, 118). The 
TLF is a retinacular belt for the muscles of the back (104) that aids extension forces in lifting (95,
113), plays a proprioceptive and nociceptive role in the back (116) and allows effective transfer of 
loads between the lower limb and upper limb.  
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 Figure 1.10. The thoracolumbar fascia 
Image of the thoracolumbar fascia and selected extrinsic muscles of the back. Labelled are the trapezius 
and latissimus dorsi muscles, which attach to the spine via the thoracolumbar fascia. (Ethics reference 
number H0017462) 
1.2.6 Cross-sectional anatomy of the muscles of the trunk 
In this section the cross-sectional or axial anatomy of the muscles of the trunk at the lumbar 
spinal level will be described.  
The rectus abdominis (RA) muscle (Figure 1.11) is a strap-like muscle located on the anterior 
aspect of the abdominal wall, lateral to the midline (84). The medial border of the RA muscle is 
close to the linea alba, a tendinous raphe formed by the interlacing of the aponeuroses of the 
lateral abdominal muscles, that separates the right and left RA muscles in the midline  (84). The 
muscle is encased by the rectus sheath. Inferior to the arcuate line (horizontal line half way 
between the umbilicus and the pubic crest), the rectus sheath does not have contact with the 
transversalis fascia, as all three layers of aponeuroses, from EO, IO and TrA, pass anterior to the 
rectus abdominis. Superior to the arcuate line, the posterior lamina of the rectus sheath is in 
contact with the transversalis fascia (84, 119). The lateral abdominal muscles are from superficial to 
deep, the external oblique, internal oblique and transversus abdominis muscles respectively. 
Anteriorly, the aponeuroses of the lateral abdominal muscles blend to form the rectus sheath on 
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the lateral border of the RA muscle. The aponeurosis of the IO muscle splits to contribute to the 
anterior and posterior layers of the rectus sheath above the arcuate line. The aponeurosis of the 
EO blends with the anterior layer, while the aponeurosis of the TrA muscle blends with the 
posterior layer of the sheath (84, 120). The size of the abdominal muscles is correlated with BMI, 
and the descending order of thickness for these muscles has been reported to be RA the thickest, 
followed by IO, EO and TrA muscle the thinnest (121).  
Figure 1.11 Cross-sectional image of right trunk muscles (approximately L2-3 spinal level) 
Interactive archive book. Image from page 326, Sobotta’s Atlas and text-book of human anatomy, 1914. 
Modified by William Cuellar 
Posteriorly (Figure 1.12) the multifidus muscle is the most medial of the large back muscles and 
extends from the tip of the spinous process and along its lateral surface to the vertebral lamina, 
filling the space between spinous and transverse processes (101). The muscle covers the area of 
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the lamina, from its medial aspect to the mamillary process (105). The posterior fascicles of the 
MF muscle attach to the posterior layer of the TFL (105), and the lateral border is at the 
intermuscular fascia with the longissimus muscle (122). The size and shape of the MF muscle 
changes from L1 to L5, being slightly more round and smaller at the upper spinal levels and 
larger and broader in the lower ones (122). The difference in size of the MF muscle from L1 to L5 
relates to its anatomical arrangement which, in the lumbar spine, is comprised of 5 bands, each 
one arising from the tip of the spinous process, its lateral surface and the lamina and further 
subdividing into fascicles with caudal insertions that vary at each level (105, 106). At L5 the MF 
muscle has components from all 5 bands, accounting for its larger size compared with the upper 
levels. 
Figure 1.12 Cross-section of the lumbar paraspinal muscles (approximately L3-L4 spinal level) 
Wikimedia commons, Sobotta’s Atlas and text-book of human anatomy, 1909. Modified by William 
Cuellar 
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As described previously, the LES muscle is comprised of two separate muscles, the longissimus 
muscle medially and the iliocostalis muscle laterally (100). The medial border of the LES muscle 
mass is the intermuscular fascia with the multifidus muscle. Anteriorly, it extends from the 
mamillary process along the transverse process of the vertebra and continues laterally to the 
lateral raphe, a complex of dense connective tissue formed by the aponeuroses of the latissimus 
dorsi, TrA and IO muscles, and the middle and posterior layers of the TLF (99). The middle layer 
of the TFL covers the anterior aspect of the LES (84, 116). Posteriorly, the ES muscle is covered by 
the posterior layer of the TFL. Like the MF muscle, the LES muscle becomes progressively 
larger from the upper to the lower spinal segments due to an increase in the muscle belly size (99). 
The quadratus lumborum (QL) muscle is a flat, irregularly shaped muscle that is broader in the 
lower segments (84). It is located anterior to the LES muscle and attaches medially to the apices 
of the transverse lumbar vertebrae via small tendons (84) and laterally to the aponeurosis of the 
deep lateral abdominal muscles. The investing fascia of the QL muscle is covered anteriorly by 
the anterior layer of the TFL and posteriorly by the middle layer of the TFL (84, 116). The psoas 
muscle is a large muscle that covers the area lateral to the vertebral body and anterior aspect of 
the transverse process (84). Anteriorly, it is covered by a thin layer of fascia that is an extension of 
the abdominal transversalis fascia (116).  
The three lateral abdominal muscles are also visible in the posterior aspect of the cross-sectional 
area of the lumbar region (Figure 1.7). The aponeuroses of the TrA and IO muscles blend with 
the middle layer of the TFL at the lateral raphe, which in turn provides indirect attachment to the 
vertebra (116).  
1.2.7 Function of the muscles of the trunk 
Muscles of the trunk are essential for an individual’s ability to perform fundamental functional 
activities of daily living due to the complex role they play in load transfer, force dissipation, 
control of balance and posture, and trunk and pelvic movement (6, 8, 9). Normal trunk movement 
in everyday activities requires the spinal stabilization system to constantly maintain co-
contraction and fine coordination between the different muscular systems (76, 77, 123-127). The RA, 
TrA, ES and MF muscles along with the psoas, gluteal and hamstring muscles provide trunk 
flexion and extension movements in the sagittal plane, while the IO, EO and QL muscles are 
involved in lateral flexion and trunk rotation movements (84). Co-contraction of these muscles in 
conjunction with the pelvic floor muscles and the diaphragm increase intra-abdominal pressure 
(74-77, 88, 113, 128, 129) and the TLF’s longitudinal tension (95, 113), thus facilitating the transmission of 
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forces from the upper to the lower limbs for everyday tasks. 
The ES muscle has a large proportion of type I fibres (102) and activates 
asymmetrically/contralaterally in one-sided tasks and symmetrically in two-handed tasks (130), 
making this muscles suited to extend the spine from the trunk to the pelvis, produce movement 
of the hip and increase trunk stiffness to withstand external, destabilising forces involved in 
everyday functional tasks (87). The MF muscle in particular, transfers loads through the lower 
spine and has a dual role as stabiliser of the spine, controlling intersegmental motion via its deep 
muscle fibres, and generating trunk extension and control of spine orientation via its superficial 
fibres (105, 107-109). The MF and IO muscles maintain constant activation during most everyday 
activities and symmetrical co-contraction during lifting tasks, therefore providing tonic dynamic 
control of the lumbar spine and pelvis (130, 131). The MF and TrA muscles play a major role in 
preparing the trunk to counteract the effect of gravity, postural changes and destabilizing forces 
caused by movements of the limbs and body, by tonically activating at low levels during most 
activities of daily life (76, 77, 132-135). The mechanism responsible for the anticipatory, stabilising 
responses of the muscles of the trunk are proprioceptive transducers located in the passive 
musculoskeletal system (vertebrae, facet joints, intervertebral discs, spinal ligaments and joint 
capsules) and the minor deep muscles of the back (80, 123, 124, 136). Decreased trunk proprioception 
(10) and muscle imbalance common in the presence of pathology (78) have the potential to alter
posture and balance, increasing the risk of falls due to loss of functional or dynamic stability (137).
Physical activity plays an important role in maintaining the size and quality of the abdominal and
MF muscle of older adults (138). Age-related decreases in physical activity have the potential to
affect these muscles through changes in the biochemical composition of muscle fibres and the
loss of muscle mass due to the removal of the trophic stimulus of the activity leading to
sarcopenia (20). Associations between abdominal and MF muscles and measures of physical
activity will be examined in Chapter 7 of this thesis.
1.2.8 Age-related changes in skeletal muscle, including muscles of the trunk 
With increasing age, skeletal muscle undergoes changes to its morphology, function, fibre type 
and quantity, innervation and composition (139). Many of these changes are modest and occur 
progressively until the age of 50 years, but then become more pronounced after the age of 60 
years (139). Upper and lower limb skeletal muscle mass peaks in early adulthood (11, 19) and 
gradually declines by 30% between the ages of 20 and 80 years (48). Abdominal muscle size 
decreases between 23-48% in older women living independently when compared with younger 
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controls (138). Age-related declines in skeletal muscle size match closely declines in muscle 
strength, especially after the age of 60 years. It is thought that decreases in skeletal muscle size 
occur as a consequence of decreases in the number of muscle fibres, and although this decline 
occurs equally for type I (slow twitch, fatigue resistant) and type II (fast twitch, responsible for 
muscle power) fibres, there is a greater decrease in the size of type II muscle fibres with 
increasing age (138).  
Along with decreases in muscle fibres, the two key elements contributing to the age-related 
decreases in muscle mass and strength are reductions in the number of functioning motor units 
and a decrease in muscular endurance, or the ability to resist muscular fatigue (45, 139). As the 
number of functioning motor neurones decrease with ageing, the remaining motor units increase 
in size, so that every remaining motor neuron innervates a greater number of muscle fibres, 
which has been explained as an age-related process of denervation of muscle (139). Age-related 
denervation of skeletal muscle is associated with loss of motor units and loss of muscle fibres, 
contributing to declines in strength and power and increases in muscle wasting, including muscle 
of the trunk in older adults (45, 139). An age-related decrease in muscular endurance, or the 
decrease ability to resist muscular fatigue is thought to be linked to a decrease in neural drive 
(139). In the case of the lower limbs and muscles of the trunk, this is reflected in a decline in the 
ability to activate muscles to adjust posture and centre of gravity following external disturbances, 
increasing the risk of falls (138-143). The decline in type II fibres, a decrease in functioning motor 
units, an increase in muscular fatigue and a decrease in mechanical stimuli due to decreased 
physical activity, may help to explain the progressive difficulties older adults experience 
performing daily activities and the increase in falls after the age of 60 years.  
Another of the significant age-related changes in skeletal muscle are increases in intramuscular 
fat infiltrations and connective tissue, resulting in decreases in contractile muscle mass (65). The 
obvious consequence of increases in noncontractile tissue in skeletal muscle is the increased cost 
of carrying inert mass during daily activities. Increased intramuscular fat infiltrations also have 
the consequence of increased macrophages that mediate the release of  pro-inflammatory 
cytokines/chemokines (TNF-a, IL-6, IL-1) and adipokines (leptin, adiponectin and resistin) that 
have the potential to have detrimental effects on skeletal muscle (age-related anorexia) (139) and 
insulin sensitivity (144). Increased intramuscular fat infiltrations in paraspinal muscles is 
associated with reduced functional capacity, increased risk of falls and self-reported measures of 
physical function (145, 146). 
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1.2.9 The role of trunk muscles in walking 
Walking requires a disturbance of the trunk’s balance which is sustained by the tonic action of 
the muscles of the trunk and pelvis while standing at rest (89). During walking, the pelvis 
experiences translational and rotational movements in different planes, and forces from the 
ground are transmitted to the lower limb and trunk, requiring a kinetic chain of actions by the 
muscles of the trunk that is far more complex than that at rest (89). Electromyography studies 
have described the electrical activity of muscles of the trunk during the gait cycle, reporting that 
the electrical activity of the erector spinae muscle group starts before heel strike, with maximal 
activation at heel strike (approximately 50% of the gait cycle) and then continuing to be active 
through the pre-swing phase (89, 132). The electrical activity of the MF muscle spans from the 12% 
- 90% of the gait cycle, being more active during heel strike. This electrical activity pattern is 
similar for the quadratus lumborum muscle (89, 132). The RA, EO and IO muscles show 
continuous electrical activity during the gait cycle (89, 147), with EO and IO sometime displaying 
intermittent activity towards the end of the gait cycle (89, 147). Increases in walking speed increase 
the electrical activity and the percentage of activation during the gait cycle of the abdominal and 
ES muscles, with these muscles displaying a more phasic electrical activity to provide stability of 
the trunk (89, 147).  
Gait pattern and activity of the trunk muscles and lower limb change with increasing age, that in 
turn, increases the risk and fear of falling in older adults (148). Older adults tend to walk slower, 
with shorter stride length, reduced co-activation of muscles of the trunk and reduced range of 
motion of the spine, trunk and lower limbs (149). Crawford et al. (149) reported that with increased 
walking speed, there was an increase in duration of activation in the deep MF, abdominal and ES 
muscles in older adults that was related to the increased work demand to maintain upright 
posture. However there was a decrease in activation of the superficial MF muscle along with 
decrease spine and trunk movement (149), which may help to explain the decrease in lumbar 
lordosis and kyphotic postures commonly seen in older adults (150). The changes in activation 
seen in the trunk muscles of older adults, have the potential to guide clinicians to design tailored 
exercise programs that have a walking component designed to increase activation of the muscles 
of the trunk. 
 
1.2.10 Muscles of the trunk and measures of physical function  
Functional autonomy depends on the complex interaction of four main dimensions, namely, 
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physical, social, emotional and cognitive function (151). Physical capacity or physical function 
refers to an individual’s ability to make normal use of his/her sensory-motor capabilities to 
undertake activities of daily living such as walking, climbing stairs or standing from a sitting 
position (151, 152). There are many scales and tests that have been developed to assess a person’s 
physical function such as the short physical performance battery and the timed up and go tests. 
However, these tests are mainly designed to test lower limb function. There are few studies 
addressing whether size, activation or muscle quality of the trunk muscles are associated with 
measures of physical function in older adults (138). The few studies investigating these 
associations have found that increased intramuscular fat infiltrations in paraspinal muscles is 
associated with reduced functional function, increased risk of falls and low scores in self-
reported measures of physical function, as well and being a predictor of poorer long-term 
physical function outcomes for older adults with low back pain (145, 146). The paucity of 
information on the effect of age-related changes in muscles of the trunk on physical function will 
be addressed in Chapter 3. 
1.2.6 Assessment muscles of the trunk in clinical practice 
Clinical approaches to assessing muscles of the trunk include measures of strength (e.g. 
isokinetic and isometric endurance muscle testing, dynamometry and clinical muscle testing 
(153)), measures of activation and fatigue (e.g. electromyography) and measures of morphology 
(e.g. ultrasound imaging). Standardised assessment tools that measure different aspects of trunk 
muscle morphology, function and performance are fundamental for clinical practice and 
research. Isokinetic and isometric endurance muscle testing, dynamometry and clinical muscle 
testing have been used extensively in clinical and research settings (153). As decreased muscle 
size and dysfunction with ageing are key features in sarcopenia, and there is a paucity of 
information on the effects these age-related changes have on the physical function (addressed in 
Chapter 3) of older adults, this thesis will focus on the morphology of invididual muscles to 
ascertain their individual and global contribution to normal function of older adults. Therefore, 
only modalities that allow assessment of individual muscles, i.e., electromyography and imaging, 
will be discussed in this section.  
Surface and intramuscular electromyography (EMG), an electrodiagnostic tools used to assess 
electrical activity in muscle, have been used to sense isometric muscle activity, refractory 
periods and calculate muscle activation patterns and joint compression forces, among others (123, 
124, 154-156). However, there are several limitations to this technique, particularly with the use of 
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intramuscular fine needle wires, because it is costly, uncomfortable and carries the risk of 
infection (157), which makes it difficult to use this particular technique outside research settings. 
Also, there does not seem to be an exact relationship between EMG signals and muscle force for 
either invasive or non-invasive EMG approaches (158, 159).  
Computed tomography (CT) and magnetic resonance imaging (MRI) have been used to assess 
trunk muscle thickness, cross-sectional area (CSA) and muscular moment arm (the shortest 
perpendicular distance from the line of force to the axis) for use in biomechanical studies (160, 161). 
MRI has been described as the “gold standard” measure for assessment of trunk muscles, 
because MRI images have excellent soft tissue contrast that enables clear demonstration of 
anatomy and allows accurate confirmation of spinal levels as well as making it possible to assess 
large muscles and multiple muscles at the same time (114, 162-164). CT scanning can also be used to 
measure muscle composition by measuring muscle attenuation (MA), a radiological 
characteristic that quantifies the macroscopic accumulation of intramuscular fat, with a higher 
attenuation score indicating less intramuscular fat accumulation  (138, 165). Increased fat 
infiltrations in skeletal muscle have been reported to be an indicator of poor muscle quality, and 
to be associated with decreased muscle strength (166, 167) and increased risk of hospitalization in 
older adults (168).  Both CT and MRI are expensive and not always readily accessible making it 
difficult to use these techniques in clinical settings or research studies. Also, CT exposes patients 
and research participants to ionising radiation. 
Real-time ultrasound imaging (USI) has been used to measure trunk muscle thickness, changes 
in muscle length, muscle timing and activation, CSA and to identify atrophy (122, 169-173). USI has 
also been used in clinical settings for the re-education of muscles (174), and visual biofeedback in 
rehabilitation (122, 175). USI has been increasingly used for the assessment of trunk muscles both 
for research and in clinical settings because it is safe, non-invasive, portable, patients are not 
exposed to ionising radiation and is relatively inexpensive (157, 176). However, some limitations of 
this technique include its limited field of view that makes it unsuitable for imaging large muscles 
(162).  
1.2.7 Validity and reliability of EMG and imaging techniques used to measure 
muscles of the trunk of older adults 
Establishing the reliability of measurements is essential to interpret outcomes and make clinical 
decisions based on research findings (177). Reliability has been defined as the extent to which 
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measurements can be consistently replicated (178, 179), while validity concerns whether the 
instrument used is accurate and it measures what it intends to measure (178). 
The trunk muscles investigated in this thesis included the RA, TrA, IO, EO muscles and the MF 
muscles. Studies in younger people have demonstrated the validity and reliability of a range of 
methods for measuring abdominal and MF muscles in this age group. Reliability measures of 
peak moment and normalised EMG values during submaximal contractions of MF and 
abdominal muscles have been reported to have good reliability (dependability coefficient 0.65 - 
0.88) (180). CT and MRI-based studies have reported high reliability (Intraclass Correlation 
Coefficient ICC>0.75) for measures of abdominal and MF muscle size and attenuation (145, 181-
184). The validity of USI has been examined in young adults; if strict protocols were followed, 
USI was as accurate as MRI in determining the size of MF (162). Reliability of measurement of 
abdominal and MF muscles using USI have been reported to be moderate to substantial 
(ICC=0.75-1.00) (177). 
The validity and reliability of methods established in younger people may not be similarly 
observed in older people for several reasons, including features of aging such as spinal 
degeneration, decreased water content in skeletal muscle and increased fat infiltrations and 
fibrous tissue content of skeletal muscle, which increase the difficulty of assessing ageing 
muscles (122, 185). Therefore, a comprehensive understanding of the performance of these methods 
in older people is important. The systematic review and narrative update in Chapter 3 addresses 
this gap in the literature by describing the validity and reliability of these measures in older 
adults. The study in Chapter 5 addresses the gap in test-retest reliability measures of abdominal 
and MF muscles using USI, identified in the systematic review in Chapter 3. 
1.2.8 Concluding Comments 
This section described the trunk muscles, particularly the abdominal and MF muscles, as postural 
muscles tonically active during daily upright activities and essential to perform fundamental 
functional activities of daily living due to the complex role they play in load transfer, force 
dissipation, control of balance and posture, and pelvic movement  (6, 8, 9, 77, 86, 132, 147, 186). It also 
discussed the actions of these muscles, their involvement in physical function, and the validity 
and reliability of measurements of abdominal and MF muscles using various EMG and imaging 
modalities. The systematic review in Chapter 3 addresses the paucity in information regarding 
the validity and reliability of measures of trunk muscles using EMG and imaging techniques by 
providing a synthesis of the literature on measures of validity and reliability of trunk muscles 
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using various imaging modalities and associations between trunk muscles and physical function 
of older adults 
In the next section, vitamin D will be discussed including production, prevalence of deficiency, 
aetiology and its role in skeletal muscle morphology, strength and physical function in older 
adults. 
1.3 VITAMIN D 
In Section 1.1, sarcopenia was described as an age-related process characterised by a generalised 
decrease in lean muscle mass, peripheral muscle size and the consequent loss of muscle strength 
and muscle function (16-18). In section 1.2, the essential role of muscles of the trunk was 
described, as well as the current gaps in knowledge. In this section, vitamin D and its effect on 
skeletal muscle will be discussed. Vitamin D deficiency is common in community-dwelling and 
institutionalised older adults and has the potential to impact on skeletal muscle, contributing to 
sarcopenia and affecting physical function (187). 
1.3.1 Introduction 
Population levels of serum vitamin D are variable around the world, but deficiency is common in 
older adults due to decreased production of vitamin D in the skin, insufficient dietary intake and 
decreased sun exposure due to decreased physical activity, mobility or institutionalisation (188-
191). This section will discuss vitamin D production, classification, prevalence and symptoms of 
vitamin D deficiency. The effects of vitamin D deficiency and supplementation on skeletal 
muscle size, mass and strength, and associations with measures of physical function will also be 
discussed.  
1.3.2 Vitamin D Production 
The molecules known as vitamin D are, in fact, not vitamins, but steroid hormones. Their active 
form (1,25-dihydroxyvitamin D) is primarily involved in the regulation of plasma calcium and 
phosphate levels which are essential for mineralisation of bone and the normal functioning of the 
nervous and muscular systems and hormonal secretion (192, 193). Humans obtain vitamin D by 
exposure to sunlight (Figure 1.12), from diet and supplements. Very few foods naturally contain 
vitamin D therefore in general food has a minor contribution to vitamin D levels (192). When the 
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skin is exposed to ultraviolet B radiation, naturally occurring 7-dehydrocholesterol in the skin is 
converted to pre-vitamin D3, which is immediately converted to vitamin D3 (Cholecalciferol). 
Any excess pre-vitamin D3 or vitamin D3 produced in the skin is destroyed by sunlight, thus 
preventing vitamin D intoxication (192). Over-the-counter supplements available are made by 
ultraviolet irradiation of ergosterol from yeast (D2 or ergocalciferol) or ultraviolet irradiation of 
7-dehydrocholesterol contained in lanolin (D3). 
   Figure 1.13 Vitamin D cycle  
 
Vitamin D cycle. Drawings: Rhiannon Arnold. Sources (192, 194-196) 
 
Vitamin D (D2 or D3) synthesised in the skin or acquired through diet is stored in fat cells and 
later released and circulated to the liver where it undergoes hydroxylation and converted to the 
still biologically inactive form 25-hydroxyvitamin D (25(OH)D or Calcidiol) (192). 25-
hydroxyvitamin D is the most abundant circulating form of vitamin D and is used to assess 
vitamin D status. 25-hydroxyvitamin D undergoes further hydroxylation in the kidneys where it 
is converted to the biologically active form 1,25-dihydroxyvitamin D (1,25(OH)2D or calcitriol) 
(192). The most critical role of 1,25-dihydroxyvitamin D is the tight regulation of extracellular 
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calcium and phosphate within the required limits to maintain homeostasis which is essential for 
the normal function of nerve and muscle (197).  
Vitamin D production is dependent on age, body mass index, sun exposure, time of day, latitude, 
the season of the year, geographical location and skin pigmentation. Serum 25(OH)D levels are 
lower in winter than summer as less vitamin D is synthesised in winter, especially in those who 
have dark skin, the elderly and those who dress with decreased potential for skin exposure to 
sunlight for cultural reasons or for sun protection (60, 198-200). Although older adults can 
photosynthesize pre-vitamin D3, ageing itself can substantially decrease the capacity to produce 
pre-vitamin D3 in the epidermis and dermis (58, 190, 201). Obese individuals produce about half the 
amount of vitamin D compared to non-obese individuals after sunlight exposure (60).  
1.3.3 Classification of vitamin D status 
The vitamin D status of an individual can be classified into vitamin D adequacy, mild deficiency, 
moderate deficiency and severe deficiency according to their serum 25(OH)D level (table 1.2). 
Vitamin D adequacy is defined as serum 25-OHD concentration above 50 nmol/L. In the state of 
adequacy, vitamin D has no adverse effect on skeletal homeostasis and 50 nmol/L is considered 
the minimum target level for adequate bone health, mineral homeostasis and muscle function (191,
193, 200).  
Table 1.2  Classification of vitamin D status (200) 
Vitamin D status Serum 25-OHD levels 
Vitamin D adequacy  ≥ 50 nmol/L 
Vitamin D mild deficiency   30 - 49 nmol/L 
Vitamin D moderate deficiency  12.5 - 29 nmol/L 
Vitamin D severe deficiency     < 12.5 nmol/L 
1.3.4 Vitamin D deficiency - prevalence 
Population levels of serum vitamin D are variable, but deficiency is highly prevalent all over the 
world, particularly in Asia and the Middle East. In Australia, approximately 31% of adults have 
serum 25-hydroxyvitamin D below the minimum 50 nmol/L and it may be as high as 50% for 
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women living in the southern states during the winter months (200). The most common groups at 
risk of vitamin D deficiency include young children, pregnant women and older adults (191). 
Vitamin D deficiency is common in older adults with reports of 30-90% of older aged adults 
recording deficiency (188-191, 198, 202-205). In Australia, the groups of people most at risk of 
developing vitamin D deficiency include the elderly, people in residential care, dark-skinned 
people and people who have limited sun exposure (Table 1.3).  Some reports estimate the 
number of people with vitamin D deficiency or insufficiency to be 1 billion worldwide (192, 205, 
206). Low vitamin D levels have been described as endemic in North America, Europe, the 
Middle East, Africa and South Asia (55, 199, 204, 207, 208). In the United States (US), the prevalence of 
vitamin D deficiency has been reported to be 10 times higher in African-American than 
Caucasian older women (204).  
Table 1.3 Adult groups at high risk of vitamin D deficiency (200) 
a) Older or disabled people in low-high level residential care 
b) Dark-skinned people of either sex 
c) People with a disability or chronic disease 
d) Fair-skinned people who avoid skin exposure 
e) Obese people 
f) People working in enclosed environments 
 
1.3.5 Vitamin D deficiency symptoms in older adults  
The common clinical symptoms of vitamin D deficiency in the elderly include symmetrical 
proximal muscle weakness, particularly in the lower limbs, associated with a feeling of heaviness 
in the legs, easy fatigability, increased medio-lateral body sway, hyperreflexia and difficulty 
climbing stairs or rising from a chair (53-61).  
Mild vitamin D deficiency leads to hyperparathyroidism and high bone turn over (198). Moderate 
vitamin D deficiency has been associated with decreased bone density, increased bone turn over 
and the risk of hip fracture in older adults (198). Finally, severe vitamin D deficiency has a 
significant effect on calcium homeostasis, bone mineralisation and skeletal muscle metabolism, 
resulting in osteomalacia in adults (198, 200).   Patients with severe deficiency can present with 
bone and muscle pains, weakness and pseudofractures (58, 192, 198, 200). 
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1.3.6 Vitamin D and its role in skeletal muscle size, mass and strength  
Vitamin D plays a vital physiological role in normal skeletal muscle function, muscle 
development and growth (59, 209). The mechanism is thought to be through 1,25(OH)2D binding to 
a specific vitamin D receptor found in skeletal muscle (54, 210) leading to de novo protein synthesis 
and thus muscle cell proliferation and growth (59, 211). Vitamin D regulates muscle phosphate and 
calcium transport across sarcolemma membranes. It influences intracellular calcium levels in the 
muscle cell and contributes to the general calcium homeostasis in the body (61, 212-215). The main 
functions of vitamin D on muscle are listed in table 1.4 
Table 1.4 Main functions of vitamin D on muscle (60) 
a) Increases amino acid uptake in muscles 
b) Alters phospholipid metabolism in muscles 
c) Vitamin D deficiency causes myopathy 
d) Nongenomic effects on muscles 
e) Increases troponin C in muscles 
A systematic review and meta-analysis of 17 RCTs examining the effect of vitamin D 
supplementation on muscle strength revealed that vitamin supplementation had no significant 
effect on grip strength (8 studies, standard mean difference (SMD) -0.02), proximal trunk muscle 
strength (latissimus dorsi, trapezius, rhomboid muscles) (1 study, SMD -0.23) or lower limb 
strength (8 studies, SMD 0.01). However, 4 studies reported positive effects of vitamin D 
supplementation on grip strength and lower limb strength in participants with baseline 25(OH)D 
≤ 25 nmol/L (206). A more recent systematic review and meta-analysis of 30 RCTs examined the 
effect of vitamin D supplementation on peripheral muscle strength, mass and power (216). There 
was great variation in the vitamin D supplementation doses in the studies included in this review 
(300 – 8600 IU/day). Pooled results from 19 studies (2349 people) revealed a small but 
statistically significant positive effect of vitamin D supplementation on lower limb muscle 
strength (SMD 0.19). Participants with 259(OH)D was ≤30 nmol/L obtained greater benefit than 
those with 25(OH)D ≥30 nmol/L (p=0.02). However, the pooled results from studies 
investigating the effect of vitamin D supplementation on grip strength (16 studies), muscle mass 
(6 studies) and power (5 studies) showed no statistically significant effect of vitamin D 
supplementation on these measures (216). The evidence from these systematic reviews on the 
effect of vitamin D supplementation on upper and lower limb muscles seems conflicting. 
Nevertheless, in both cases, subjects with baseline serum 25(OH)D ≤30 nmol/L obtained greater 
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and positive effect of vitamin D supplementation on peripheral muscle strength. It is important to 
note that there were no studies investigating the effect of vitamin D supplementation on muscles 
of the trunk, more specifically, muscles that are prime torque producers such as the abdominal, 
erector spinae or MF muscles, included in these systematic reviews. Although the muscles 
assessed by Stockton et al. (206) are located in the trunk region, they are anatomically considered 
muscles of the upper limb as they received innervation from the anterior rami of cervical nerves 
and providing attachment of the shoulder girdle to the back and movement the upper limb are 
their primary functional roles. Therefore, studies investigating the effect of vitamin D on the 
size, mass, quality and strength of muscles of the trunk are needed (this will be examined in 
Chapter 6). 
1.3.7 Vitamin D and its role in physical function 
In a systematic review and meta-analysis, Muir et al. (217) reviewed 13 studies investigating the 
effect of vitamin D supplementation on gait, balance and quadriceps muscle and grip strength in 
older adults (60 years of age and older). In these studies, the baseline serum 25(OH)D ranged 
from 24.46 to 65.7 nmol/L, and supplementation doses ranged from 400 to 3000 IU/day. The 
SMD from these studies comprising 207 participants was -0.20 (95% CI = -0.39 to -0.01, P = 
.04), indicating a decrease in postural sway. Increased postural sway has been shown to be 
positively associated with balance and risk of falling (62). Studies in which the participants were 
given doses of 800 to 1000 IU per day reported beneficial effects on lower limb muscle strength 
(SMD=0.05, 95% CI = -0.11 to 0.20). Three studies comprising 274 participants, reported 
improvements in time to complete the timed up and go test (TUG). The TUG test is a reliable 
and valid test that has been found to be positively associated with balance and functional 
mobility (218, 219). No statistically significant effect of vitamin D supplementation on gait was 
found (217).  
1.3.8 Concluding Comments 
The literature reviewed in this section described the different classifications of vitamin D status, 
the prevalence of vitamin D deficiency and the effect of vitamin D supplementation on muscle 
size, muscle strength and functional capacity. The evidence from RCTs indicate that although 
vitamin D supplementation does not have a positive effect on upper or lower limb muscle 
strength, mass or power in subjects with serum 25(OH)D ≥30 nmol/L, there is a small, but 
significant positive effect on these muscles in subjects with 25(OH)D ≥30 nmol/L at baseline, 
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especially those who are older or in care institutions. The potential effects of vitamin D 
deficiency on muscles of the trunk and the effect of vitamin D supplementation on the size, 
strength or quality of these muscles have not been examined.  
1.4 Summary 
Sarcopenia is an age-related process characterised by a generalised decrease in lean muscle 
mass, peripheral muscle size and the consequent loss of muscle strength and muscle function 
(13-15). There is some evidence that ageing has a detrimental effect on muscles of the upper and 
lower limbs. However, the effect of ageing on muscles of the trunk is not fully understood. 
Although it would be reasonable to assume that the age-related changes described in peripheral 
muscle mass and strength for upper and lower limbs would be present in the muscles of the 
trunk, the potential effects these changes have in physical activity, physical function, quality of 
life and healthy ageing have not been established and should be investigated.  
The reliability of EMG and imaging measures of the abdominal and MF muscles in older adults 
is not well established. The reliability of measurements of abdominal and MF muscles is 
essential to interpret outcomes and make clinical decisions based on research findings (177). 
Finally, evidence from RCTs indicate that vitamin D supplementation may have a significant 
positive effect on muscles of the upper or lower limbs in subjects with 25-OHD ≥30 nmol/L at 
baseline, especially those who are older or in care institutions. However, the potential effects of 
vitamin D on muscle of the trunk have not been examined. The gaps in knowledge outlined in 
this chapter have directly informed the research questions of this work and will be discussed in 
the following chapter.                                                                
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2.1 Research question 1 
Upper and lower limb muscles decrease in size, isokinetic strength and percentage of type I 
fibres with increasing age (48). These changes have been shown to be associated with decreases in 
physical function and quality of life of older adults (12, 152, 220). However, there is little 
information regarding the changes in size that muscles of the trunk undergo with age and the 
effect these changes may have on the physical functioning of older adults. Research question 1 
investigates the evidence for changes in function, composition and morphology of the muscles of 
the trunk and the effects of any changes on the physical function of older adults. It also 
investigates the evidence for the validity and reliability of measures of individual trunk muscle 
using EMG or imaging. 
2.1.1 What evidence is there for changes in mass, strength, power, muscle composition/fat 
infiltrations and size and shape of the abdominal and MF muscles and the effects of any 
changes on the physical function of older adults?  
2.1.2 What is the validity and reliability of measurements of abdominal and MF muscles 
among older adults.  
A systematic review will be conducted to: 
a. Provide a summary of the evidence for changes in function, composition and morphology 
of the abdominal and multifidus in adults aged 50 years and older. 
b. Provide a summary of the evidence for the effect any composition or morphology 
changes in the abdominal and multifidus have on the physical function of adults aged 50 
years or older. 
c. Document the validity and reliability of electromyographic and imaging measurements of 
abdominal and multifidus muscles among adults aged 50 years and older. 
Research questions 2 – 4 are defined in a volunteer sample of people that were part of The 
Vitamin D Effect on Osteoarthritis (VIDEO) study. The VIDEO study was a randomised, 
placebo-controlled and double-blind clinical trial conducted between June 2010 and December 
2013 (221). Participants were people aged 50-79 years, with symptoms of knee OA for at least six 
months with pain levels between 20-80 mm on a 100 mm visual analogue scale, and serum 
25(OH)D levels between 12.5 and 60 nmol/L.  Exclusion criteria included: severe knee pain or 
OA, conditions affecting oral drug absorption and surgery.  
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2.2 Research questions 2 
The reliability of measurements of abdominal and MF muscles is essential to interpret outcomes 
and make clinical decisions based on research findings (177).  
2.2.1 What is the test-retest reliability of ultrasound imaging for assessing abdominal and 
MF muscle thickness and MF CSA at the L2 - L5 vertebral levels in people aged 50-79 years 
with symptoms of knee osteoarthritis. 
2.3 Research questions 3 
Although there is RCT evidence that indicate that vitamin D supplementation may have a 
significant positive effect on muscles of the upper or lower limbs, the potential effects of vitamin 
D on muscle of the trunk have not been examined.  
2.3.1 What is the effect of 12 months of vitamin D supplementation compared with placebo, 
on morphology and function of the abdominal and MF muscles of adults aged 50 to 79 years 
with low serum 25(OH)D levels. 
2.4 Research questions 4 
Age-related changes in muscles of the upper and lower limbs are well documented, as well as the 
effect of these changes on physical function. However, there is limited information regarding 
age-related changes in the abdominal and multifidus muscles and the potential effect these 
changes have on physical activity, physical function and quality of life.  
2.4.1 Are there associations between abdominal and MF muscle size and muscle function and 
measures of physical activity, physical function and quality of life among older adults? 
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CHAPTER 3. THE ASSESSMENT OF ABDOMINAL AND 
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3.1 Prelude 
Chapter 1 described trunk muscle anatomy, their actions and the potential for ageing to affect 
these muscles and cause deterioration in physical function in older adults. Furthermore, it found 
that the validity and reliability of methods of assessment for abdominal and MF muscles 
established in younger people may not be similarly observed in older people. Features of ageing 
such as spinal degeneration, increased intramuscular fat infiltrations, increased fibrous tissue 
content and decreased water content of skeletal muscle, increases the difficulty of assessment of 
ageing muscles (122, 185) . This chapter has two parts.  Firstly, it reproduces the text of a published 
systematic review to provide holistic picture of the current state knowledge on abdominal and 
MF muscles and their assessment in older adults. Secondly, the last part of this chapter provides 
a narrative update of relevant literature published subsequent to the last search date of the 
systematic review i.e. May 2013. The following text in this chapter up to page 43 (Authors 
contributions) has been published in the journal Physiotherapy; Cuellar W, Wilson A, Blizzard 
C, Otahal P, Callisaya M, Jones G, et al. The assessment of abdominal and multifidus muscles 
and their role in physical function in older adults: a systematic review. Physiotherapy. 
2017;103(1):21-39.  2017, 103:21 – 39 (138). This journal has an impact factor of 3.12 and the 
paper has been cited in 7 publications. 
3.2 Introduction  
The muscles of the trunk are essential for normal functional activities such as walking and are 
involved in the control of balance and posture (8). Research on the influence of low back pain 
(LBP) on these muscles forms the basis of rehabilitation and motor control programs used by 
physiotherapists to address alterations in the function of these muscles (222).  Research has 
focused on the abdominal (internal oblique (IO), external oblique (EO), rectus abdominis (RA) 
and transversus abdominis (TrA)) and lumbar multifidus muscles (MF), but predominantly in 
younger adults. While physical capacity, skeletal muscle mass and strength (5) deteriorate with 
age (sarcopenia), the age-related changes of trunk muscles and the impact of such changes are 
poorly understood.  A comprehensive summary of the current literature is critical to guide 
current clinical practice aimed at reducing age-related losses in physical function and to identify 
evidence gaps for future research.   
Electromyography (EMG), ultrasound imaging (USI), computerised tomography (CT) and 
magnetic resonance imaging (MRI) are commonly used to assess trunk muscle activation, 
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morphology and function.  EMG assesses muscle activation patterns which are associated with 
muscle function (223). USI, CT and MRI assess muscle morphology, including thickness and 
cross-sectional area (CSA), which are associated with the amount of force an individual can 
develop (224). CT and MRI can also evaluate muscle composition, which includes muscle density 
or muscle attenuation (MA). Muscle attenuation is a radiological characteristic used to quantify 
macroscopic accumulation of intramuscular fat (muscle quality). The greater this accumulation, 
the lower the attenuation score in Hounsfield units (HU) (165). 
The validity and reliability of trunk muscle measurements using EMG and imaging techniques 
have been reported for younger populations(177, 180), a variety of factors may affect reliability for 
older adults. The presence of LBP, chronic disease, increases in water content and intramuscular 
fat accumulation as well as technical issues such as repositioning of the patient for scanning, 
muscle activation sequences and rate of imaging have the potential to affect reliability of 
imaging(122). Concerns regarding the reliability of EMG measures due to problems with task 
standardization, “out-of-plane” movements and normalization of EMG signals, have also been 
documented (180).  It is therefore important to determine the validity and reliability of these 
measures specifically for older adults.   
The first aim of this systematic review was to provide a summary of the evidence for changes in 
function, composition and morphology of the abdominal and MF muscles and the effects of any 
changes on the physical function of older adults.  The second aim was to document the validity 
and reliability of measurements of abdominal and MF muscles among older adults.  
3.3 Methods 
3.3.1 Literature search 
A systematic literature search was conducted on PubMed, CINAHL, EMBASE and The 
Cochrane library databases as detailed in supplementary file 2 (Appendix 7). 
Inclusion/exclusion criteria: 
Studies were included if they: 
 Were an observational study or randomised controlled trial assessing abdominal or MF 
muscles. 
 had at least 80% of participants ≥50 years old, or data for ≥50 year olds could be 
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extracted from published results. 
 Used EMG, USI, CT, or MRI to assess abdominal (RA, EO, IO or TrA) or MF muscles. 
 Reported: 
o validity/reliability or descriptive data for any those muscles, and/or 
o associations of muscle measures with measures of physical function (excluding 
bodily functions such as micturition, coughing, sneezing and defecation), and/or 
o associations of muscle measures with other factors including but not limited to age, 
sex, serum vitamin D, medical conditions and medications. 
Studies of post-acute abdominal or post-acute back surgery, animals and cadavers were excluded. 
3.3.2 Data collection and analysis 
Two reviewers (WAC and TMW) independently screened all titles, abstracts and if required full-
text articles for inclusion, with differences resolved by consensus. Two reviewers (WAC and 
AW) independently extracted data from included studies, with a third reviewer (TW) available to 
adjudicate any disagreements but this was not needed. Data extracted were participant 
characteristics (age, body mass index (BMI), gender, ethnicity) and study characteristics 
(number of participants, inclusion/exclusion criteria, study design, trunk muscles measured, 
assessment method, adjustment for confounders and study setting). Information on measures of 
validity/reliability and results of any associations tested between the muscles of interest and 
other factors were extracted as outcomes.  
3.3.3 Assessment of methodological quality of studies 
Methodological quality was assessed independently by two reviewers (WAC and AW) by an 
established approach for systematic reviews of observational studies on musculoskeletal topics 
(225) modified as appropriate for our topic. Twenty-three criteria assessed internal validity and 
informativeness of the studies (Supplementary file 3) (Appendix 8). Each criterion was assessed 
as met (+), not met (-) or unclear (?) based on the descriptions given in Supplementary file 4 
(Appendix 9). Studies with a score >60% were considered to be high quality (225). 
3.3.4 Best evidence synthesis  
The marked methodological heterogeneity of the included studies precluded meta-analysis, so a 
best evidence synthesis was undertaken. As the first step, studies were grouped according to the 
condition or population studied, namely healthy older adults and participants with a specific 
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spinal condition (as described in the individual studies e.g. vertebral fracture or lumbar 
degenerative kyphosis, and in which LBP was not the primary outcome measure), non-specific 
low back pain, stroke and other conditions. Studies reporting reliability were also grouped 
together. Synthesis was performed separately for each of these groups.  
The level of evidence was determined using the criteria of Lievense and colleagues (225): strong 
evidence - generally consistent findings in multiple high-quality cohort studies; moderate 
evidence - general consistent findings in one high quality cohort study and 2 or more high 
quality case-control studies or in three or more high quality case-control/cross-sectional studies; 
limited evidence – general consistent findings in a single cohort study, in one or two case-control 
studies or in multiple case-control/cross-sectional studies; conflicting evidence - <75% of the 
studies reported consistent findings; no evidence - no studies found. Reliability was categorised 
as per  Shrout (226) (≤0.10 = virtually none, 0.11–0.40 = slight, 0.41–0.60 = fair, 0.61–0.80 = 
moderate, and 0.81–1.0 = substantial). 
3.4 Results 
Of 2176 potential references, 395 were excluded as duplicates, and 1326 were excluded from 
abstract and title. A further 427 articles were excluded after full text review, leaving twenty eight 
included articles (Figure 1) (122, 135, 145, 181, 183, 184, 186, 223, 227-246).   
3.4.1 Characteristics of included studies 
Sixteen cross-sectional and eleven case-control studies, and one longitudinal observational study, 
were included (Table 3.1). Fourteen studies used EMG to measure trunk muscle motor activity, 
reflex latencies, muscle fatigue and postural responses. Six used USI to measure muscle 
thickness and CSA, two used MRI to measure CSA, and six used CT to measure CSA, muscle 
density and MA. Twelve studies were of healthy adults, five were of participants with spinal 
conditions, three were of participants with LBP and six were of participants after stroke. There 
were single studies of people with Parkinson’s disease and with hip osteoarthritis. The number of 
participants ranged from 3 to 1194 (median = 27) and mean ages ranged from 50 to 88 years. 
Twenty-two studies (79%) were scored as high quality (Supplementary File 5) (Appendix 10). 
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3.4.2 Best evidence synthesis  
3.4.2.1 Measures of reliability 
There was limited evidence that abdominal or MF muscle CSA, density or attenuation of older 
adults can be reliably measured with CT. There was limited evidence that MF muscle CSA can 
be reliably measured with MRI. There was limited evidence that abdominal muscle thickness can 
be reliably measured with USI. There was no evidence of the reliability of EMG measures, 
abdominal muscle measurements using MRI, MF measurements using USI or of the test-re-test 
reliability or validity of any modality. 
Moderate to substantial intraclass correlation coefficients (ICCs) were reported for CT 
measurements of abdominal muscle CSA and attenuation and USI measurements of muscle 
thickness (ICCs ranged from 0.75 - 1.00, Table 3.2). Reliability of CT measurements of MF 
muscle density and CSA, and MRI measurements of CSA, was also moderate to substantial (ICC 
= 0.70 - 0.99). One USI study reported a Pearson correlation of r = 0.948 for intra-observer 
reliability of RA and EO muscle thickness (243), but this is not a recommended reliability 
measure. One CT study reported a coefficient of variation of less than 5% for measurements of 
CSA and MA of the EO, IO and MF muscles at the L4-5 vertebral levels (145). Most reliability 
measures were obtained from stored images of healthy participants (145, 181, 183, 238, 243, 245), but one 
study involved participants with spinal conditions (184).
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Table 3.1 Characteristics of participants and studies 
Author  
Country       
Year 

























**Incl: Participants from larger 
Framingham Heart Study families, 
residents of Greater New England area, 
men ≥35 y.o., women ≥40 y.o., weight 
< 320 pounds 
Excl: Participants with only 1 parent in 
the Framingham Heart Study with a 
father <55 y.o. or a mother <65 y.o. 
59.4(14.6)  (M)                       
58.1(13.3) (F) 
NS 51 NS 
Cross 
Sectional 














78.6(2.7) (M)         
78.4 (3.3) (F) 
28.4 (4.1) (M)           













14 (“up to” 20)          
34 (21-50)                       
3 (>50) 
NS 69 NS 
Cross 
Sectional 












Incl: ≥50 years of age. Asymptomatic or 
LBP> 8 moths 
Excl:  LBP associated with known 
pathology, spinal fracture or surgery. 
Previous spinal fracture. MSK, CR, or 
Neuro conditions, dizziness, pain or 
recurrent falls. 
68.7 (3.5) 27.2 (3.5) 60 NS 
Cross 
Sectional 









Incl: healthy volunteers ≤30 y.o. 
younger group and  ≥60 y.o. for elderly 
group 
26.7 (3.3) Y                       
63.1 (2.7) O 
NS 53 NS 
Cross 
Sectional 




Excl: Young: Hx of Trunk muscle or 
bone disease, LBP, spinal surgery. 
Excl: elderly: Unstable physical 
condition, Hx of spinal or lower limb 





22.1 (2.3) Y 
20.5 (3.2) IE 




RA, EO, IO, 
TrA, LM 




Incl: Old: 68-82 years of age. 
Young: 19-31 years of age 
Excl: Old: Hx of Neuro or MSK 
disorders. Young: NS 
22.6(4.4) Y                        
73(5.7) O 





IO, LM EMG NS NS 8/14 57 
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Author  
Country       
Year 

























Incl: Participants in good physical 
condition. 
Excl: Hx of disabling low back injury, 
recent recurrent pain 
69(3.5) NS 42 NS 
Cross 
Sectional 
RA, EO, IO, 
LM 




Incl: middle-aged long distance runners 
and untrained individuals. 
† 61.4(3) High            
62.9 (2.7) Inter           
61.4 (2.8) Low 
21.8 (1.8) High         
22.7 (2.4) Inter         




RA, EO USI 
Height, length 
of extremities 




Incl:  Healthy physically active women 
Excl: History of trunk or lower 
extremity surgery or Neuro impairment, 




58 (4.5) MA       
70.6(2.6) YO      
79.7(2.6) OO 
NS 0 Japanese 
Cross 
Sectional 









Incl: Healthy aging adults                   
Excl: LBP, history of abdominal, spinal 
or lower limb surgery. Respiratory or 
neurological disorders. Structural 
scoliosis, urinary incontinence, 
BMI>30, pacemaker, Mini Mental State 
Exam <24, severe OA. 
72(9.36) 25.9 (2.96) 25 NS 
Cross 
Sectional 





Excl: Hx of Neuro, neuromuscular, 
rheumatological or systemic disease.  
Pregnancy, medication which may 
affect muscle size, any skin condition or 
wound in the area to be scanned. 
Lifetime LBP interfering with ADL's. 
Lifetime Hx of spinal fractures, lumbar 
surgery, scoliosis or spondylolisthesis 
L4                               
40.1 (13) 
Male, 34.2 
(12.8) Female                                               
L5                                    
39 (13) 
Male                  
31 (11.7) Female 
L4                               
25.8 (3.2) Male 
23 (3.1) Female             
L5                                    
25.7 (2.9) Male                  
22.3 (2.2) 
Female 
L4  43          




LM USI NS NS 10/14 71 






Excl:  NS 
68.4 (6.7)  














**Incl: Participants from larger 
Framingham Heart Study families, 
residents of Greater New England area, 
men ≥35 y.o., women ≥40 y.o., weight 
< 320 pounds 
54.4(9.3)  LBP                          
52.2(11.1) 
NLBP 
28.7(5.5) LBP        
27.6(4.9) NLBP 
49 







age, sex, BMI 
NS 12/14 86 
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Author  
Country       
Year 
























**Excl: Participants with only 1 parent 
in the Framingham Heart Study with a 
father <55 y.o. or a mother <65 y.o. 
50-59 n=55 
60+   n=36 
NS 58 NS 
Cross 
Sectional 




Incl: PT: Patients with Lumbar 
degenerative kyphosis (LDK) who 
underwent corrective surgery from 
1997 -2003. 
Incl: Controls: Mechanical chronic LBP 
with or without disc protrusion 
Excl: Controls: LDK, isthmic 
spondylolisthesis, spinal fracture, 
tumour, infection, Hx of previous 
surgery or presence of lumbar scoliosis 
exceeding 10 degrees 
60.19(5.89) PT                   
60.15(6.23) 
Controls 










Incl: PT: Surgery for Lumbar spinal 
stenosis (LSS) with Degenerative 
lumbar scoliosis (DSL) 
Incl: Controls: Surgery for LSS without 
DSL                                 Excl: 
adolescent idiopathic scoliosis, previous 
lumbar surgery, pyogenic scoliosis, or 
vertebral fracture in the lumbar spine. 
70.2(7.3) 











MF MRI NS Hospital 14/16 86 





Incl: 50 y.o. or older and LBP>8/12 for 
LBP group                             Excl: LBP 
associated with unknown pathology, 
radicular syndrome or cauda equina, 
spinal fracture, surgery or nonspecific 
LBP 
61.4 (9.8) CLBP        
64.9 (8.8) NLBP 
26 (6.6) 










Incl: 70-79 y.o. no difficulty walking 
1/4 mile, walking up 10 steps or 
performing ADL's. no cancer or plans 
to move  from area for 3 years 
73.72 (2.88) 
NLBP      
73.6(2.82) LBP 
27.32 (4.58) 



















Community 16/19 84 
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Author  
Country       
Year 
























Incl: PT: motion induced intermittent 
LBP (MILBP) 
Controls: No Hx of LBP or sciatica 
Excl: NS 
75.7(5.14) 











RA, ES EMG NS Hospital 8/14 57 




Incl: PT: Communicative, “clear-
minded” patients with hemiparesis or 
hemiplegia following a single unilateral 
stroke 
Incl: Controls: Healthy controls 
Excl: Sensory or motor deficiencies 
unrelated to stroke 
74.2 (9.9) 
PT                         
67 (9.6) Controls 
NS 
54 













Incl: PT: a-hemiparesis (or plegia) 
following first unilateral stroke in the 
territory of the middle cerebral artery, 
b- sufficiently stable physical health 
condition to participate in study c- able 
to sit without support. 
Incl: Controls: Healthy controls 
Excl: cognitive or communication 
deficits Neuro or MSK disorders 
unrelated to stroke. 
72 (9) 



















Incl: PT: hemiparetic patients 
Incl: Controls: Healthy controls 
72(9) 
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Author  
Country       
Year 
























Incl: PT: hemiparesis due to first 
ischemic stroke 
Incl: Controls: community dwelling 
individuals free of Neuro or MSK 
disorders that could interfere with side 
rolling 
Excl: aphasia, previous Neuro or 
orthopaedic disorders limiting 
performance of side rolling. 
71.9(5.8) 















Incl: PT: post unilateral stroke 
Hemiparesis, Ashworth scale spasticity 
1-4, Bartel index >85, able to ambulate 
with or without assistance 
Incl: Controls:  individuals matched by 
sex, age, height and weight, free of 
Neuro symptoms                            Excl: 
neurological syndromes preventing 
them from participating in the study 
58.7(9.3) 




PT                     
24.8 Controls 
75 










Incl: Unilateral stroke, able to walk 
alone or with help. MAS score 1-3 and 
able to perform exercises. 
Incl: Controls: Healthy controls 
Excl: Neuro or MSK disorders 
unrelated to stroke, obesity or cognitive 
deficits 
57.5(8.5) 
PT                        
58.7(9.7) 
Controls 















Incl: PT: unilateral or bilateral  Hip OA 
Incl: controls: Healthy women without 
hip OA 
Excl: Hx of limb or back surgery, 
symptoms affecting knees, ankles or 
back. RA vestibular, central or 
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Author  
Country       
Year 
























Incl: PT: Parkinson's disease (PD)          
with painful abdominal contractions 
(PAC). 
Incl: Controls: PD without PAC 
Excl: multisystem atrophy, another 
atypical parkisonian syndrome, non-
reducible spine flexion and large vessel 
disease, infarction or tumour on cranial 
MRI 
77 and 80 Pat              
Age-matched 
controls 






RA CT NS NS 3/17 18 
Chapter 3. Abdominal and multifidus muscles – Systematic review      55 
 
Table 3.2 Reliability measures 
Author Assessment 
Modality Measurements tested Reliability Coefficients 
Reliability  
Type 
Anderson 2013 CT 
CSA EO, IO, MF taken at L3 





Hicks 2005 CT 
Muscle CSA and attenuation at level L4-L5 EO, IO, MF CV<5% Not stated 
Kalichman 2010 CT 
Density of MF at levels L3-L5 
Density of MF at levels L3-L5 
ICC = 0.94-0.99 
ICC = 0.70 – 0.97 
Intra-observer 
Inter-observer 
Kang 2007 MRI 
CSA MF taken at level L4-L5 ICC = 0.89 – 0.92 Intra-observer 
Shafaq 2012 MRI 
CSA MF, spinal level at which image was taken was not specified 
CSA MF, spinal level at which image was taken was not specified 
ICC = 0.98 
ICC = 0.97 
Intra-observer 
Inter-observer 
Oguri 2004  USI  
Muscle thickness RA taken 3 cm distal to and right of the umbilicus 
Muscle thickness EO taken 10 cm on the "diagonal rear" of iliocostalis 
r = 0.948 
r = 0.948 
Intra-observer 
Intra-observer 
Stetts 2009 USI 
Muscle thickness EO, IO, TrA transducer placed in a transverse plane halfway between 
ASIS and the lower rib cage, along the axillary line 
 
Muscle thickness EO, IO, TrA transducer placed in a transverse plane halfway between 
ASIS and the lower rib cage, along the axillary line 
 
ICC = 0.95-1.00 
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3.4.2.2 Evidence in healthy adults 
There was limited evidence for a detrimental association between age and abdominal or MF 
muscle morphology (MA, thickness or CSA) in healthy adults, although not all studies were 
consistent (Table 3.3). Data for RA, EO and IO were most consistent,  with significantly smaller 
RA (27-38%), EO (23-47%) and IO (26-48%) muscles in healthy independent older women 
compared to younger controls (186, 244) and these muscles being smaller with increasing age(227). 
Abdominal muscle MA was also, 33% lower in adults ≥75 years compared with younger 
controls (30-50 years) (181).  Associations of age with MF and TrA were less consistent. In most 
studies age-related differences in muscle thickness or CSA were small or not statistically 
significant for the TrA (12-23%) and MF (12%) muscles (122, 186, 244) but MF MA was 51% lower 
in adults ≥75 years compared with younger controls (30-50 years) (181) and age was associated 
with smaller MF CSA in one study (227).  
There was conflicting evidence to support an association between age and EMG measures of 
abdominal muscles.  Hwang et al. reported a 45% decrease in reflex latency of the MF muscle of 
older compared to younger adults when sudden loads were applied to the upper limbs (235). 
Hanada et al. found lower muscle activation of abdominal and MF muscles during hip/knee 
movements by older adults than in normative data from younger adults (233). Caix et al. reported 
much lower abdominal muscle motor activity among older than younger adults during 
contralateral axial twisting of the trunk (229). Contrary to those studies, McGill et al. reported 
higher motor activation of abdominal muscles among older adults during movements of the trunk 
(242), and Kai et al. found no differences between activation of the IO and MF muscles of older 
and young adults controls when moving from a two-leg to a one-leg standing position(237).  
There was conflicting evidence for an association between abdominal or MF muscle measures 
and physical activity (PA).  Oguri et al. found no difference in thickness of the rectus abdominis 
muscle in endurance compared to untrained men (243). Conversely,  in other studies individuals 
with higher levels of physical activity had better muscle quality (181) and, at the extreme end of 
inactivity, chronically bedridden female nursing home residents had greater declines in muscle 
thickness in abdominal (~33%) and MF (~2%) muscles compared with independent residents 
(186). No studies in healthy adults investigated associations between trunk muscle measures and 
any aspect of physical function included in this review (see inclusion criteria). 
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3.4.2.3 Participants with spinal conditions 
There was limited evidence for an association between spinal conditions and detrimental changes 
in MF muscle morphology or muscle activation. Nevertheless, some evidence of a detrimental 
effect was found in every study of both muscle morphology and muscle activation (Table 3.4). 
MF muscle activation was delayed in older adults with osteoporotic vertebral fractures (228). MF 
muscle CSA was decreased by 36% in older adults with lumbar degeneration (183). Similarly, 
Shafaq et al. reported decreases of MF muscle CSA on the concave side of older adult patients 
with degenerative lumbar scoliosis (10-22%)  and on the affected side of patients with lumbar 
spinal stenosis (15-20%) with increases in muscle fat infiltrations in both populations (184). 
Kalichman et al. reported associations of age and moderate to severe facet joint osteoarthritis 
with low MF density (238) and an association between increased lumbar lordosis and low MF 
density (239).  
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Table 3.3 Studies of healthy older individuals 
Author Factors tested Results Statistical methods Summary 
Anderson         
(USA 2012)                 
CT (227) 
RA, IO, EO and MF CSA at  Levels   
L2-L5 and association with age, sex 
and body mass 
Among 36-87 year olds, abdominal and MF muscle CSA was 
negatively associated with sex and age and positively associated with 
body mass. The regression models explained 52-65% of RA, 20-64% of 
EO, 36-63% of IO and 22-39% of MF CSA variability. 
Linear regression 
Muscle CSA is smaller for women, older 
subjects, and those of lesser weight 
Anderson          
(USA 2013)              
CT (181) 
Muscle attenuation (MA) of 
abdominal and MF muscles and 
association with age, sex and PA 
At L3 level: MA was lower among adults ≥75 years old (-15.9(1.07) 
HU, P<0.001) compared with adults 30-50 years and lower in women (-
6.9(0.46) HU, p<0.001) compared with men. There was a significant 
association between PA and low MA (effect sizes not reported) 
ANOVA, linear 
regressions, ANCOVA 
RA, EO, IO and MF muscle attenuation was 
lower among older adults, women and people 
with decreased physical activity. 
Caix                   
(France 1984)           
EMG (229) 
Abdominal muscle motor 
performance according to age, sex, 
mass and physical activity 
Compared with the younger group ("up to 20" y.o.), the older group 
(>50 y.o.) showed decreased motor activity of RA in tonus (19%), 
posture (66%) and movement (98%). The flat abdominals showed 
decreased motor activity in tonus (64%), posture (80%) and movement 
(97%). 
Not stated 
Abdominal muscle activation was lower for 
participants 50 years or older 
Hanada             
(Canada 2008)              
EMG (233) 
Abdominal and MF muscle 
response to change in load 
During hip/knee flexion/extension exercises, abdominal muscles 
activation amplitudes varied according to level (1-3) of difficulty (15% 
- 34% of max voluntary isometric contraction (MVIC)). Muscle 
activation amplitudes of MF was less than 10% MVIC and there were 
little changes between levels of difficulty (7(3)% - 7(3)% MVIC) 
None 
Among healthy adults (65-80 years), 
abdominal muscle activation amplitudes were 
low to moderate, depending on the level of 
exercise difficulty. There is low MF muscle 
activation irrespective of level of exercise 
difficulty. 
Hwang              
(Korea 2008)              
EMG (235) 
Reflex latencies, flexion movement 
and flexion moment of the trunk 
and association with age and upper 
limb loading 
During UL sudden loads: significant age-related delay of multifidus 
reflex latency during expected loads (mean=-26.08, 95% CI -42.45 - -
9.71 ms, p=0.0026.  
ANOVA 
Age-related delay in multifidus muscle reflex 
activation and trunk flexion movement in 
response to sudden loading 
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Author Factors tested Results Statistical methods Summary 
Ikezoe              
(Japan 2012)                
USI (186) 
Abdominal and MF muscles of 
elderly women and association with 
age and inactivity 
A significant decrease in muscle thickness of RA (36%, 51%), EO 
(40%, 66%) and IO (48%, 57%) in independent and chronic bedridden 
elderly women correspondingly, was found compared with the young 
women group. A significant decrease in muscle thickness of TrA 
(52%),  MF (30%) was found only in chronically bedridden elderly 
women compared with the young women group 
ANOVA and Mann-
Whitney U-tests 
Age-related muscle atrophy was smallest for 
the deep trunk muscles (TrA and MF) of 
elderly women. Chronically bedridden elderly 
women had greater decrease in all trunk 
muscle thickness compared with independent 
elderly. 
Kai                    






Muscular activity of left IO and MF 
while moving from two-leg 
standing to one-leg standing in 
healthy elderly (n=5) compared 
with young (n=8) subjects 
Higher levels of muscle activity were observed in IO and MF in the 
young person group, compared with the healthy elderly group. 
However, the differences were not statistically significant in this small 
sample. No effect sizes were reported. 
Mann-Whitney U-test 
No significant difference in IO or multifidus  
muscle activation between young and older 
adults during the two-leg standing to one-leg 
standing task 
McGill               
(Canada 1999)    
EMG (242) 
RA, EO and IO muscle activation 
and association with age and trunk 
movement 
RA, EO and IO muscle activity was greater in the elderly group 
compared with a young control group during the flexion (p=0.0001) 
and lateral bending (p=0.0001) tasks, but not the axial twisting (p>0.05) 
task. No effect sizes were reported 
Unclear 
 
Greater abdominal muscle activation during 
trunk flexion and lateral bending tasks among 
elderly subjects, compared with younger 
subjects  
Oguri                 
(Japan 2004)    
USI (243) 
RA and EO muscle thickness and 
association with running training 
levels 
Ra muscle thickness was not significantly correlated (r=0.326) with 
weekly training distance. No significant difference was found between 
mean RA muscle thickness of high level (7.09 mm), intermediate (6.3 
mm) or untrained groups (6.3 mm). EO muscle thickness results were 
not reported. 
ANOVA, Tukey's post hoc 
test, Pearson correlation. 
There was no significant difference in RA 
muscle thickness among older men despite 
differences in running training levels 
Ota                    
(Japan 2012)     
USI (244) 
RA, EO, IO and TrA muscle 
thickness and association with age 
Muscle thickness (mm) was significantly smaller in older subjects for 
RA (27 (16) % to 38(20) % p<0.01), EO (23(13) % to 46(17) % 
p<0.05)) and IO (26(17) % to 47(18) % p<0.05)), compared with young 
controls. There was no significant age effect on TrA (19(17)% to 
23(25)% p>0.05)) 
ANCOVA, ANOVA, 
Tukey’s post hoc test 
Age-related decrease in RA, IO and EO muscle 
thickness. Non-significant decrease in TrA 
muscle thickness 
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Author Factors tested Results Statistical methods Summary 
Stokes               
(UK 2005)      
USI (122) 
CSA and shape of multifidus and 
association with age 
Significant difference in MF shape ratio (AP/Lat) at L5 between the 20-
29 y.o. (0.89(0.11)) and the 50-69 y.o. (1.12(0.14)) male groups 
(p=0.0001). No significant age-related change in CSA of MF and no 
significant differences of MF symmetry between age groups. However, 
specific data from the 50-69 age group was not provided. 
t-test 
Significant difference in shape of multifidus 
between young and older adults. No significant  
difference in MF CSA or symmetry at L4 and 
L5 levels 
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3.4.2.4 Participants with LBP 
There was limited evidence for an association between MF muscle attenuation and LBP, 
conflicting evidence for an association between alterations in abdominal or MF muscle 
activation and LBP and limited evidence supporting there being no association between muscle 
size and LBP (Table 3.5).  
Longitudinally, trunk MA but not muscle area was positively associated with physical functional 
capacity assessed by the Health ABC Physical Performance Battery (145), with a stronger 
association for people with than without moderate to severe LBP. (145). Results from the two 
EMG studies were mixed. Bilateral muscle activation was lower in the RA  and higher in the MF 
muscle with some side differences in IO muscle activity during gait, for older adults with non-
specific chronic LBP compared with controls without LBP (234). Takahashi et al. reported no 
differences in RA muscle fatigue with mechanical loading among older women with “motion-
induced intermittent LBP” compared with controls (246). 
3.4.2.5 Participants after stroke 
There was conflicting evidence for an association between alterations in abdominal muscle 
activation and stroke.  All studies of patients after stroke used EMG and results were inconsistent 
(Table 3.6). Comparing the affected to the non-affected side, some studies reported no difference 
in symmetry index between groups of patients with hemiparesis and healthy controls or side 
differences for activation of the RA(135, 231, 236) or EO muscles (230, 236). Others found either 
decreased (135, 231) or increased (223, 241) RA and EO muscle activity on the affected side, during 
movements of the trunk or hip joint. 
3.4.2.6 Other studies 
Only single studies examined associations between abdominal muscle thickness and hip 
osteoarthritis and painful abdominal contractions among patients with Parkinson’s disease (Table 
3.5).  Patients with hip osteoarthritis had 3-6% thinner abdominal muscles compared with 
healthy controls (232). Kataoka et al. reported greater RA thickness for two patients with 
Parkinson’s disease affected by painful abdominal contractions, compared with controls without 
painful contractions (240). 
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Table 3.4 Studies of participants with spinal conditions 
Author Factors tested Results Statistical methods Summary 
Briggs    
(Australia 2007)           
EMG (228) 
Associations between vertebral 
fracture and paraspinal muscle 
recruitment of subjects with 
osteoporosis 
The time to initiate postural response differed between the non-
fracture (epoch 4 = 50-25 ms before deltoid onset) and fracture 
(epoch 5 = 25-0 ms before deltoid onset) groups. 
 t-tests, Mann-Whitney U-
test, ANOVA, Sharpened 
Bonferroni post hoc test 
Paravertebral muscle activation is delayed among 
older adults with osteoporotic vertebral fractures 
Kalichman   
(USA 2010)           
CT (238) 
Associations between different lumbar 
spine degenerative features and 
density of the MF muscle 
Density of MF decreases with age (p<0.0001) in people with spinal 
degeneration features (50-59 y.o. 32.8% of subjects and >60 y.o. 
68.8% of subjects). Moderate to severe facet joint OA was associated 
with decreased density of multifidus (odds ratio 3.68, CI 1.36 - 
9.977). 
Chi-square test,  t-test, 
Cochrane-Armitage trend 
test, logistic regression  
Significant association between  LBP and presence 
of facet joint OA and decreased density of 
multifidus 
Kalichman  
(USA 2011)                  
CT (239) 
Associations of CT-evaluated lumbar 
lordosis and density of multifidus 
After adjusting for age, sex and BMI, lumbar lordosis angle was 
positively associated (p<0.05) with density of multifidus (odd ratio 
1.06, 95% CI 1.01 - 1.11) 
t-test, linear regression,  
logistic regression 
Lumbar lordosis angle positively associated with 
density of multifidus 
Kang                           
(Korea 2007)         
MRI (183) 
Paraspinal muscle wasting of lumbar 
degenerative kyphosis (LDK) patients 
compared with chronic low back pain 
(CLBP) patients 
MF muscle CSA was smaller (36.3%, p<0.0001) in the LDK group 
compared with the CLBP group 
ANOVA, logistic 
regression, Chi-square test 
Older adults with lumbar degenerative kyphosis 
had significantly smaller MF muscle CSA, 
compared with CLBP patients 
Shafaq             
(Japan 2012)        
MRI (184) 
Muscle degeneration of patients with 
lumbar spinal stenosis (LSS) with and 
without degenerative lumbar scoliosis 
(DLS) 
In the DLS group CSA of MF was smaller on the concave side L3-5 
(CI 51.79 59.21 p=0.035), L4-5 (CI 60.52 70.48 p= 0.008) and L5-S1 
(CI 72.70 82.10 p=0.0001). In the LSS group with unilateral 
radiculopathy CSA of MF was smaller on symptomatic side L4-5 (CI 
61.37 70.02 p= 0.007) and L5-S1 (CI 75.40 84.00 p= 0.001). 
Increases in fat infiltrations in both populations ranging from 2% to 
28.3% in the lower spinal levels 
Mann-Whitney test, Chi-
square test, paired t–test, 
Pearson correlation 
Smaller MF CSA on concave side of DLS patients 
and on the affected side of LSS patients with 
unilateral radiculopathy. increases in fat 
infiltrations in both populations at all spinal levels 
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Table 3.5 Studies of participants with low back pain and other studies 
Author Factors tested 
 
Results 
Statistical methods Summary 
Hanada            
(Canada 2011)           
EMG (234) 
RA, IO and MF muscle activation 
amplitudes during gait and association 
with low back pain 
Compared with the control group, the LBP group: had lower 
muscle activation levels of their RA on the right (4% MVIC, 
P<0.001) and left (7% MVIC, p<0.001) sides, MF muscle activation 
was greater on the right (10% MVIC) and left (5% MVIC). 
Significant activation differences were observed in right IO 
depending on the phase of gait they were measured and left IO muscle 
activation levels were not significantly different. 
t-test, ANOVA, Tukey’s 
post test 
Depending on the phase of gait, there were 
altered RA, IO and multifidus muscle activation 
levels of older adults with low back pain (LBP) 
during gait 
Hicks                 
(USA 2005)                      
CT (145) 
Longitudinal associations between 
trunk muscle composition, back pain 
(LBP) and physical function 
Trunk muscles MA lower but muscle area was similar in those with 
compared to without severe LBP). Abdominal and paraspinal muscle 
attenuation was a significant predictor of composite functional scores 
(β=0.006, p<0.01). Significant interaction between trunk muscle 
attenuation and back pain status in predicting physical function for 
no/mild pain group (β=0.005, p=0.043) and moderate/extreme pain 
(β=0.011, p=0.011) 
Linear regression, t-tests 
Positive longitudinal association between 
abdominal and paraspinal muscle attenuation, back 
pain status and physical function among older adults 
with low back pain. No interaction between trunk 
muscle CSA and back pain status. 
Takahashi       
(Japan 2007)                      
EMG (246) 
Effect of mechanical load on RA 
muscle fatigue 
RA muscle fatigue was not induced in either controls (-5.3(12.3) MPF 
(%/min), 95% CI -14.09 - 3.49) or low back pain group (-1.5(15.0) 
MPF (%/min) between 30-60 seconds after loading, 95% CI -12.23 - 




No significant changes in RA muscle fatigue with 
loading in older participants with LBP or those 
without LBP 
Other Studies 
Fukumoto         
(Japan 2012)   
USI (232) 
Abdominal muscle thickness and 
association with hip osteoarthritis 
Compared with healthy controls, abdominal muscles in the OA group 
were: RA 6%, IO 5% and TrA 3% thinner. However, EO was thicker 
by 12%. These differences were of no statistical significance in this 
small sample group 
Mann-Whitney U-test 
No significant difference in abdominal muscle 
thickness, except for EO, between individuals with 
hip OA and healthy individuals 
Kataoka           
(Japan 2012)     
CT (240) 
Activation and muscle thickness in 
Parkinson's patients with painful 
abdominal contractions (PAC) 
Constant hypertonic activity and greater muscle thickness (mm) of 
RA (48% L4 and 49% L5 vertebral level) in the 2 patients with PAC 
compared with 14 controls. 
Not stated 
Constant hypertonic activity was demonstrated in 
the rectus abdominis muscle of Parkinson’s subjects 
with painful abdominal contraction 
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Table 3.6 Studies of participants after stroke  
Author Factors tested Results Statistical methods Summary 
Dickstein           
(Israel 2000) 
EMG (230) 
Bilateral activity of RA and EO 
muscles during basic symmetrical 
movements and association with 
hemiparesis 
No significant difference in muscle activation of RA (0.85(0.1) - 
0.81(0.2), p>0.05) or EO (0.71(0.1) - 0.64(0.2), p>0.05) between 
healthy and hemiparetic subjects. No significant difference in muscle 
activation RA (0.66(0.15) - 0.63(0.21, p>0.05) or EO (0.71(0.13) - 
0.59(0.28), p>0.05) between the paretic and non-paretic sides 
ANOVA, t-test 
No differences in RA or EO muscle activation of 
hemiparetic subjects compared with healthy 
individuals 
Dickstein           
(Israel 2004a) 
EMG (231) 
Function of RA and EO in 
voluntary trunk movements and 
association with stroke 
Lower RA and EO muscle activation latency in patients compared with 
controls (F(1,69) =3.96, p<0.05).  In the patient group, SI of the RA 
muscle was significantly lower -17(30) % (concentric), -15(35) % 
(eccentric) compared with the control group 2(22) %, -1(22) %. SI of 
EO between patients and controls was not significant. 
ANOVA, t-test 
Impairment of rectus abdominis muscle function 
on paretic side and also EO to a lesser degree 
Dickstein          
(Israel 2004b) 
EMG (135) 
RA and EO muscle activation and 
association with hemiparesis 
No significant differences in RA anticipatory muscle activation 
between hemiparetic and control subjects or between sides on 
hemiparetic subjects. Reduced EO muscle activation on the hemiparetic 
side (F(1,74) = 4.6, p<0.04). Significant difference in symmetry 
activation of EO on the paretic side of patients compared with 
corresponding side of controls (t(74) = 4.84, p<0.0001). No significant 
difference in RA SI between groups. 
ANOVA, linear regression 
No difference in anticipatory muscle activation 
for RA. Reduced EO muscle activation on 
hemiparetic side. 
Kafri                 
(Israel 2005) 
EMG (236) 
EO muscle activation during side 
rolling from supine lying position 
and association with hemiparesis 
In hemiparetic subjects, symmetry index of EO muscle activation on 
the paretic side, was comparable or lower -0.22(0.22) than the non-
paretic side 0(0.24), but not significantly different 
Paired t-test 
Among post stroke patients, EO muscle 
activation symmetry was comparable between 
paretic and non-paretic sides when rolling from 
supine to side lying 
Marcucci           
(Brazil 2007) 
EMG (241) 
RA and EO muscle behaviour and 
association with hemiparesis 
During MVIC there were no statistically significant differences in the 
muscle activation of RA or EO between the paretic RA (73.97(27.65) 
µV, EO (69.9(13.0) µV and control RA (52.44(6.16) µV, p=0.46), EO 
(97.46(25.7) µV, p=0.36) groups. However, during the hip flexion task 
the muscle activation level of RA in the hemiparetic  group  was higher 
(p=0.031) than the control group (hemiparetic group (59(31)% of 




Hemiparetic subjects showed increased RA and 
muscle activity during hip flexion task 
Pereira               
(Brazil 2011) 
EMG (223) 
RA and EO muscle activation and 
association with hemiparesis 
RA muscle activation was higher on the paretic side during leg 
elevation (p=0.035, Cohen's d=0.94), during lower trunk rotation 
(p=0.017 d=0.85) and during non-paretic side trunk rotation (p=0.005, 
d=1.22). EO muscle activation was higher on the non-paretic side 
during trunk flexion (p=0.019, d=0.75) 
 t-test, Mann-Whitney test, 
Shapiro-Wilk test, 
Wilcoxon test, MANOVA, 
Box M test, f test, Tukey’s 
post-hoc test 
Hemiparetic subjects showed increased RA 
muscle activity during leg elevation, lower trunk 
rotation and contralateral trunk rotation. EO 
activation was higher on non-paretic side during 
trunk flexion 
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3.5 Discussion 
This systematic review provides a comprehensive assessment of the current literature 
investigating trunk muscles in older people. Overall, the evidence base has significant 
limitations, but the available data highlight four key points. Firstly, measurement of stored 
images of abdominal and MF muscles of older adults can be performed with moderate to 
substantial reliability using various imaging modalities. Secondly, ageing and possibly decreased 
physical activity appear to have detrimental effects on the morphology of abdominal and MF 
muscles. Thirdly, a variety of spinal conditions adversely affect the activation and morphology 
of MF but LBP appears to mainly affect MA, which in turn affects physical function. Lastly, the 
effects of stroke on the abdominal and MF muscles and implications for physical function and 
rehabilitation have not been established.  
Consistent evidence was found that measurement of CT, MRI or USI images of older adults’ 
abdominal and MF muscles can be performed with moderate to substantial reliability. Studies of 
USI test-retest reliability were lacking during the timeframe of our search, but subsequent studies 
have reported “good-to-excellent” test-retest reliability for muscle thickness at L4-L5 of older 
adults with and without LBP (247, 248). Thus, overall, current data are consistent with previous 
reports of reliability of measurements of younger adults, especially for USI (177), and support the 
use of these modalities in both research and clinical settings.  Conversely, until the reliability of 
EMG in older adults is assessed, this modality is of unknown utility.   
The differences in thickness of abdominal muscles in older compared to younger adults reported 
in this review  (36% - 48% between 20-86 years and 38% - 47% between 21-80 years, excluding 
TrA in both cases) (186, 244) are consistent with previously reported estimates of decreases in  
upper and lower limb muscle CSA with age of 1% per year after age 50 years and in muscle 
mass of 30% between the ages of 20 and 80 years (48).  The absence of age-related differences in 
TrA and MF muscles (122, 186, 244) may be due to their tonic activation and spinal stabilising role, 
which require them to be active at low levels when in upright positions to counteract the effects 
of gravity and postural changes during most activities of daily living (132). In contrast, the more 
superficial muscles, which have a greater role in torque generation may be influenced by lifestyle 
factors or clinical and sub-clinical disease. Strategies to maintain trunk muscles may need to be 
tailored to different muscles. 
 The potential influence of physical activity on abdominal and MF muscles has been 
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demonstrated in the extreme case of chronically bedridden nursing home residents (186), studies 
of healthier older adults (181) and in studies of subjects during prolonged bed rest (249) but not in 
the thickness of RA in endurance vs untrained men (243). The latter were a small group of 
relatively active older men (for example undertaking hill walking and golf) which could explain 
this lack of difference. Overall, the results suggest that physical activity plays an important role 
in maintaining the size and quality of the abdominal and MF muscle of older adults. These 
findings have clinical significance because physical activity decreases with ageing and older 
adults are more likely to undergo periods of bed rest due to injury or illness (18). Future research 
investigating the effects of maintaining physical activity in older adults and rehabilitation of 
trunk muscles after prolonged bed rest is needed. There is also a significant evidence gap on the 
role of trunk muscles in maintaining long-term physical functioning of older adults. 
There was limited, but consistent evidence for an adverse effect of various spinal conditions on 
activation, attenuation and CSA of the MF muscle (183, 184, 228, 238, 239). Clinically, this suggests that 
motor control and other rehabilitation programs used by physiotherapists to target MF muscles 
may also be useful for older adults affected by spinal conditions. It is less clear if this is also the 
case for non-specific LBP, though longitudinal data (145) do suggest deterioration in the quality of 
the MF muscle in the presence of LBP. Furthermore, there was a significant longitudinal 
association between abdominal and paraspinal MA and greater physical function deficits, with 
stronger associations seen for participants with moderate-extreme LBP, but with no associations 
with muscle size. It may be that muscle quality rather than quantity is important functionally in 
older adults. Although strength and endurance exercise programs specifically targeting trunk 
muscles have been devised (222, 250), their effectiveness for reducing intramuscular fat 
accumulation and improving muscle quality is not established. Future studies investigating this 
could lead to improved exercise programs for improving physical capacity of older adults, 
especially those with LBP. 
Reports of abdominal muscle activation from studies of patients after stroke were conflicting. 
This may be due to the diversity of EMG measures used, the diversity of clinical presentations 
associated with stroke and movements tested. As we report, reliability of EMG measures in the 
elderly has not been reported and if low could also contribute to the conflicts between studies. It 
is possible that addressing trunk muscle function may have clinical relevance for rehabilitation 
but substantial further research is required.  In particular, the lack of investigation of the effects 
of stroke on abdominal and MF muscle size and quality is an evidence gap that requires further 
research if we are to understand what role, if any, these muscles have in stroke rehabilitation. 
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3.6 Limitations  
We were unable to undertake meta-analysis because the studies were too heterogeneous to pool.  
However, we performed a systematic review with a best evidence synthesis to maximise the 
robustness. Not all studies clearly separated age groups when reporting (122), so there has been 
some minor mixing of data for adults younger than 50 years.  Many studies were small (64% had 
≤40 participants) and only one was a longitudinal study, which limits the strength of evidence for 
the review findings. The review was limited to muscle outcome measures assessed with EMG or 
imaging and does not address the full spectrum of procedures in which muscle structure and 
function can be assessed. 
3.7 Conclusion 
Overall, the evidence examining EMG and imaging measures of trunk muscles in older people 
has significant limitations, and the role of physiotherapy interventions aimed at these muscles 
remains unclear.  The results suggest areas in which further research could lead to clinically 
useful outcomes.  These include determining the role of the trunk muscles in the physical 
function of healthy older adults and in those with disease, in particular stroke; developing and 
testing rehabilitation programs for older people with spinal conditions and LBP; identifying 
modifiable factors that could mitigate age-related changes, including physical activity and testing 
whether exercise programs can reduce intramuscular fat accumulation in trunk muscle of older 
adults.  
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3.9 The assessment of abdominal and multifidus muscles and their role in physical 
function in older adults: a systematic review - update 
3.9.1 Update to April 2018 
This section summarises additional relevant studies published since the search date of the 
systematic review (May 2013) and discusses how these additional data relate to our systematic 
review findings and contribute further to our understanding of trunk muscles in older adults. For 
ease of comparison, the studies have been grouped in the same categories as in the published 
review, i.e. measures of reliability, studies of healthy older adults, studies of participants with 
spinal conditions, studies of participants with low back pain and other studies. There is no update 
on studies of participants after stroke as no new studies in this area appear to have been 
published.  
3.9.2 Measures of reliability 
The evidence from the systematic review suggested that measurements of abdominal and MF 
muscles of older adults can be made with moderate to substantial reliability, using CT, MRI and 
USI. It also identified some key gaps including the lack of studies of USI test-retest reliability, 
the lack of studies reporting the reliability of abdominal and MF muscle measurements using 
EMG and the lack of studies reporting the validity of abdominal and MF muscle measurement 
using any modality. For this update, studies reporting reliability and validity of measurements of 
abdominal and MF muscles using imaging modalities were grouped by assessment method: CT, 
MRI and USI and are summarised in Table 3.7.  
Among the studies in this update, estimates of reliability of abdominal and multifidus muscle 
measurements of CSA and attenuation from CT images ranged from moderate to substantial 
(ICC = 0.78-0.99) (251-255), and coefficient of variation were 0.2% for CSA and 0.4% for muscle 
attenuation (256). Similarly, estimates of reliability for measures of MF muscle CSA and 
attenuation from MRI images ranged from moderate to substantial (ICC = 0.78-0.99) (257-262) and 
intra-observer correlation for MF CSA measurements was Pearson’s r=0.612 (263). The results 
from these studies support the findings of our systematic review and provide further support for 
our findings of consistent evidence that in older adults, assessment of MF muscle size and 
attenuation using CT and MRI can be accomplished with moderate to substantial reliability. 
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Studies investigating the reliability of abdominal and multifidus muscle measurements using USI 
included participants with and without LBP and assessed reliability for both experienced and 
novice operators. The estimates of reliability ranged from fair to substantial (ICC 0.55 – 0.98) 
(247, 248, 264-266) (Table 3.7). An evidence gap identified in the systematic review was the lack of 
test-retest reliability studies for measurements of trunk muscles in older adults. Since 2013, four 
new studies have been published reporting fair to substantial ICCs for test-retest reliability for 
the measurement of abdominal and MF muscles of older adults at different spinal levels, using 
USI. In three of these studies, estimates of reliability for measurements of MF muscle thickness 
at the L4/L5 spinal level range from moderate to substantial (ICC 0.69 – 0.99) (247, 248, 265) and 
moderate to substantial (ICC = 0.70-0.98) for the measurement of the transversus abdominis 
muscle (265). The fourth test-retest reliability study is part of this thesis and is described in full in 
chapter 5.  This study was in older people with knee osteoarthritis and uniquely provided a 
comprehensive assessment of intra-observer test-retest reliability for measurement of the rectus 
abdominis, transversus abdominis, internal oblique and external oblique muscles and MF 
thickness at spinal levels L2-L5, as well as CSA of MF at spinal levels L2-L5. Reliability was 
substantial (ICC > 0.81) for all measures except for intra-observer test-retest reliability for the 
measurement of MF muscle thickness at spinal levels L2-L5, which was fair to substantial (ICC 
= 0.55-0.86) (264). Overall, the findings of these studies are in line with the systematic review and 
extend the evidence for reliability of measurements of abdominal and MF muscles using USI to 
people with LBP. They also show that measurements of abdominal and MF muscles can be 
reliably performed by a novice operator. 
Another important evidence gap highlighted in the systematic review was the lack of validity 
studies for any modality of muscle measurements of older people. This has been addressed in a 
single study, in which criterion validity of USI compared with MRI, for the assessment of MF 
CSA at the L4 spinal level was evaluated in 20 adults aged 60-85 years with and without chronic 
LBP (267). Agreement between USI and MRI was substantial (ICC=0.90-0.97) for the assessment 
of single images of participants with LBP and for the average measure of 3 images in both 
participants with and without LBP (ICC= 0.95-0.99). Agreement was lower for single images of 
participants without LBP (ICC= 0.48-0.86) (267). The findings from this study complement those 
of the systematic review and other studies in this update, supporting the use of USI as a valid and 
reliable tool for the assessment of abdominal and MF muscles of older adults in research and 
clinical practice.  
 
Chapter 3. Abdominal and multifidus muscles – Systematic review       71 
   



















Abbas et al. 
 2016 (251) 









MF taken at L3 
CSA 




























Banno et al. 
2017 (252) 






























Katzman et al. 
2014 (255) 







taken at L4/L5 
ICC ≥ 0.98  
ICC  ≥ 0.96 
Intra-observer 
 inter-observer 



















Chapter 3. Abdominal and multifidus muscles – Systematic review       72 




















































taken at L5 
ICC=0.92 Inter-observer 


















Sions et al. 
2016 (262) 


































Ni Mhuiris et al. 
2016 (259) 














Chapter 3. Abdominal and multifidus muscles – Systematic review       73 































MF taken at 
L2-L5 
Abdominals 
ICC ≥ 0.90  
ICC ≥ 0.97 
MF          
ICC ≥ 0.96 
 ICC ≥ 0.86 
Intra-observer 
Inter-observer 


































































































Chapter 3. Abdominal and multifidus muscles – Systematic review       74 
   
3.9.3 Evidence in healthy older adults 
Evidence from the systematic review highlighted an age-related decrease in abdominal muscle 
thickness ranging from 36% to 48% between the age of 20 and 86 years. In this update, two 
studies provide further evidence that ageing has a detrimental effect on the morphology of the 
trunk muscles. In a cross-sectional study of 796 Japanese community-dwelling adults with and 
without LBP, with a mean age of 63.1 years, Sasaki et al. (261) used MRI to assess paraspinal 
muscle fat infiltrations and CSA. In this study, men had significantly larger MF muscle CSA 
than women at all lumbar spinal levels and older age was associated with smaller MF CSA and 
greater fat infiltrations, with a larger effect size in participants with LBP. Similarly, a 15-year 
study of 99 monozygotic twins (aged 62.3 at follow up) (268) described decreases in MF muscle 
CSA at L3-L4 and L5-S1 spinal levels and statistically significant age-related increase in MF fat 
infiltrations at both spinal levels. The data in these two studies support the finding in the 
systematic review and importantly, add valuable longitudinal data to the evidence base for 
detrimental effects of age on abdominal and MF muscles. This information is relevant to clinical 
practice where strategies to maintain abdominal and MF muscles may be included in 
rehabilitation programs. 
In this update, the evidence for the potential influence of physical activity on abdominal muscles 
identified in the systematic review has been highlighted and further expanded to the MF muscles. 
In a study of 281 adults aged 61-71 years, Azuma et al. (167) reported that smaller paraspinal 
muscle CSA and lower muscle attenuation (increased fat infiltration) were associated with 
radiographic knee osteoarthritis (RKOA). Also, that females (with or without RKOA) who 
exercised on a regular basis had greater abdominal muscle CSA and decreased paraspinal muscle 
fat infiltrations compared with females who did not exercise regularly. Contrary to these 
findings, decreased maximal walking speed was not associated with MF muscle thickness, in a 
cross-sectional study of 35 women aged 56-91 years (269). Fortin et al. (268, 270) reported findings 
from two separate studies using data from the 15-year longitudinal Twin Spine Study of 
monozygotic twins. While the 15-year analysis showed no associations between level of physical 
activity for work or leisure and age-related changes in MF muscle size or composition (268), a 
separate analysis of the same data reported significant associations between less demanding jobs 
and increased side to side MF asymmetry at the L3-L4 spinal level, but not the L5-S1 level (270).  
Although the evidence for an association between decreased physical activity and MF muscle 
thickness or composition is not clear, the associations with abdominal muscle size are consistent, 
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making it relevant to clinical practice as adults tend to decrease their physical activity with 
increased age and are more likely to endure prolonged periods of bed rest due to illness. 
One of the gaps in knowledge identified in the systematic review was the lack of studies 
assessing associations between trunk muscle measures and measures of physical function in 
healthy older adults. Results from a study of 174 community-dwelling adults, with a mean age of 
82 years (271), indicated that increased abdominal and paraspinal muscle size was associated with 
increased incidence of falls as well as increased anterior-posterior (AP) motion and velocity and 
increased mediolateral (ML) motion, which are indicative of decreased balance and increased 
risk of falls. Plausible explanations for these results may be that trunk muscles size is only 
partially representative of muscle strength, or that greater weight is associated with both 
decreased balance and increased muscle size (271). Another important finding from this study was 
that decreased abdominal and paraspinal muscle fat infiltrations were associated with decreased 
incidence of falls and decreased AP and ML velocity and motion (271). These results seem to 
indicate that trunk muscle attenuation may be a more important aspect than muscle size for 
balance.  
Finally, the evidence from EMG based studies in this update appear to be as conflicting as those 
described in the systematic review. In a study of 49 adults with a mean age 78.2 (272), there were 
significant associations between trunk muscle extension strength and muscle attenuation and 
electrical impedance myography, independent of muscle size. This was a small pilot study with 
small effect sizes that limited the clinical relevance of the findings. In another study investigating 
the effect of a 4-week balance exercise program on static balance of 16 women with a mean age 
46.9 years (273), there was a significant decrease in EMG activity in the RA, but not in other 
abdominal or back muscles examined, despite overall improvements in balance (273).  
3.9.4 Participants with spinal conditions 
In the systematic review there was limited, but consistent evidence for an adverse effect of spinal 
conditions on the activation, attenuation and CSA of the MF muscles. The studies include in this 
update provide further evidence for a detrimental effect of spinal conditions such as Lumbar 
spinal stenosis (LSS), degenerative scoliosis and adult spinal deformity (ASD) on the MF 
muscles and added new information of the effect of spinal conditions on physical function. In a 
retrospective study of 62 older adults with unilateral symptoms of LSS, MF muscle infiltrations 
at the L4/5 spinal level were greater in older patients with LSS and in those with poorer 
functional performance as measured by the Japanese Orthopaedic Association Score (274). 
Similarly, in a small study of 36 patients diagnosed with LSS, mean age 67 years, increased fat 
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infiltrations, of the MF muscle and decreased CSA of the psoas muscle at the L5 spinal level 
were associated with lower physical function scores as measured by the Oswestry Disability 
Index (ODI) (275). A cross-sectional study that included 180 patients diagnosed with LSS and a 
similar number of controls, reported findings that were at odds with the previous reports. In this 
study, patients diagnosed with LSS had decreased fat infiltrations in the MF muscle and 
increased CSA of the erector spinae muscle at the L3 spinal level compared with controls. Also, 
increased MF muscle density was associated with developing LSS (251). As a possible 
explanation for this discrepancy, it has been proposed that since the symptomatic effects of LSS 
are more commonly seen at the lower levels of the lumbar spine, the upper levels tend to 
compensate for the muscle atrophy and increased fat infiltrations seen in the lower lumbar spinal 
levels (251), but this has not been corroborated.  
The systematic review reported 10% to 22% decrease in MF muscle CSA and increased fat 
infiltrations on the concave side of patient with degenerative lumbar scoliosis (DLS) (184). The 
studies in this update expanded the evidence to adult spinal deformity (ASD), a condition that 
comprises disorders such as scoliosis, kyphosis and spondylolisthesis. In a case-control study of 
patients with DLS and age and weight-matched controls, Banno et al. (252) reported a negative 
correlation between age and MF CSA at the L4/L5 spinal level in patients with DLS. Decreased 
MF CSA was also strongly correlated with increase in lumbar kyphosis and sagittal spinal 
deformities. Similar to this and consistent with finding from the systematic review, Kim et al. 
(276) reported asymmetry in MF muscles, with larger MF CSA on the convex side of patients with 
DLS, independent of the level, direction or magnitude of the deformity. Finally, in a study of 26 
adults aged 50-81 years with degenerative spondylolisthesis by Nava-Bringas et al. (277), there 
was no correlation between MF muscle size, measured by MRI at L3-S1 spinal levels and 
physical function (measured by the ODI). Overall, the findings from the studies in this update 
agree with the consistent evidence from the systematic review for a detrimental effect of spinal 
conditions on the size and composition of the MF muscles. As is the case in LBP, detrimental 
effects of spinal conditions on the MF size and composition appear to be primarily at the L4/L5 
spinal level. 
3.9.5 Participants with low back pain 
One longitudinal study in the systematic review provided evidence for associations between 
increased fat infiltrations in the MF muscles of older adults and greater physical dysfunction 
over 3 years (145). Studies of patients with LBP in this update provide further support for an 
association between increased MF fat infiltrations and decreased physical function in patients 
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with moderate to severe LBP (146). They also support findings of increased MF fat infiltrations 
with increased age in healthy adults and patients with spinal conditions (278-281). These studies 
have expanded the evidence to indicate that LBP prevalence and severity is greater in older 
adults, particularly in women (278, 279).  
Resembling the findings in the systematic review, the results of the studies in this update were 
inconsistent. A 15-year longitudinal study of 99 twins revealed that increased age was not 
significantly associated with frequency or intensity change in LBP at 1-year follow-up, and 
instead, there was an association between increased age and decrease LBP frequency at the 15-
year follow-up (282). Although the longitudinal findings regarding MF CSA asymmetry and MF 
fat infiltrations in this study were inconsistent between L3-L4 and L5-S1 spinal levels, the 
overall findings are consistent with cross-sectional studies indicating that independent of the 
duration of LBP symptoms, there were no statistically significant differences in MF CSA or fat 
infiltrations between the affected and non-effected sides (281, 283), and that neither MF CSA nor 
size ratio were associated with severity or duration of LBP or nerve root compression (263). The 
inconsistency of findings from the studies in this update is similar to the findings in the 
systematic review, making it difficult to determine the clinical relevance of findings such as MF 
muscle CSA asymmetry and increased fatty infiltrations when designing rehabilitation programs 
for older adults with LBP. 
3.9.6 Other studies 
In the systematic review, there were a small number of studies that did not fit into the previously 
described categories and were grouped into the “other studies” category. Similarly, in this 
update, there are several studies grouped under this category. Studies of patients with 
Parkinson’s disease (PD) and camptocormia (abnormal thoracolumbar spinal flexion >30o when 
standing or walking that disappears in a resting position) in which paravertebral muscles were 
assessed by MRI, reported increased intramuscular fatty degeneration of the paravertebral 
muscles in the chronic stage (284), with non-neuropathic-related atrophy of paraspinal muscles 
with fatty infiltrations on the side of parkinsonian symptom onset (285). Also, among these 
patients, there was increased paraspinal muscle activity (286) and an increase in muscle activation 
among those patients who had sustained falls in the 12-months prior to the study, independent of 
medication use and severity of symptoms (287), indicating that more motor units are needed to be 
activated to counteract gravitational forces due to changes in posture due to PD.  
The final three studies in this group described individual findings from small studies in patients 
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with facioscapulohumeral muscular dystrophy, multiple sclerosis and transtibial amputations. A 
study of ten patients with facioscapulohumeral muscular dystrophy and who were frequent 
fallers, reported negative associations between abdominal fat infiltrations and posture instability 
and balance, highlighting a possible important role of abdominal muscles on balance among 
these patients (288). In a study of 15 people with multiple sclerosis (MS) and 15 healthy controls, 
Freund et al. (289) reported no statistically significant differences in abdominal or MF muscle size 
at rest or change in thickness with contraction between people with MS and control subjects, as 
measured with USI. Also, there were no significant correlations between muscle contraction 
ratios and measures of gait or balance in people with MS, and the results from flexion and 
extension endurance were mixed. The clinical implications of this study are not clear, 
particularly from such a small number of participants for a condition in which patients can 
present with a wide variety of symptoms. Finally, an increased muscle activation demand on 
muscles of the trunk during step ascend and descend exercises in patients with unilateral 
transtibial amputations was described in a study by Gaffney et al. (290). This last finding is 
perhaps not unexpected as some of the main functions of the muscles of the trunk is to transmit 
forces between upper and lower limb and to provide posture stability during upright activities 
which would require increased muscle activation to compensate for the asymmetrical trunk 
muscle movement of these patients. 
In conclusion, the studies in this update have strengthened the findings from the systematic 
review. Significantly, these studies have filled important gaps in the literature that were 
previously identified, by exploring validity and reliability of abdominal and MF muscle 
measures at various spinal levels, longitudinal effects of age on muscles of the trunk and 
associations between muscle of the trunk and physical function. Further evidence was presented 
highlighting that imaging modalities are reliable tools for the assessment of abdominal and MF 
muscles of older adults, particularly ultrasound imaging which was shown to be a valid tool for 
the assessment of these muscles when compared with MRI. the results from this group of studies 
add support to the findings in the systematic review of evidence for an age-related decrease in 
trunk muscle size and increase in fat infiltrations. Complementing the findings of the systematic 
review, the studies of participants with spinal conditions provide consistent evidence for a 
detrimental effect of these conditions on the abdominal and MF muscles. The evidence from 
studies of participants with LBP remains inconsistent for older people, making it difficult to 
interpret their relevance to clinical practice. Finally, the evidence for a detrimental effect of 
increased fat infiltrations in abdominal and MF muscles appears to be consistent throughout the 
studies, although more so for the MF muscle at the L4-L5 spinal level.  
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4.1 Prelude 
Three chapters of this thesis utilised data from an ultrasound imaging (USI) sub-study of the 
Vitamin D Effect on Osteoarthritis (VIDEO) clinical trial. This chapter provides a general 
overview of the study population and design of the VIDEO as well as the measures from the 
VIDEO study and the ultrasound imaging sub-study that were used in chapters 5 to 7 (Table 4.1). 
Further detail of other factors is included in the methodology section of each chapter.  
4.2 VIDEO study population and design 
The Vitamin D Effect on Osteoarthritis (VIDEO) study was a randomised, placebo-controlled 
and double-blind clinical trial, conducted with the main objectives of determining if vitamin D 
supplementation could reduce knee cartilage volume loss, prevent progression of knee structural 
abnormalities, improve lower limb muscle strength, and alter the progression of knee pain. The 
protocol for VIDEO, including its pre-specified analyses, has been published (Appendix 1) (221).   
The inclusion criteria were: 
 adults aged 50 – 79 years 
 ongoing symptoms of knee osteoarthritis for at least six months 
 pain levels between 20-80 mm on a 100 mm visual analogue scale (VAS)   
 serum 25(OH)D levels between 12.5 and <60 nmol/L.  
 Meeting the American College of Rheumatology (ACR) criteria for symptomatic knee 
OA assessed by a rheumatologist 
 ACR functional class rating I, II and III 
 relatively good health as indicated by a score of 0 – 2 on a 5-point Likert scale, were zero 
indicates good health 5 indicates very poor health 
 able to read and speak English 
 able to understand what the study required and willing to comply with the study 
instructions 
The exclusion criteria were:  
 severe radiographic knee osteoarthritis, grade 3 according to Altman’s atlas (291) 
 severe pain on standing (more than 80 mm on 100-mm VAS)  
 any contraindications to having MRI scans 
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 rheumatoid or psoriatic arthritis, lupus or cancer 
  severe cardiac or renal impairment 
 hypersensitivity to vitamin D 
 any condition affecting oral drug absorption (for example, gastrectomy or 
malabsorption syndromes) 
 significant trauma to knees, including arthroscopy or significant injury to ligaments 
or menisci of the knee within one year preceding the study 
 anticipated need for knee or hip surgery within the next two years  
 history of taking vitamin D supplements within the previous 30 days 
 history of taking an investigational drug within the previous 30 days (221) 
Participants were recruited in Tasmania and Victoria between June 2010 and December 2011 
through advertisements in the local media and community groups, and referrals from general 
practitioners, specialist rheumatologists and orthopaedic surgeons. Participants were randomly 
assigned to a vitamin D or a placebo group using computer-generated allocation in a 1:1 ratio. 
Participants, researchers and study administrators were blinded to treatment allocation until all 
data were collected, cleaned and statistical analyses for primary outcomes and the data for this 
thesis were completed.  
4.3 25-Hydroxyvitamin D Assays 
Serum25-hydroxyvitamin D was assayed as per the clinical trial protocol, at screening, 3 months, 
and 24 months using direct competitive chemiluminescent immunoassays (DiaSorin Inc). The 
intraassay and interassay coefficients of variation were 3.2% and 6.0% (292). 
4.4 Intervention 
Participants in the treatment group were asked to take one 50,000 IU vitamin D3 
(cholecalciferol) capsule per month, for 24 months.  Participants in the control group were given 
an identical inert placebo. The vitamin D3 capsules and inert placebo were acquired from 
Nationwide Compounding Pharmacy, Melbourne, Australia (221). 
4.5 Ethics 
The clinical trial received ethics approval from The Tasmanian Health and Human Medical 
Research Ethics Committee (reference number H1040) and Monash University Human Research 
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Ethics Committee (reference number CF10/1182 - 2010000616). Informed written consent was 
obtained from all participants.  
The photographs of muscles in the first chapter were taken during various stages of dissections 
performed by Derek Choi-Lundberg and William Cuellar, during the development of audio-
visual resources for medical students at the school of medicine, College of Health, University of 
Tasmania. The bodies were kindly donated by community members to the Body Bequest 
Program at the school of medicine. All donors signed informed written consent for their bodies 
to be used for medical education and research (Appendix 14). The reproduction of the 
photographs for this thesis received ethics approval from The Tasmanian Health and Human 
Medical Research Ethics Committee (reference number H0017462) (Appendix 15) 
4.6 Ultrasound imaging sub-study 
The studies reported in chapters 5 to 7 of this thesis originated from a USI sub-study of the 
VIDEO clinical trial that was undertaken at the Hobart site. Data from this sub-study were used 
to investigate the test-retest reliability of abdominal and multifidus measurements using 
ultrasound imaging (chapter 5) and the effect of 12 months of vitamin D supplementation on the 
size of the abdominal and multifidus muscles (chapter 6). The latter was a secondary analysis of 
the VIDEO clinical trial. Finally, these data were also used to investigate the associations 
between abdominal and multifidus muscle size and physical activity, physical function and 
quality of life (chapter 7). This sub-study received ethics approval from The Tasmania Health 
and Human Medical Research Ethics Committee (reference number H1040) as part of the main 
VIDEO ethics application. Informed written consent was obtained from all participants. 
4.7 Outcome measures 
Measurements from ultrasound images of abdominal and multifidus muscle thickness and cross-
sectional area were outcome factors for the studies reported in chapter 5 and 6 and the study 
factor for the analysis reported in chapter 7. Methods of capture and measurements are described 
in detail in chapter 5, under 5.3.2 “Image capture and measurement” of the methods section (264) 
and brief descriptions of the process are included in chapters 6 and 7 in the methods sections.  
4.8 Measures of physical activity, physical function and quality of life 
Measures of physical activity were assessed by the short version of the International Physical 
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Activity Questionnaire (IPAQ) (293) (Appendix 2). Ambulatory physical activity was measured 
using Yamax Digi-Walker SW-200 pedometers that recorded total daily steps for 7 days. 
Deficits in physical function were assessed by the functional deficit subscale of the Western 
Ontario and McMaster Universities Arthritis Index (WOMAC) (Appendix 3) (294). Quality of life 
was assessed by the Assessment of Quality of Life instrument (AQoL) (Appendix 4) (295). 
Detailed descriptions of these instruments are included in the methods section in chapter 7. 
4.9 Other measures 
Each participant’s body weight was measured using calibrated scales (Heine S-7307, Heine, 
New Hampshire, USA). Height was measured by stadiometer to the nearest 0.1 cm (Leicester 
Height Measure, Invicta Plastics Ltd, Leicester, UK). Body mass index (BMI) was calculated as 
weight (kg)/height (m2).  
Current low back pain status was assessed by a questionnaire that included the question “Do you 
currently have any pain in your back?” Pain scores were obtained using a Visual Analogue Scale 
(0-100 mm) with zero indicating no pain and 100 the worst pain the participant had ever had 
(Appendix 5). History of back surgery, abdominal surgery and medication use were obtained by 
questionnaire (Appendix 6).  
Leg strength measures to the nearest kilogram were obtained for both legs simultaneously using 
a dynamometer (TTM Muscular Meter, Tokyo, Japan) as described by Scott, 2009a (296). This is 
an isometric strength muscle test, predominantly for the quadriceps and hip extensor muscles. 
Hand grip strength was assessed to the nearest kg using a hydraulic hand dynamometer (Saehan 
Corporation, Masan, Korea) (Appendix 6).  
4.10 Statistical analysis 
The statistical methods used in this research are described in detail in the corresponding chapters. 
Statistical significance was set at a two-tailed p-value ≤ 0.05. All statistical analyses were 
performed using STATA 12 and 14 for Windows (StataCorp, College Station TX, USA). 
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5.1 Prelude 
Chapter 1 gives a brief overview of the reliability of EMG and imaging methods used to assess 
muscles of the trunk. The validity and reliability of measurements of abdominal and MF muscles 
using USI are well established in young people, but this may differ in older people for several 
reasons, including morphological features of ageing muscle, which increase the difficulty of 
assessing these muscles. The systematic review in chapter 3 provided a synthesis of the current 
literature on the assessment of abdominal and MF muscles and reported that in older adults, there 
were gaps in knowledge regarding validity and test-retest reliability of measurements of these 
muscles using USI.  
Thus, this study aimed to evaluate the test-retest reliability of USI for assessing abdominal and 
MF muscle thickness and MF CSA at the L2–L5 vertebral levels. It should be noted that apart 
from the numbering of tables and figures that were changed to follow the thesis sequence, the 
text in this chapter is presented as published in The Journal of Musculoskeletal Science and 
Practice; Cuellar WA, Blizzard L, Callisaya ML, Hides JA, Jones G, Ding C, et al. Test-retest 
reliability of measurements of abdominal and multifidus muscles using ultrasound imaging in 
adults aged 50-79 years. Musculoskelet Sci Pract. 2017;28(e1-e88):79-84 (264). This journal has 
an impact factor of 2.12 and the paper has been cited 2 times. 
5.2 Introduction 
The muscles of the lumbopelvic region have a role in stability and function of the spine, 
locomotion and maintenance of posture and balance (6, 9). However, research on abdominal and 
lumbar multifidus (MF) muscles in older adults is limited (138). 
Ultrasound imaging (USI) is used clinically and in research to assess muscle morphology. Its 
reliability in older adults is not yet fully ascertained.  There are two key aspects of reliability, 
namely reliability of repeatedly measuring the same image and test-retest reliability, where the 
entire imaging process is repeated by the same person days or weeks apart and measurements 
made on the resulting sets of images (297). Test-retest reliability is critical to clinical practice and 
longitudinal research where imaging is repeated to monitor patients’ progress. This has greater 
potential for measurement error than just remeasuring the same image due to additional sources 
of variation, for example, from repositioning the participant and transducer and identification of 
landmarks (298).  
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The inter and intra-rater reliability of repeatedly measuring ultrasound images of abdominal and 
multifidus muscles has recently been reported as substantial in adults aged 65 to 89 years (266), 
consistent with that in lateral abdominals in adults of mean age 72 years (245). However, despite 
the critical importance of test-retest reliability to clinical and research practice, in older adults 
this has only been reported for MF thickness at the L4-L5 spinal level (247, 248) (138) and not for 
MF cross-sectional area (CSA) or abdominal muscle thickness. Test-retest reliability of MF 
thickness beyond L4-5 is important as MF morphology varies by spinal level (162) and clinical 
conditions such as low back pain (LBP) affect MF at levels additional to L4-5. Therefore, this 
study aimed to evaluate the test-retest reliability of USI for assessing abdominal and MF muscle 
thickness and MF CSA at the L2–L5 vertebral levels.  
5.3 Methods 
5.3.1 Participants  
Participants were drawn from an USI sub-study on trunk muscles (n=186) of the “Vitamin D 
Effect on Knee Osteoarthritis” (VIDEO) clinical trial in Tasmania (n=261) (292). In brief, VIDEO 
participants aged 50-79 years, with symptomatic knee osteoarthritis for at least six months, and 
serum 25-(OH)D levels between 12.5 to 60 nmol/L, were recruited from the community. 
Twenty-three participants from the USI sub-study took part in the reliability study. The USI sub-
study was approved by The Tasmania Health and Human Ethics Committee. All participants 
gave written informed consent. We measured each participant’s height by stadiometer, weight by 
calibrated scales, calculated body mass index (BMI) (weight (kg)/height (m2)) and ascertained 
LBP status by questionnaire asking, “Do you currently have any pain in your lower back?”.  
5.3.2 Image capture and measurement 
USI was performed twice, one week apart, using a Phillips HDI 5000 diagnostic ultrasound 
(Bothwell, WA, USA) in brightness (B) mode, with a hand-held 4-7 MHz curved array 
transducer. All USI was conducted by a physiotherapist who undertook 36 hours of practical 
training in USI from JAH. Single sets of images were obtained to reduce time to accommodate 
the USI sub-study within the clinical trial.   
Transverse images of transversus abdominis (TrA), internal oblique (IO) and external oblique 
(EO) were obtained at rest and contracted with participants directed to “take a relaxed breath in 
and out, hold your breath out, and then draw in your lower abdomen without moving your spine” 
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(298). Images were obtained along a line halfway between the lower angle of the rib cage and the 
iliac crest for right, then left, sides. The transducer was oriented transversely such that full vision 
of all muscle bellies was possible and the fascial insertion of TrA was close to the medial edge of 
the image with the muscle relaxed. In younger adults, the medial fascial insertion of TrA would 
be positioned 2 cm from the medial edge of the screen image (298), but this was not possible in 
these older adults due to body habitus. Transverse images of rectus abdominis (RA) were 
obtained at rest, for right, then left sides, with the transducer oriented transversely and placed 
lateral to the umbilicus until RA was centred on the screen (121). 
For MF thickness, parasagittal images were obtained on the right side at rest and on isometric 
contraction at L2-L3 to L5-S1 vertebral levels. For the latter, participants were instructed to take 
a relaxed breath in and out, hold their breath out and try to slowly “swell” and contract the 
muscle without moving the spine (174). Participants lay prone with one pillow under the abdomen 
to reduce lumbar lordosis. L2 to L5 spinous processes were palpated, marked with a pen and 
then confirmed using USI (299). Bilateral CSA images of MF were obtained in the transverse 
plane at vertebral levels L2 to L5 with the muscles relaxed.   
Images were stored and later measured offline by a single examiner using ImageJ software 1.36b 
(http://imagej.nih.gov/ij/). Abdominal muscle thickness was measured as the perpendicular 
distance between the superior and inferior muscle fascias at approximately the middle of the 
image identified using the software’s Cartesian coordinates (Figure 5.1A and 5.1B)  (298). MF 
CSA was measured by tracing the inner edge of the fascial boundaries (Figure 5.1C) (300) and 
thickness measured from the tip of the zygapophyseal joint to the inferior fascial edge of the 
superior border of the muscle (Figure 5.1D) (301)  
5.3.3 Statistical Analysis: 
Percentage thickness change was calculated as 100*(thickness of muscle contracted - thickness 
relaxed)/thickness relaxed. Bland and Altman plots were inspected to identify any systematic 
patterns in the differences associated with muscle size (302).  Intraclass correlation coefficients 
were calculated (ICC 3,1) (303) and classified according to the recommendations of  Shrout (226) 
(≤0.10 = virtually none, 0.11–0.40 = slight, 0.41–0.60 = fair, 0.61–0.80 = moderate, and 0.81–
1.0 = substantial). Standard error of measurement (SEM) (304) and minimal detectable change 
(MDC) were also calculated.  STATA 12 was used for data analysis. 
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5.4 Results: 
Table 5.1 summarises the characteristics of the reliability study participants and of the other 
participants in the USI sub-study of the VIDEO trial. The reliability study group included 
relatively more males, and women who were shorter and lighter than the other women in the USI 
sub-study.  
Other than for the right IO when contracted (ICC 0.75), ICC values for abdominal muscles were 
substantial (0.87-0.98) (Table 5.2 and 5.3). Other than for IO when contracted (difference 6.5%), 
the differences between measurements were relatively small (≤3.2%) and considerably smaller 
than their corresponding MDC values. ICCs were lower, and SEM values higher, for percentage 
thickness change.  Reliability of measurements of right MF thickness (at rest and contracted) was 
fair to moderate at the L2-L3 and L3-L4 spinal levels (ICC 0.55-0.74) (Table 5.4) and moderate 
to substantial at other levels. On average, the test-retest differences were small (≤3%) and 
considerably smaller than the corresponding MDC. Percentage change thickness was not reliably 
measured. Reliability of MF CSA measures was substantial (ICC 0.84-0.91) (Table 5.5), with 
small test-retest differences that were much smaller than the MDC. Bland and Altman plots of all 
muscle measurements revealed no systematic pattern of variability across the range of 
measurement (data not shown).  
5.5 Discussion 
This study reports test-retest reliability of USI and measurement of thickness of abdominal and 
MF muscles, and MF CSA (L2-L5) in adults aged 50 to 79 years. Importantly, we assessed test-
retest reliability for muscles for which this has not previously been reported in older adults (138).  
Reliability was substantial for all measures other than thickness of IO and of MF at L2-L3 and 
L3-L4 spinal levels, supporting the use of USI as a reliable tool for the assessment of abdominal 
and MF muscle thickness and MF CSA of older adults for clinical and research purposes. 
Age related changes in skeletal muscle such as decreased water and increased fat content and 
fibrous tissue can increase ultrasound image echogenicity and could reduce the reliability of 
muscle measurements in older adults (122, 185). 
Despite this and the additional potential for measurement error during the process of taking 
repeated ultrasound measures, test-retest reliability of abdominal muscle thickness and MF CSA 
in our study were substantial (ICC = >0.81), and comparable with the reliability of just 
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measuring images of the same muscles in a population-based sample of adults aged 65 to 89 
years (ICC= > 0.85) (266). Furthermore, the test-retest reliability of MF CSA was comparable to 
that of young adults (ICC= 0.72-0.80) (305).  This suggests that USI test-retest assessment of 
abdominal and MF muscle thickness at rest and contracted, MF CSA at rest and percentage 
change in abdominal thickness of older adults can be reliably performed by a trained assessor 
following a standardised protocol. 
The test-retest reliability of measurements of MF muscle thickness in our study ranged from fair 
to substantial (ICC = 0.55-0.86), being somewhat lower at L2-3 and L3-4 spinal levels. This is 
lower than previously reported for at L4-L5 in older adults (247, 248), which may be in part due to 
that study using the average of three measurements to calculate ICCs and SEMs. Averaging three 
measurements improves measurement precision (SEM) by up to 50% (306), but only delivers 
modest improvements in reliability of MF thickness compared with single measurements (265, 301). 
Potential gains in reliability need to be weighed against the logistical disadvantages (e.g. time) of 
performing multiple measurements in clinical and research settings. 
The reasons for the lower reliability of measuring upper spinal segments in our study are not 
clear.  One contributing factor may be the higher degree of difficulty localising these segments 
and excluding longitudinal muscle fibres from the erector spinae in the measurement of MF 
thickness. Although the reasons for the marked side-to-side difference in the reliability of 
thickness and percentage thickness change of the IO are also unclear, our results are consistent 
with a previous image reading study confined to lateral abdominals in adults of mean age 72 
years (Stetts et al (2009). It is possible that consistently imaging the right side first created a 
learning effect that lessened variability in the contraction of the left IO. 
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Figure 5.1 Split-screen image showing the 
muscles of the left anterolateral abdominal wall 
(A and B) and multifidus thickness and cross-
sectional area (C and D) 
A 
 
Split-screen image showing the muscles of the left 
anterolateral abdominal wall at rest (A) and contracted 
(B). Abbreviations: SST: superficial soft tissue, (EO): 




   
Spinous process L2 
Bilateral image of multifidus in transverse section at the 
L5 vertebral level. Cross-sectional area (CSA) of the 
multifidus muscle was measured by tracing around the 
inner edge of the fascial boundaries of the muscle as 
shown on the left side of the image. Abbreviations: SST, 



















Ultrasound image showing the right rectus abdominis 
muscle. Thickness of the muscle was measured at rest 
as the perpendicular distance between the superior and 








Split-screen parasagittal image of the right multifidus 
muscle at rest (A) and contracted (B). Thickness 
measurements were made from the tip of the 
zygapophyseal joint to the inferior fascial edge of the 
superior border of the muscle. Abbreviations: SST, sub-
cutaneous soft tissue 
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Table 5.1 Characteristics of participants in the reliability study and of remaining ultrasound sub-
study participants (non-participants) 
Characteristic  Reliability study (N=23) Non-participants (N=163) 
Age (yrs.) 62.4 (6.3) 64.7 (7.3) 
Sex: Males, % (n/N)  70 (16/23) 54 (88/163) 
Height (cm) (males, 
females 
177.8(6.1), 158.4(6.6) 176.1(6.5), 161.6(6.1) 
Weight (kg) (males, 
females) 
88.4(12.6), 68.5(16.0)    91.8(13.6), 78.4(14.7) 
BMI (kg/m2) 29.7 (11.7) 29.8 (4.8) 
Low Back Pain, % (n/N) 39.1 (9/23) 35.6 (58/163) 
 
Results are reported mean (standard deviation) unless otherwise stated. %: percentage; BMI: 
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          Table 5.2 Test-retest reliability of measuring right abdominal muscle thickness (cm) 
  Test Retest Difference   Intraclass Correlation 
Muscle N Mean (SD) Mean (SD) Mean (SD) SEM MDC95 ICC(3,1) 95% CI 
RA 23 0.86 (0.19) 0.88 (0.19) -0.016 (0.061) 0.04 0.12 0.95 (0.88, 0.98) 
TrA (rest) 23 0.39 (0.10) 0.40 (0.11) -0.004 (0.034) 0.02 0.07 0.95 (0.88, 0.98) 
TrA (contract) 23 0.58 (0.16) 0.59 (0.16) 0.010 (0.004) 0.04 0.10 0.95 (0.89, 0.98) 
Thickness change, % 23 50.66 (32.76) 54.35 (38.03) -3.689 (21.704) 15.35 42.54 0.81 (0.61, 0.92) 
IO (rest) 23 0.73 (0.16) 0.75 (0.17) -0.024 (0.013) 0.05 0.12 0.92 (0.83, 0.97) 
IO (contract) 23 0.95 (0.24) 1.01 (0.28) -0.062 (0.185) 0.13 0.36 0.75 (0.49, 0.89) 
Thickness change, % 23 30.54 (22.65) 35.12 (31.71) -4.580 (32.967) 23.31 64.61 0.28 (-0.14, 0.62) 
EO (rest) 23 0.41 (0.10) 0.41 (0.10) -0.008 (0.031) 0.02 0.06 0.95 (0.89, 0.98) 
EO (contract) 23 0.47 (0.99) 0.49 (0.10) -0.013 (0.052) 0.04 0.10 0.87 (0.71, 0.94) 
Thickness change, % 23 19.34 (21.80) 19.84 (19.89) -0.5 (15.440) 10.92 30.26 0.73 (0.46, 0.87) 
Abbreviations:  RA, rectus abdominis; EO, external oblique; IO, internal oblique; TrA, transversus abdominis; rest, resting thickness (cm); contract, contracted 
thickness (cm); SD, standard deviation; SEM, standard error of measurement; MDC, minimal detectable change; ICC, intra-class correlation coefficient (95% 
confidence interval) 
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          Table 5.3 Test-retest reliability of measuring left abdominal muscle thickness (cm) 
  Test Retest Difference   Intraclass Correlation 
Muscle n Mean (SD) Mean (SD) Mean (SD) SEM  MDC95  ICC(3,1)  95% CI 
 RA 23 0.85 (0.18) 0.86 (0.19) -0.007 (0.036) 0.03 0.07 0.98 (0.96, 0.99) 
TrA (rest) 23 0.37 (0.10) 0.38 (0.10) -0.000 (0.036) 0.03 0.07 0.93 (0.84, 0.97) 
TrA (contract) 23 0.60 (0.15) 0.60 (0.16) -0.003 (0.049) 0.04 0.10 0.95 (0.87, 0.98) 
Thickness change, % 23 63.53 (36.04) 61.77 (28.92) 1.762 (17.916) 12.67 35.11 0.85 (0.68, 0.93) 
IO (rest) 23 0.77 (0.19) 0.75 (0.20) 0.024 (0.068) 0.05 0.13 0.94 (0.86, 0.97) 
IO (contract) 23 1.06 (0.32) 1.03 (0.33) 0.026 (0.086) 0.06 0.17 0.96 (0.92, 0.99) 
Thickness change, % 23 37.08 (22.90)  38.36 (27.19) -1.287 (15.460) 10.93 30.30 0.81 (0.61, 0.92) 
EO (rest) 23 0.42 (0.11) 0.42 (0.09) 0.006 (0.040) 0.03 0.08 0.92 (0.82, 0.97) 
EO (contract) 23 0.52 (0.14) 0.52 (0.14) -0.001 (0.043) 0.03 0.09 0.95 (0.89, 0.98) 
Thickness change, % 23 24.07 (27.13) 25.55 (28.95) -1.477 (16.359) 11.57 32.06 0.83 (0.64, 0.92) 
Abbreviations: RA, rectus abdominis; EO, external oblique; IO, internal oblique; TrA, transversus abdominis; rest, resting thickness (cm); contract, contracted 
thickness (cm), SD, standard deviation; SEM, standard error of measurement; MDC, minimal detectable change; ICC, intra-class correlation coefficient (95% 
confidence interval).  
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          Table 5.4 Test-retest reliability of right lumbar multifidus muscle thickness measures (cm) 
 
 
  Test Retest Difference   Intraclass Correlation 
Muscle n Mean (SD) Mean (SD) Mean (SD) SEM  MDC95  ICC(3,1) 95% CI 
MF L2-L3 (rest) 23 2.60 (0.30) 2.52 (0.41) 0.078 (0.338) 0.24 0.66 0.55  (0.19, 0.78) 
MF L2-L3 (contract) 23 2.83 (0.38) 2.80 (0.43) 0.032 (0.292) 0.21 0.57 0.74 (0.48, 0.88) 
Thickness change, % 23 8.95 (10.42) 11.44 (9.20) -2.491 (11.586) 8.19 22.71 0.30 (-0.11, 0.63) 
MF L3-L4 (rest) 23 2.42 (0.33) 2.372(0.32) 0.044 (0.302) 0.21 0.59 0.57 (0.21, 0.79) 
MF L3-L4 (contract) 23 2.66 (0.40) 2.61 (0.33) 0.052 (0.315) 0.22 0.62 0.63 (0.31, 0.83) 
Thickness change, % 23 10.58 (11.52) 10.55 (10.10) 0.033 (15.896) 11.24 31.16 -0.08 (-0.47, 0.34) 
MF L4-L5 (rest) 23 2.85 (0.48) 2.87 (0.60) -0.027 (0.315) 0.22 0.62 0.83 (0.64, 0.92) 
MF L4-L5 (contract) 23 3.02 (0.52) 3.05 (0.65) -0.031 (0.313) 0.22 0.61 0.86 (0.69, 0.94) 
Thickness change, % 23 6.12 (6.89) 6.28 (8.97) -0.165 (8.546) 6.04 16.75 0.43 (0.03, 0.71) 
MF L5-S1 (rest) 23 2.84 (0.37) 2.86 (0.49) -0.016 (0.311) 0.22 0.61 0.74 (0.48, 0.88) 
MF L5-S1 (contract) 23 3.04 (0.47) 3.09 (0.57) -0.048 (0.413) 0.29 0.80 0.69 (0.39, 0.86) 
Thickness change, % 23 6.90 (6.95) 8.46 (11.36) -1.561 (12.244) 8.66 24 0.16 (-0.27, 0.53) 
Abbreviations: MF, Multifidus; L2 - L5, lumbar vertebral level; rest, resting thickness (cm); contract, contracted thickness (cm); SD, standard deviation;   SEM, 
standard error of measurement; MDC, minimal detectable change; ICC, intra-class correlation coefficient (95% confidence interval) 
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      Table 5.5 Test-retest reliability of lumbar multifidus cross-sectional area measures (cm2) 
  Test Retest Difference   Intraclass Correlation 
Muscle n Mean (SD) Mean (SD) Mean (SD) SEM  MDC95  ICC(3,1) 95% CI 
 (R) MF L2 23 2.93 (0.46) 3.01 (0.50) -0.079 (0.271) 0.19 0.29 0.84 (0.66, 0.93) 
(L) MF L2 23 2.90 (0.46) 2.94 (0.49) -0.039 (0.266) 0.19 0.28 0.84 (0.67, 0.93) 
 (R) MF L3  23 3.78 (0.53) 3.87 (0.57) -0.088 (0.252) 0.18 0.22 0.90 (0.77, 0.96) 
(L) MF L3  23 3.86 (0.58) 3.79 (0.59) 0.067 (0.259) 0.18 0.22 0.90 (0.78, 0.96) 
 (R) MF L4 23 4.74 (0.60) 4.79 (0.67) -0.048 (0.274) 0.19 0.23 0.91 (0.80, 0.96) 
 (L) MF L4 23 4.84 (0.56) 4.82 (0.62) 0.014 (0.293) 0.21 0.27 0.88 (0.74, 0.95) 
(R) MF L5 23 5.31 (0.56) 5.39 (0.60) -0.085 (0.260) 0.18 0.22 0.90 (0.78, 0.96) 
 (L) MF L5 23 5.39 (0.57) 5.38 (0.56) 0.008 (0.264) 0.19 0.23 0.89 (0.76, 0.95) 
Abbreviations: (R), right side; (L), left side; MF, Multifidus; L2 - L5, lumbar vertebral level; SD, standard deviation; SEM, standard error of measurement; 
MDC, minimal detectable change; ICC, intra-class correlation coefficient (95% confidence interval) 
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Estimates of reliability for percent thickness change were low, particularly those for MF (ICC -
0.08-0.43), consistent with previous reports for L4-5 MF thickness (247) and IO. This is not 
unexpected, as multiple factors influence percentage muscle thickness changes such as resting 
state, contraction type, and variability in performance of the contraction (307). Therefore, current 
approaches to assessing percentage thickness change of lumbar MF and IO appear insufficiently 
reliable to measure changes in muscle size over time. Further research could investigate ways to 
improve the reliability of these measures, possibly through different approaches to standardising 
the performance of contractions, and alternative approaches that more closely target IO. 
5.6 Study limitations 
This study has several limitations. A trained examiner performed USI so the results may not be 
generalizable to examiners with less training, though MF thickness has been measured with high 
test-retest reliability in older adults by operators with limited USI training (247). Reliability may 
have been higher with multiple rather than single measurements, but the reliability we achieved 
suggests that single measurements can be made with substantial consistency, at least at the lower 
spinal levels where LBP is more prevalent. Lastly, participants were vitamin D insufficient and 
so the muscle measures are not normative for the general population. 
5.7 Conclusion 
Despite the challenges of imaging older adults using USI, a trained assessor can reliably assess 
abdominal and MF muscle thickness at rest and contracted, CSA at rest and percentage change in 
abdominal thickness, but not percentage change in MF thickness, on different days. The 
substantial reliability of most measures suggest that USI performed by a trained assessor using 
established protocols is sufficiently reliable to be used in clinical practice and for research in 
older people.  
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6.1 Prelude 
Having established the test-retest reliability of USI for assessing abdominal and lumbar 
multifidus muscles, allowed us to proceed to use this technique to assess these muscles and use 
these measures as outcomes factors in a randomised controlled trial design. The third section of 
the introduction chapter discussed previous research that investigated associations between 
vitamin D supplementation and measures of muscle function, namely, muscle strength, muscle 
mass and power. However, only a few studies have been conducted on the effect of vitamin D 
supplementation on muscle size (309, 310). In the systematic review in chapter 4, no studies had 
examined the effect of vitamin D supplementation on muscles of the trunk of older adults. As 
discussed in the third section of the introductory chapter, the effect of vitamin D supplementation 
on muscles of the trunk is of particular interest because low vitamin D levels are associated with 
decreased postural balance and increased risk of falls in older adults (62). This study aimed to 
evaluate the effect of 12 months vitamin D supplementation on the size and function of the 
abdominal and multifidus muscles in a sample of community-dwelling adults aged 50 – 79, with 
low-level serum 25(OH)D. It should be noted that apart from the numbering of tables and figures 
that were changed to follow the thesis sequence, the text in this chapter is presented as published 
in the Journal of Cachexia, Sarcopenia and Muscle. Cuellar WA, Blizzard L, Hides JA, Callisaya 
ML, Jones G, Cicuttini F, et al. Vitamin D supplements for trunk muscle morphology in older 
adults: secondary analysis of a randomized controlled trial. Journal of Cachexia, Sarcopenia and 
Muscle. 2018, DOI: 10.1002/jcsm.12364. This journal has an impact factor of 12.5 and the paper 
was accepted in late 2018.  
6.2 Introduction 
Population levels of serum 25-hydroxyvitamin D (25(OH)D) are variable around the world, but 
deficiency is common in older adults due to decreased sun exposure, decreased production of 
vitamin D in the skin, insufficient intake of vitamin D in their diet and institutionalisation (188-191). 
Mean population 25(OH)D levels commonly fall below 50 nmol/L (20 ng/ml), which is 
considered to be the minimum target level for adequate bone health, mineral homeostasis and 
muscle function (191, 193, 200).  
Common clinical presentations of severe vitamin D deficiency include bone pain, gait 
disturbances and muscle weakness, especially of proximal muscles of the upper and lower limbs 
and muscles of the trunk (213). Previous research has found that vitamin D plays a vital role in 
muscle development and growth (209). The mechanism may be through 1,25(OH)2 binding to a 
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specific vitamin D receptor found in skeletal muscle (54, 210) leading to de novo protein synthesis 
and thus muscle cell proliferation and growth (59, 211). Furthermore, a review of randomised 
controlled trials (RCTs) has examined the effect of vitamin D supplementation on several aspects 
of muscle function including lower limb strength, handgrip, postural balance, gait speed and 
physical performance (timed-up-and-go (TUG) test) (311).  Even though evidence in this review 
was conflicting,  7 of 11 studies demonstrated beneficial effects, as has another published RCT 
(312). A more recent systematic review and meta-analysis of 30 RCTs by Beaudart et al. (216) 
found small but significant positive effects of vitamin D supplementation on lower limb muscle 
strength, although there were no effects on muscle mass or power. Thus, there is both a 
biological basis and clinical trial evidence for considering that correcting vitamin D deficiency 
may improve muscle strength and function. 
Muscles of the trunk, particularly the abdominal and lumbar multifidus muscles (MF), are 
postural muscles tonically active during daily upright activities (186) and essential for the stability 
of the spine, balance and posture (6, 9, 132). Trunk muscle size is correlated with strength (272, 313) 
and among older adults, trunk muscle strength has been found to be associated with mobility and 
falls (7, 271). The effect of vitamin D supplementation on muscles of the trunk is of particular 
interest because low 25(OH)D levels are associated with decreased postural balance (311) and 
increased risk of falls by older adults (314). Consequently, vitamin D supplementation has the 
potential to be a relatively cheap intervention to improve postural muscle function and decrease 
the risk of falling among older adults. Despite this, to our knowledge, the effects of vitamin D 
supplementation on trunk muscles has not been assessed previously. Therefore, the objective of 
this randomised controlled trial was to evaluate the effect of 12-months of vitamin D 
supplementation compared with placebo, on morphology and function of the trunk muscles of 
adults aged 50 to 79 years with low serum 25(OH)D levels. 
6.3 Methods 
6.3.1 Trial design 
The Vitamin D Effect on Osteoarthritis (VIDEO) study was a randomised, placebo-controlled 
and double-blind clinical trial conducted between June 2010 and December 2013, with the main 
objectives of determining if vitamin D supplementation could reduce knee cartilage volume loss, 
prevent progression of knee structural abnormalities, improve lower limb muscle strength, and 
alter the progression of knee pain (221, 292). The protocol for VIDEO and its pre-specified analyses 
has been published (221). This pre-specified secondary analysis investigating the effects of 
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vitamin D supplementation on the size of abdominal and lumbar multifidus muscles over twelve 
months was undertaken in one of the two VIDEO sites, namely Hobart, Tasmania, Australia. 
VIDEO was registered with the Australian New Zealand clinical trial registration agency, 
ClinicalTrials.gov identifier: NCT01176344; Australian New Zealand Clinical Trials Registry: 
ACTRN 12610000495022 (221). The clinical trial and sub-studies were conducted following the 
Note for Guidance on Good Clinical Practice (CPMP/ICH/135/95) and the 2007 Australian 
National Statement on Ethical Conduct in Human Research. 
6.3.2 Participants  
Participants were recruited through advertisements in the local media and community groups, 
and referrals from general practitioners, specialist rheumatologists and orthopaedic surgeons. 
Inclusion and exclusion criteria are described in detail in the published clinical trial protocol (221). 
In brief, participants were people aged 50-79 years, with ongoing symptoms of knee 
osteoarthritis for at least six months with pain levels between 20-80 mm on a 100 mm visual 
analogue scale (VAS), and serum 25(OH)D levels between 12.5 and 60 nmol/L (5.2 to 24  
ng/ml). Exclusion criteria included: severe radiographic knee osteoarthritis, severe pain on 
standing, hypersensitivity to vitamin D, any condition affecting oral drug absorption and 
anticipated need for knee or hip surgery within the next 2 years. Ethics approval was received 
from The Tasmania Health and Human Ethics Committee (reference number H1040). Written 
informed consent was obtained from all participants. 
6.3.3 Randomisation and blinding 
Participants were randomly assigned to a vitamin D or a placebo group using computer-
generated allocation with a 1:1 ratio. Allocation concealment was ensured by using a central 
automated process independent of the investigators. Participants, investigators and research 
coordinators were all blinded to the treatment allocation. Blinding for both the main study and 
for the trunk muscle outcomes was maintained until all data were collected, cleaned, confirmed 
for accuracy and statistical analysis were completed.  
6.3.4 Interventions      
Participants in the treatment group were given one 50,000 IU (1.25 mg) vitamin D3 
(cholecalciferol) capsule per month, for 24 months.  Participants in the control group were given 
an identical inert placebo. The vitamin D3 compound and inert placebo were acquired from 
Nationwide Compounding Pharmacy, Melbourne, Australia. (221) 
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6.3.5 Outcomes 
Primary outcome measures in this pre-specified secondary analysis were between-group 
differences in change in muscle morphology: a- changes in muscle thickness of the abdominal 
muscles (rectus abdominis (RA), transversus abdominis (TrA), internal oblique (IO), external 
oblique (EO)) and the lumbar multifidus (MF) muscles; b- changes in cross-sectional area (CSA) 
of the MF muscles and c- changes in muscle thickness with contraction of the abdominal 
muscles (except RA) and the MF muscles from baseline to 12 months. 
6.3.6 Image capture and measurement 
Ultrasound muscle images were taken using a Phillips HDI 5000 ultrasound machine (Bothwell, 
WA, USA) in brightness mode (B-mode) with a handheld 4-7 MHz broadband curved array 
transducer. Image capture and measurement of the abdominal wall and MF muscles was 
undertaken following previously published protocols (121, 122, 185, 264, 266, 298, 301, 315-317). The 
ultrasound imaging (USI) assessments were conducted by a physical therapist who undertook 36 
hours of practical training in USI at the beginning of the project.   
Muscles of the abdominal wall were imaged in transverse section.  Participants were positioned 
in supine lying, with a pillow under their knees (121, 298). To elicit a voluntary contraction of the 
abdominal wall, participants were asked to “take a relaxed breath in and out, hold your breath 
out, and then draw in your lower abdomen without moving your spine” (298). The RA muscles 
were only imaged at rest, and the TrA, IO and EO muscles were imaged at rest and on 
contraction. (121) 
Imaging of the lumbar multifidus muscles was performed with participants positioned in prone 
lying, with a pillow placed under their abdomen to reduce lumbar lordosis (122, 301, 317). Images of 
the lumbar MF muscles were captured both at rest (in the transverse plane) and during 
contraction (in the parasagittal plane). Instructions for the isometric contraction were “take a 
relaxed breath in and out, hold your breath out and try to slowly “swell” and contract the muscle 
without moving the spine” (174).  
Ultrasound images were stored and later analysed offline by a single examiner using a software 
package (Image J Image Processing and Analysis, version IJ 1.46r, http://imagej.nih.gov/ij/). The 
thickness of the abdominal muscles was measured as the perpendicular distance between the 
superior and inferior hyperechoic muscle fascias at approximately the middle of the image 
identified using the software’s Cartesian coordinates (298). The CSA of the MF muscle was 
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measured by tracing around the inner edge of the fascial boundaries of the muscle (122, 315) and the 
thickness of the MF muscle was measured from the tip of the zygapophyseal joint to the inferior 
fascial edge of the superior border of the muscle (301). Intraclass correlation coefficients (ICC) for 
abdominal and MF muscle measurements were ICC= > 0.85 for interrater USI image 
measurement reliability (266), and ICC= 0.74-0.98 for test-retest reliability (264). 
6.3.7 Other factors 
Height was measured by stadiometer to the nearest 0.1 cm (Leicester Height Measure, Invicta 
Plastics Ltd, Leicester, UK). Weight was measured by calibrated scales (Heine S-7307, Heine, 
New Hampshire, USA) and BMI was calculated (weight (kg)/height (m2)). Knee pain scores 
were obtained using a visual analogue pain scale in 100 mm, assessing pain during walking, 
using stairs, in bed, sitting or lying and standing. The total pain score was calculated as the sum 
of the 5 items (range 0-500) (294). Total WOMAC score was calculated as the sum of the scores in 
each of its subscales that included pain, stiffness and physical function. Missing data were 
managed according to the WOMAC user guide (294). Physical activity was measured using the 
short version of the International Physical Activity Questionnaire (IPAQ) instrument. Data were 
collected on vigorous and moderate activity as well as walking and sitting, but data on sitting 
were not used in the analysis. Total IPAQ scores were calculated according to published 
guidelines (293, 318). Current low back pain status was assessed by a questionnaire asking, “do you 
currently have any pain in your back?”, and pain scores were obtained using a Visual Analogue 
Scale (0-100 mm). History of back surgery, abdominal surgery and medications were obtained 
by questionnaire. Leg strength measures to the nearest kilogram were obtained for both legs 
simultaneously using a dynamometer (TTM Muscular Meter, Tokyo, Japan) as described by 
Scott et al. (296). This is an isometric strength muscle test, predominantly for the quadriceps and 
hip extensor muscles. Grip strength was assessed with a hand-held dynamometer. 
6.3.8 25-Hydroxyvitamin D  
Serum25-hydroxyvitamin D was assayed at screening, 3 months, and 24 months. Blood samples 
were centrifuged after standing for 10 minutes at room temperature and the resultant serum 
frozen at -80C until assayed using direct competitive chemiluminescent immunoassays 
(DiaSorin Inc). The intraassay and interassay coefficients of variation were 3.2% and 6.0% (292). 
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6.3.8 Sample size 
Calculations were based on the standard deviations reported by Rankin et al (121) for the thickness 
of the abdominal muscles and by Wallwork et al (299) for thickness and CSA of the lumbar 
multifidus. Correlations between measurements and re-measurement of r = 0.9 for abdominal 
muscle thickness, r = 0.5 for multifidus thickness and r = 0.7 for multifidus CSA, were observed 
in our reliability study (264). On that basis, this study of projected size 200 subjects (100 in each 
arm) would have 80% power to detect between-group differences of 0.02 to 0.05 cm for change 
in abdominal muscle thickness, 0.20 to 0.21 cm for change in multifidus thickness, and 0.28 to 
0.40 cm2 for change in multifidus CSA. 
6.3.9 Statistical analysis 
As summary measures of their distributions, means and standard deviations were used for 
continuous measures, and percentages and frequencies were used for categorical factors. 
Random intercept linear mixed models were used to estimate the change between baseline and 
follow-up in both treatment arms, and the difference in change for the treatment groups, in this 
intention-to-treat analysis. The models included binary terms for side (left or right) in 
measurements of muscle thickness and CSA, and for state (relaxed or contracted) of muscle 
thickness. Changes in muscle morphology, that is thickness and CSA in the relaxed state, and 
change in function (assessed by changes in muscle thickness on contraction) were compared for 
each group of participants. Because there was no statistically significant differences between the 
2 sides for either group, the means of the right and left muscle sizes were used in the analysis. In 
additional analyses, adjustments were made for age, sex and BMI (pre-specified in the protocol) 
and for additional factors that were potential confounders and for which there was an imbalance 
between the treatment arms. Only the adjustment for lower limb strength resulted in a marked 
change in the estimated effect of the intervention (see Table 1). To test for interaction by serum 
25(OH)D status at baseline, a binary term generated using a serum 25(OH)D cut-point of 25 
nmol/L (10 ng/mL) was included as a covariate and as a component of a product term in the 
regression model. Similarly, testing for interaction by BMI category (normal (≤25 kg/m2), 
overweight (>25 - <30 kg/m2) and obese (≥30 kg/m2)) was performed. The step-down procedure 
of Holm (319) was used to control the family-wise error rate (table 3). Statistical analyses were 
performed using Stata (Version 14.0, Stata Corporation, TX, USA) and a two-sided p-value of 
0.05 was deemed statistical significance. 
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6.4 Results 
Of the 422 potential VIDEO participants screened at the Hobart site, 265 were randomised and 
assigned to the treatment or placebo groups. Of these, 104 participants in the treatment group 
(39.3%) and 113 participants in the placebo group (42.6%) had images of their trunk muscles 
taken at baseline for this sub-study. Ninety-five and ninety-one participants had trunk muscle 
images taken at follow-up one year later in the treatment and placebo groups respectively (Figure 
1).  
Table 1 summarises the baseline characteristics of participants in the treatment and placebo 
groups in this sub-study. The groups were reasonably well matched, with some difference in 
proportions for gender, low back pain, history of abdominal surgery, statins use and lower limb 
strength.  Overall knee pain scores measured by the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) were in the low ranges (122/500), while physical activity levels 
measured by the international physical activity questionnaire (IPAQ) were in the higher ranges 
(>3000 MET-minutes/week) (293). Mean serum 25(OH)D levels in the vitamin D group increased 
by 39.3 nmol/L (15.6 ng/ml) and 44.5 nmol/L (18.0 ng/ml) at 3 and 24 months respectively, 
compared with an initial increase of 17.6 nmol/L (7.2 ng/ml) at 3 months and a total increase of 
6.8 nmol/L (2.8 ng/ml) at 24 months in the placebo group. There were no baseline differences 
between the participants in this sub-study and the entire VIDEO cohort (n=413) (292). The BMI of 
the study population was relatively high (over 85% were overweight or obese). In the 172 
participants of this US sub-study who had serum 25(OH)D measured at 24 months, increase in 
serum 25(OH)D levels from baseline to 24 months in overweight (>25 - <30 kg/m2) and obese (
≥30 kg/m2) was 8.7 nmol/L (3.6 ng/ml) and 5.2 nmol/L (2.0ng/ml) lower respectively than in 
participants with normal BMI (≤25 kg/m2) and those. In fact, 76% of the treatment group 
achieved serum 25(OH)D levels ≥ 75 nmol/L (≥30 ng/ml)  by 24 months compared with only 
7% of the placebo group, the former including 25/33 (76%) of obese, 22/33 (67%) of overweight 
treatment arm participants. 
The between-group treatment effects for trunk muscle size and change in thickness with 
contraction were small (less than 4% in each muscle), inconsistent in direction and not 
statistically significant (Table 2 and 4). Adjusting for age, sex and BMI did not change these 
results (Table 3 and 5). While additional adjustment for leg strength increased the effect size for 
multifidus thickness at the L2/L3, L3/L4 and L4/L5 vertebral levels, the only between-group 
difference that was statistically significant after controlling for family-wise error was at the 
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L2/L3 vertebral level and the effect size (3.5%) remained small (Table 3 and 5). Results were 
similar after further adjustments for statin use, current low back pain, and history of abdominal 
or back surgery. There were not significant within-group differences in trunk muscle size or 
function over 12 months in either group. There were no interactions between treatment effect and 
either baseline 25(OH)D status or BMI in adjusted analyses for any muscle measure (all p<0.05).  
6.4.1 Adverse events 
A description of adverse events for the full clinical trial has been reported previously (292). In this 
sub-study, 44 (42%) out of 104 participants in the vitamin D group reported adverse events 
compared with 30 (27%) out of 113 participants in the placebo group (Table 6). Two cases of 
hypercalcemia were reported in each group. One instance of hyperthyroidism and two episodes 
of renal calculus were reported in the vitamin D group (292) 
6.5 Discussion 
To our knowledge, this is the first RCT investigating the effect of vitamin D supplementation on 
the morphology of key postural trunk muscles of older adults. Apart from the thickness of the 
MF muscles at the L2-L3 vertebral level, there were no statistically significant differences in 
change in muscle thickness or CSA between the vitamin D and placebo groups, and all effect 
sizes were small and not clinically significant. The results suggest that vitamin D 
supplementation alone is not an effective means to improve or maintain trunk muscle size over 
time for adults aged 50-79 years, even for those individuals with moderate to severe deficiency.  
The purpose of this study was to determine whether vitamin D supplementation alone had 
beneficial effects in maintaining or improving trunk muscle size and function. In the present 
study, the within-group changes in trunk muscle size and function over time were all very small. 
Despite there being plausible reasons to hypothesise that vitamin D supplementation could 
improve trunk muscle size, our results suggest that increases or maintenance of muscle size or 
function of older adults cannot be expected from vitamin D supplementation alone, at least over 
the limited timeframe of one year. In peripheral muscles, two systematic reviews reported 
positive effects of vitamin D supplementation on muscle strength in older adults with baseline 
25(OH)D <30 nmol/L (<12 ng/ml) (206, 216).  However, in our study of trunk muscles, the 
response to supplementation did not vary between people with moderate to severe deficiency 
(25(OH)D (<25 nmol/L, <10 ng/ml) at baseline and those with 25(OH)D levels above this level. 
Thus, even in people with this degree of deficiency, vitamin D supplementation does not 
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improve trunk muscle size or muscle function as assessed by change in muscle thickness during 
submaximal contraction. 
Whilst there is no consensus on the amount of variation in trunk muscle size required to ascertain 
clinically meaningful changes in these muscles (121), previous studies investigating the effect of 
exercise programs on trunk muscles in people with low back pain have found interventions that 
increased muscle size were associated with decreases in pain (174, 320, 321). The changes in muscle 
sizes observed in those studies were larger than those seen in our study, for example being over 
5% for measures of the multifidus and transversus abdominis muscles at rest (174, 320).  Thus, 
exercise programs or a combination of exercise and functional activities that target trunk muscles 
may be more effective in improving these muscles than vitamin D supplementation alone.  
The effects of vitamin D supplementation on peripheral muscle strength, mass and power have 
been examined in a systematic review and meta-analysis (216). The studies in this review 
administered a wide range of vitamin D doses (as low 300 IU per day, up to intermittent doses 
equivalent to around 8600 IU/day). For muscle strength, there was a small but statistically 
significant positive effect of vitamin D supplementation on lower limb muscle strength (19 
studies in 2349 people; vitamin D dose range 400 to 8600 IU; standard mean difference (SMD)= 
0.19 (95% CI 0.05–0.34)). However, there was no statistically significant effect of vitamin D 
supplementation on grip strength (16 studies, doses 400-8600 IU/d) nor on muscle mass (6 
studies, n=538, doses 300-4000 IU/d) or power (5 studies, n=245, doses 400-4000 IU/d). The 
latter is consistent with the lack of effect on muscle size observed in the current study, but as 
trunk muscle strength and power were not measured in our study, it remains to be determined 
whether vitamin D supplements affect strength or power in trunk muscles. 
Previous studies have reported improvements in measures of functional mobility (walking test 
and “timed up and go” test) and reduced risk of falls with vitamin D supplementation of older 
adults (56, 314). Although the present study did not investigate the effect of vitamin D 
supplementation on falls or functional mobility, our results suggest changes to these outcomes 
are not mediated by trunk muscle size. The effect of vitamin D supplementation on other aspects 
of trunk muscle function such as strength cannot be ruled out and should be the focus of future 
research. 
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6.6 Strengths and Limitations  
The strength of the current investigation is its design. It is a double-blind randomised controlled 
trial, which provides robust evidence regarding the efficacy of vitamin D supplementation for 
improving trunk muscle size. Participants in this study were community-dwelling adults with 
low serum 25(OH)D. This is the sub-population most likely to benefit from vitamin D 
supplementation. 
It has limitations nevertheless.  While the use of random allocation helps to reduce the possibility 
of imbalance between the treatment arms, in this case, randomisation did not produce exact 
balance. However, we collected information that made it possible to adjust for these factors and 
the results of the adjusted analyses did not alter the overall conclusions of the study. While the 
study sample was on average only mildly deficient, there was no interaction between treatment 
response and vitamin D status at baseline, suggesting that the results are generalizable to both 
mildly and moderately deficient people.  While our sample size was modest, we powered the 
study appropriately to detect treatment effects that were likely to be clinically meaningful based 
on existing literature (174, 320, 322). We are therefore unlikely to have failed to detect any clinically 
important treatment effects. The majority of participants were either overweight or obese, which 
could have influenced their serum 25(OH)D response to supplementation. However, participants 
with high BMI still achieved large increases in 25(OH)D and a much higher proportion of these 
participants reached levels ≥ 75 nmol/L (≥30 ng/ml) than in the placebo group. Furthermore, 
there was no interaction between treatment response and BMI, so the impact of being an obese 
population on our results was minimal. The lack of any interaction also suggests that our results 
are generalizable to people with OA who are of normal weight. It is possible mobility restrictions 
from knee OA may have affected participants’ ability to improve trunk muscle size. 
Nevertheless, levels of knee pain in the study were relatively low, functional limitations were 
modest and physical activity levels reasonable, which makes this scenario unlikely. We used a 
DiaSorin immunoassay method to measure serum 25(OH)D, rather than mass spectrometry 
which is considered the gold standard. However, mass spectrometry is not readily available in 
clinical practice, which would affect translation into practice and a recent study found that the 
DiaSorin immunoassay achieved acceptable performance when compared to mass spectrometry 
(323). Our only measure of muscle function was change in muscle thickness with contraction so 
we cannot rule out effects of vitamin D supplementation on other aspects of muscle function 
such as strength, power, physical function or falls. 
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6.7 Conclusion 
There is no evidence that a monthly dose of 50,000 IU of vitamin D3 alone has an effect on the 
size or ability to contract trunk muscles of independent, community-dwelling older adults with 
symptomatic knee osteoarthritis and low serum 25(OH)D levels regardless of BMI status or 
degree of vitamin D deficiency. An effect of vitamin D supplementation on other aspects of 
trunk muscle function such as strength, power or physical function cannot be ruled out. 
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   Table 6.1  Baseline characteristics of vitamin D and placebo groups  




Male sex % (n/N) 53 (55/104) 51 (58/113) 
Age (yrs.) 63.7 (7.4) 63.0 (7.3) 
Weight (kg) 84.4 (15.5) 84.4 (15.1) 
Height (cm)   169.1 (10.2) 170.0 (9.7) 
BMI (kg/m2) 29.5 (5.3) 29.5 (4.5) 
BMI ≤25 kg/m2 % (n/N) 15 (16/104) 11 (12/113) 
BMI >25 - <30 kg/m2 % (n/N) 47 (49/104) 43 (49/113) 
BMI ≥30 kg/m2 % (n/N) 38 (39/104) 46 (52/113) 
25-hydroxyvitamin D (nmol/L) 42.5 (12.0) 43.9 (12.1) 
Total knee WOMAC score (0-2400) 576.3 (394.9) 571.7 (373.3) 
    Pain (0-500) 121.3 (88.3) 122.7 (84.5) 
    Stiffness (0-200) 52.6 (41.9) 58.1 (40.5) 
    Function (0-1700) 402.4 (287.0) 390.9 (274.7) 
Physical activity – IPAQ score 3628.9 (4762.0) 3057.6 (3054.0) 
Current low back pain %(n/N) 39 (41/104) 34 (38/113) 
Current low back pain - VAS score 28.0 (19.3) 28.3 (22.0) 
History of low back surgery: % (n/N) 6 (6/104) 11.0 (12/113) 
History of abdominal surgery: % (n/N) 55 (57/104) 50 (56/113) 
Medication: Statins % (n/N) 6.7 (7/104) 12.0 (13/113) 
Lower limb strength (kg) 67.1 (42.9) 70.0 (44.8) 
Grip strength: right (kg) 30.7 (12.3) 30.8 (11.0) 
Grip strength: left (kg) 29.7 (12.0) 29.7 (11.1) 
All results reported mean (standard deviation) or % (n/N) where indicated.  BMI: body mass index. WOMAC, 
Western Ontario and McMaster Universities Osteoarthritis Index. IPAQ: International physical activity 
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Excluded (n= 157) 
   Ineligible pain (n=15) 
   Ineligible age (n=2) 
   Ineligible X-ray (n=9) 
   Ineligible VitD (n=4) 
   Having VitD (n=39) 
  Other arthritis (n=18) 
  Too unwell (n=10) 
  Not suitable for MRI (n=4) 
  Relocated (n=8) 
  Surgery (n=24) 
   Declined to participate (n=14  ) 
   Other reasons (n=10) 
Follow-up (n= 95) 
   Complete muscle measurements (n=80) 
   Incomplete muscle measurements (n=15) 
Lost to follow-up (n= 9) 
   Knee surgery (n=2) 
   Relocated (n=2) 
   Other (n=5) 
 
Allocated to vitamin D group (n=129) 
Lost to follow-up (n= 22) 
   Knee surgery (n=3) 
   Relocated (n=1) 
   Other (n=10) 
   Put on VitD (n=8) 
 
Allocated to placebo group (n=132) 
Follow-up (n= 91) 
   Complete muscle measurements (n=76) 
   Incomplete muscle measurements (n=15) 
Randomized (n=265) 
Withdrawn (n=4) 
















Screened for eligibility (n= 422)  
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Table 6.2 Changes in relaxed abdominal muscle thickness (cm) and in change in muscle thickness with contraction from baseline to follow-up by 
intervention group 
 Vitamin D group Placebo Group Between-group 
differences in 
change Muscle Baseline Follow up Change Baseline Follow up Change 



























































































































EO * 0.075 (0.009) 0.091 (0.010) 0.016 (0.010) 0.085 (0.009) 0.093 (0.010) 0.009 (0.010) 0.007 (0.014) 
               
 
All measures are in cm, and are reported as mean (standard error)  
Abbreviations: RA, rectus abdominis; TrA, transversus abdominis; IO, internal oblique; EO, external oblique  
* Absolute change in muscle thickness with contraction, calculated as (thickness when contracted – thickness when relaxed) 
† Statistically significant p<0.05 
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Table 6.3. Between group differences in changes in relaxed abdominal muscle thickness (cm) and in 
change in muscle thickness with contraction from baseline to follow-up without and with 
adjustment for relevant factors 
  Adjusted for 
Muscle Unadjusted model Age + Sex + BMI Age + Sex + BMI + Leg strength 
 



















































EO * 0.007 (-0.019, 0.034)  0.006 (-0.021, 0.034)  0.011 (-0.017, 0.040) 
         
 
All measures are in cm and are reported as mean (confident interval)  
Abbreviations: RA, rectus abdominis; TrA, transversus abdominis; IO, internal oblique; EO, external oblique  
* Absolute change in muscle thickness with contraction calculated as (thickness when contracted – thickness when 
relaxed) 
† Statistically significant p<0.05 
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All measures are in cm, and are reported as mean (standard error) 
Abbreviations: MF, multifidus muscle; CSA, cross-sectional area  
* Absolute change in muscle thickness with contraction calculated as (thickness when contracted – thickness when relaxed) 
† Statistically significant p<0.05 
Table 6.4 Changes in relaxed multifidus muscle thickness (cm), changes in muscle thickness with contraction and in changes cross-sectional area (cm2) 
from baseline to follow-up by intervention group 
 Vitamin D group Placebo Group Between-group 
differences in 
change Muscle Baseline Follow up Change Baseline Follow up Change 
 
Muscle thickness 




























































































































L5/S1_MF * 0.138 (0.019) 0.153 (0.020) 0.015 (0.021) 0.170 (0.018) 0.178 (0.020) 0.008 (0.021) 0.007 (0.030) 
 
Cross-sectional area  































L3_MF_CSA 3.500 (0.061) 3.830 (0.062) 0.330 (0.037) 3.423 (0.058) 3.774 (0.060) 0.350 (0.038) -0.021 (0.053) 
L4_MF_CSA 4.416 (0.068) 4.831 (0.069) 0.415 (0.038) 4.230 (0.065) 4.708 (0.067) 0.478 (0.039) -0.063 (0.054) 
L5_MF_CSA 5.211 (0.081) 5.519 (0.082) 0.307 (0.048) 4.979 (0.077) 5.399 (0.080) 0.420 (0.049) -0.112 (0.068) 
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Table 6.5 Between group differences in change in relaxed multifidus muscle thickness (cm), in 
change in muscle thickness with contraction and cross-sectional area (cm2) from baseline to follow-
up without and with adjustment for relevant factors 
 Adjusted for 
Muscle Unadjusted model Age + Sex + BMI Age + Sex + BMI + Leg strength 
 
















(0.048, 0.296) † ‡ 



















































L5/S1_MF * 0.007 (-0.052, 0.066)  0.015 (-0.043, 0.073)  0.017 (-0.044, 0.078) 
 

















L3_MF_CSA -0.021 (-0.125, 0.083)  -0.016 (-0.120, 0.089)  0.039 (-0.069, 0.147) 
L4_MF_CSA -0.063 (-0.169, 0.043)  -0.062 (-0.168, 0.045)  -0.041 (-0.148, 0.067) 
L5_MF_CSA -0.112 (-0.246, 0.022)  -0.129 (-0.260, 0.003)  -0.120 (-0.259, 0.019) 
         
 
All measures are in cm and are reported as mean (standard error)  
Abbreviations: MF, multifidus muscle; CSA, cross-sectional area  
* Absolute change in muscle thickness with contraction calculated as (thickness when contracted – thickness when 
relaxed) 
† Statistically significant p<0.05 
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Table 6.6 Adverse events 
  Vitamin D (N=104) 








Serious Adverse Events   
 
  
Death 1 (1.0)  0 (0.0) 
Malignancy 2 (1.9)  2 (1.8) 
Coronary artery disease 1 (1.0)  1 (0.9) 
Severe infection 0 (0.0)  1 (0.9) 
Major depression 1 (1.0)  0 (0.0) 
Nephrolithiasis 1 (1.0)  1 (0.9) 
Hospitalization 1 (1.0)  0 (0.0) 
   
 
  
Adverse Events   
 
  
Hypercalcemia 2 (1.9)  2 (1.8) 
Hyperparathyroidism 1 (1.0)  0 (0.0) 
Renal 2 (1.9)  0 (0.0) 
Falls 2 (1.9)  0 (0.0) 
Musculoskeletal 1 (1.0)  1 (0.9) 
Neurological 1 (1.0)  1 (0.9) 
Gastrointestinal 1 (1.0)  3 (2.7) 
Respiratory 2 (1.9)  1 (0.9) 
Ocular 1 (1.0)  1 (0.9) 
Infection 4 (3.9)  2 (1.8) 
Cardiac arrhythmia 1 (1.0)  0 (0.0) 
Chest pain 4 (3.9)  4 (3.5) 
Pain 6 (5.8)  2 (1.8) 
Allergy/immunology 0 (0.0)  2 (1.8) 
Other events^ 9 (8.7)  6 (5.3) 
 
^Including headache, lethargy, flu symptoms and other events. 
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Having studied the effects of Vitamin D supplementation on trunk muscle size, we proceeded to 
investigate another important gap in the literature identified in both the second section of the 
introduction chapter and the systematic review. As discussed in the second section of the 
introductory chapter, there was limited evidence for associations between trunk muscle measures 
and measures of physical function in older adults. The evidence is also conflicting, with studies 
reporting positive (7, 137, 271, 313)  and negative (145, 325) associations between measures of muscle 
size and composition and measures of physical function. The limited number of studies 
investigating the role that trunk muscle morphology plays in the physical function of older adults 
prompted us to address this important gap in the literature. Therefore, the study in this chapter 
aimed to evaluate cross-sectional associations between trunk muscle size and muscle function 
with measures of physical activity, physical function and quality of life in a sample of 
community-dwelling adults aged 50 – 79, with knee osteoarthritis and low-level serum 
25(OH)D. The following text in this chapter is in the last stages of preparation prior to 
submission to a peer review journal. 
7.2 Introduction 
Ageing has a detrimental effect on the mass, strength and size of upper and lower limb muscles, 
which is associated with deterioration in physical activity, physical function and quality of life, 
as well as an increase in fear of falling among older adults (11-15). Like peripheral muscles, there 
are age-related decreases in trunk muscle size and muscle function, reflected in the ability of 
people to activate their muscles to adjust posture and centre of gravity following external 
disturbances (138, 140-142). Muscles of the trunk are important for an individual’s ability to perform 
fundamental functional activities of daily living due to the complex role they play in load 
transfer, force dissipation, stability of the spine, control of balance and posture, and trunk and 
pelvic movement (6, 8, 9). In older adults, there is evidence for a detrimental effect on the size, 
composition and activation of the MF muscle by conditions which limit physical function, such 
as lumbar spine degeneration, degenerative lumbar scoliosis and low back pain (138). 
The trunk muscles investigated in this study included the rectus abdominis (RA), transversus 
abdominis (TrA), internal oblique (IO), external oblique (EO) and the lumbar multifidus (MF) 
muscles. The superficial abdominal muscles are torque producers of the trunk, while the deep 
abdominal and MF muscles are tonically active during weight bearing activities (76, 77, 132, 133, 135). 
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The MF muscle was chosen because of its prominent role in the function of the lumbar spine 
(149). It transfers loads through the lower spine and has a dual role as stabiliser of the spine, 
controlling intersegmental motion via its deep muscle fibres and generating trunk extension and 
control of posture and spine orientation via its superficial fibres (105, 107-109). 
There are few studies addressing whether size, activation and muscle quality of these trunk 
muscles are associated with measures of physical function in older adults. Some studies have 
reported negative associations between intramuscular fat infiltrations (muscle attenuation (MA)) 
in abdominal and MF muscles and measures of physical function (Short Physical Performance 
Battery (SPPB), gait speed, timed up and go test (TUG) and stair descent test) (145, 146, 325) and 
balance (271) in people with chronic low back pain (CLBP). However, it is not known whether 
these associations are similar in healthy, active, community dwelling older adults. These studies 
also demonstrate a lack of association between MF muscle size and measures of physical 
function in people with CLBP (145, 146, 271, 325). Contrary to these findings, a recent study reported 
significant positive associations between the RA muscle size and measures of functional 
mobility in community-dwelling adults aged 65 years and over (313), indicating a possible 
mediating role of trunk muscle size on the physical function of older adults. Understanding the 
role abdominal and MF muscle size and function play in healthy ageing and physical function of 
older adults is important, as these muscles are a potential target for interventions to improve or 
prevent the detrimental effect that age has on functional living. Therefore, the aim of this study 
was to investigate associations between abdominal and MF muscle size and the ability to 
contract these muscles (muscle function) and measures of physical activity, physical function 
and quality of life among active older adults.  
7.3 Methods 
7.3.1 Participants 
Participants were part of an ultrasound imaging (USI) sub-study of trunk muscles (n=217) 
conducted on participants from the “Vitamin D Effect on Knee Osteoarthritis” (VIDEO) clinical 
trial at the Tasmanian site (292). The VIDEO study was a randomised, placebo-controlled and 
double-blind clinical trial conducted between 2010 and 2013. The detailed study protocol, 
including inclusion and exclusion criteria, has previously been published (221). In brief, VIDEO 
participants were 50-79 year-old adults recruited from the general community in Tasmania and 
Victoria who had ongoing symptoms of knee osteoarthritis (OA) for at least six months, serum 
25-(OH)D levels between 12.5 and 60 nmol/L (5 to 24 ng/ml) and pain levels between 20-80 mm 
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on a 100 mm visual analogue scale (VAS) at baseline. Exclusion criteria included severe 
radiographic knee OA, severe pain (> 80 mm on a 100 mm VAS) on standing, hypersensitivity 
to vitamin D, any condition affecting oral drug absorption and anticipated need for knee or hip 
surgery within the 2-year duration of the clinical trial. Participants were randomly assigned to 
either a vitamin D treatment group (one 50,000 IU vitamin D3 capsule per month, for 24 
months) or a placebo group (identical inert placebo) using computer-generated allocation with a 
1:1 ratio (221). The Tasmania Health and Human Ethics Committee approved this study. All 
participants gave written informed consent. 
7.3.2 Physical activity, physical function and quality of life 
Physical activity was assessed by the International Physical Activity Questionnaire (IPAQ) and 
by pedometers. Participants self-reported information on vigorous and moderate activity as well 
as walking and sitting using the short form of IPAQ, which has been found to be valid and 
reliable (318, 326). Information on sitting was not included in the summary score of physical 
activity as per IPAQ guidelines (293, 318). Total summary scores for physical activity 
(MET/hour/week) were calculated following published guidelines (293, 318).  
Digi-Walker SW-200 (Yamax) pedometers were used to measure ambulatory physical activity. 
Participants recorded start and end times of usage each day, and total daily steps for 7 days. 
Daily entries were excluded for 4.3% (75/1742) of recordings as the pedometer was worn less 
than 8 hours, which was determined not to represent a full day (327).  A cap was not applied 
because the maximum recorded steps per day entry were <20000. Average daily steps were 
calculated for participants who recorded at least 5 daily readings (328). Pedometer data from 26 
participants were omitted from the analysis as they did not meet the 5-day reading criterion.  
Deficits in physical function were assessed by the functional deficit subscale of the Western 
Ontario and McMaster Universities Arthritis Index (WOMAC). The WOMAC is an 
osteoarthritis (OA) specific instrument widely used to assess the progression of disease 
symptoms and evaluate interventions. Its reliability and validity have been extensively tested (329-
331). The WOMAC version used in this study had three subscales; pain (5 questions), stiffness (2 
questions) and functional deficit (17 questions). The functional deficit subscale scores were used 
in this analysis. In this subscale, participants are asked how knee pain interfered with their 
physical function, specifically asking “Referring to your knees only, how much functional deficit 
do you experience when: descending stairs, ascending stairs, rising from bed, rising from sitting, 
putting on socks, taking off socks, bending to the floor, lying in bed, walking on flat surface, 
Chapter 7 – Associations between trunk muscles and physical activity and quality of life   123 
123 
 
getting in/out of the bath, standing, sitting, getting in/out of the car, getting on/off the toilet, 
heavy domestic chores, light domestic chores and shopping”. Each of the 17 functional deficit 
items was scored according to an analogue visual scale of difficulty from 0=None to 
100=Severe. The total score was obtained by adding the scores of the 17 items of the subscale 
(range 0 – 1700). Missing data were managed in accordance with the WOMAC user guide (294).  
Quality of life was assessed by the Assessment of Quality of Life instrument (AQoL) (295). This 
generic multi-attribute instrument has 5 subscales (illness, independent living, social 
relationships, physical senses and psychological well-being) containing three items per subscale 
and four potential responses per item (each item scored 1-4). It has high reliability and validity 
(intraclass correlation coefficient (ICC) > 0.76) in population-based settings, including for older 
adult populations (332, 333). The AQoL-4D used in this analysis is an indexed health utility score 
derived by scaling the scores of items 4-15 of the instrument (the illness subscale was excluded 
from the analysis as per the instrument scaling protocol (334)), and ranges from 1.0 (best) to -0.04 
(worst), with negative scores indicating a health state worse than death (295). The scores for each 
subscale ranged from 3-12, with higher scores indicating poorer quality of life.  
7.3.3 Trunk muscle morphology 
Abdominal and MF muscles were assessed using ultrasound imaging. A detailed description of 
the processes of image capture and measuring of abdominal and MF muscle thickness and MF 
cross-sectional area (CSA), as well test-retest reliability has previously been published (335). In 
brief, ultrasound images were obtained using a Phillips HDI 5000 diagnostic ultrasound machine 
(Bothwell, WA, USA) in brightness mode (B-mode) with a handheld C7-4 (4-7 MHz) broadband 
curved array transducer. The ultrasound imaging (USI) was conducted by a physiotherapist 
trained in USI. Images were stored and later measured offline by a single examiner using Image 
J software, version IJ 1.36B, http://imagej.nih.gov/ij/). ICC for abdominal and MF muscle 
measurements were ICC= 0.74-0.98 for test-retest reliability (335). 
Transverse images of the abdominal muscles were obtained with participants positioned in a 
supine position with a pillow positioned under their knees (121, 298). The RA muscle was imaged at 
rest and images of the TrA, IO and EO were obtained at rest and contracted. Thickness of the 
abdominal muscles was measured as the perpendicular distance between the superior and inferior 
hyperechoic muscle fascias at approximately the middle of the image identified using the 
software’s Cartesian coordinates (298). 
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Imaging of the MF muscles was carried out with participants lying prone with a pillow under 
their abdomen to reduce lumbar lordosis (122, 301, 317). Transverse images of the MF muscle were 
obtained at rest and parasagittal images were obtained both at rest and during muscle contraction, 
for which participants were directed to “take a relaxed breath in and out, hold your breath out 
and try to slowly “swell” and contract the muscle without moving the spine” (174). CSA of the 
MF muscle was measured by tracing around the inner edge of the fascial boundaries of the 
muscle (122, 315) and thickness was measured from the tip of the zygapophyseal joint to the inferior 
fascial edge of the superior border of the muscle (301).  
7.3.4 Anthropometric characteristics 
Height was measured by stadiometer to the nearest 0.1 cm (Leicester Height Measure, Invicta 
Plastics Ltd, Leicester, UK) and weight by calibrated scales (Heine S-7307, Heine, New 
Hampshire, USA). Body mass index (BMI) was calculated (weight (kg)/height (m2)).  
7.3.5 Statistical analysis 
Correlational analysis was used to estimate cross-sectional associations between abdominal and 
MF muscle thickness and MF CSA in the relaxed state, and muscle function (assessed by 
changes in muscle thickness on contraction) and four outcome factors: self-reported physical 
activity, ambulatory physical activity, WOMAC functional deficit score (294) and quality of life 
(AQoL) (295, 336). Because there were no statistically significant differences between the two 
sides, the means of the right and left muscle sizes were used in the analysis. The cross-sectional 
correlations between muscle size and physical activity and function did not differ systematically 
between the vitamin D and placebo groups (data not shown) so the data from the two treatment 
groups was pooled for these analyses. The results are reported as rank correlation coefficients 
adjusted for age, sex and body mass index (BMI).  
To assess the impact of knee pain and physical dysfunction on the outcomes, correlational 
analysis was used to estimate cross-sectional associations between the WOMAC pain scores 
and four outcome factors: self-reported physical activity using IPAQ (293), ambulatory physical 
activity, physical dysfunction (WOMAC subscale score) and quality of life (AQoL) (295, 336). 
Additionally, correlational analysis was used to estimate cross-sectional associations between 
the WOMAC pain and physical dysfunction subscales, and their associations with the measures 
of abdominal and MF muscle thickness and MF CSA. Finally,  cross-sectional associations 
between abdominal and MF muscle thickness and MF CSA in the relaxed state, and the four 
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outcome factors were adjusted by knee pain scores. We also report the correlations of self-
reported physical activity using IPAQ, ambulatory physical activity and quality of life (AQoL) 
with the muscle measures adjusted for physical dysfunction. 
 
7.4 Results 
Table 1 summarises the characteristics of participants. Of 217 participants, 48% were women. 
Women had higher average VAS scores for knee pain and functional deficit scores, but lower 
steps per day (7543 for men and 7300 for women respectively) and lower utility scores (AQoL-
4D) (0.780 for men and 0.715 for women, respectively). There were no baseline differences in 
age, sex, anthropometric measures or vitamin D status between the participants in this sub-study 
and the entire VIDEO cohort (n=413) (292). 
After adjusting for age, sex and BMI, all correlations between muscle size or function and 
measures of physical activity, physical function and quality of life were small (-0.173 –  0.099) 
and not statistically significant (Table 2 and 3). Other than an isolated instance (MET/hour/week 
and sex) among 48 tested, p-values for interaction by age or sex were greater than 0.1 (data not 
shown).  
Severity of knee pain measured using the WOMAC subscale scores (294) was not associated with 
physical activity measured using IPAQ (rank correlation adjusted for sex, age and BMI = –
0.056) or with ambulatory activity measured using pedometers (rank correlation adjusted for sex, 
age and BMI = –0.017). It was associated with physical dysfunction measured by the WOMAC 
subscale (rank correlation adjusted for sex, age and BMI= 0.808) and with quality of life 
measured by AQOL (rank correlation adjusted for sex, age and BMI = –0.295, p<0.001) (Table 
2). However, severity of knee pain was only weakly associated with trunk muscle size or 
activation (rank correlations adjusted for sex, age and BMI: -0.052 – 0.049). In consequence, it 
was not necessary to adjust the rank correlations of physical dysfunction and quality of life with 
muscle size for severity of knee pain because those adjustments produced only minor changes 
(data not shown). Similarly, physical dysfunction measured by the WOMAC subscale was 
associated with quality of life (rank correlation adjusted for sex, age and BMI = -0.354), but not 
with physical activity (rank correlation adjusted for sex, age and BMI = -0.085) or ambulatory 
activity (rank correlation adjusted for sex, age and BMI = -0.030), and adjusting the associations 
of quality of life with muscle measures for physical dysfunction produced changes of little 





To our knowledge, this is the first study investigating associations between the morphology and 
function of key postural trunk muscles and physical activity, physical dysfunction and quality of 
life of active older adults. Correlations between abdominal and MF muscle size and measures of 
physical activity, physical function or quality of life were small and not statistically significant 
indicating that muscle size and function (as determined by the change in thickness with 
submaximal contraction), may not contribute to these outcomes in older adults. Other measures 
such as trunk muscle attenuation and strength may be more relevant for functional outcomes in 
older adults. 
Our results are largely consistent with previous studies that have failed to demonstrate 
associations between abdominal and MF muscles and measures of physical function. In line with 
the findings in the present study, in a 3-year observational study of 1194 older adults, using 
computed tomography (CT) to assess abdominal and paraspinal muscles, CSA was not 
associated with tests used to assess physical function (p->0.05) (chair stands, timed standing 
balance, balance and 6 minute walk test (6MWT)) (145). Using magnetic resonance imaging 
(MRI) to measure MF muscle CSA and fat infiltrations at the L5 spinal level, Sions et al. (146) 
examined associations with measures of physical function (SF-36 PFS score, TUG, gait speed 
and fast stair descent) in 106 community-dwelling adults (60 – 85 years) that included people 
with and without CLBP. Their results showed that people with CLBP had worse self-reported 
and performance-based physical function, and that increased MF muscle fat infiltrations was 
associated with worse physical function among older adults. They also reported no association 
between MF muscle size and self-reported or performance-based physical function on older 
adults with or without CLBP. Despite the encouraging results from Shahtahmassebi et al (313), the 
results from previous studies and the current study suggest that neither abdominal or MF muscle 
size are associated with measures of physical activity, physical function or quality of life in older 
adults. 
In the present study, there was no association between abdominal and MF muscle size or ability 
to contract these muscles and the ambulatory activity level (steps/day) of the participants, even 
when knee pain was included as a potential confounder. Walking has many identified health 
benefits for older adults that include prevention of cardiovascular disease, control of blood 
glucose, reduction in risk of cognitive impairment and increased social interaction (337). Similar 
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to the findings in the present study, a 15-year observational study of monozygotic twins, reported 
that despite age-related decreases in MF and erector spinae muscle size, measured by MRI, there 
were no associations between levels of physical activity at work or leisure and changes in MF 
muscle size (268). Similarly, in a study of 281 adults aged 61-71 years, Azuma et al. (167) reported 
that paraspinal muscle CSA was not associated with habitual exercise (exercising for at least 30 
minutes per session, at least twice per week, for at least 1 year). Despite the health benefits of 
walking described above, there may be other elements such as increased exercise intensity, 
resistance exercises or weight bearing exercises that along with walking would be important to 
integrate in rehabilitation programs aiming to preserve abdominal and MF muscle size or 
function. 
In contrast to our findings for abdominal and MF muscle size, there is evidence that other 
properties of trunk muscle such as composition (fat infiltrations) and strength are associated with 
measures of balance and physical function. Cross-sectional and longitudinal studies have 
reported that increased fat infiltrations in abdominal and paraspinal muscles was associated with 
poorer physical function (slower gait speeds, reduced TUG and stair descent performance) (146) 
and was a predictor of poorer functional function over three years (145). Other studies have 
reported significant, positive associations between trunk muscle strength and measures of 
physical function, including the 30-second Chair Stand Test, the Sitting and Rising Test, the 6-
minute walk time test, Berg Balance Scale (313), Unipedal Stance Test and SPPB (7) and balance 
(338, 339). These studies included community-dwelling participants such as the ones in this study, 
and suggest that attributes of abdominal and MF muscles other than size, such as muscle 
composition and strength may be more relevant factors when investigating balance and physical 
function in older adults.  
One of the strengths of this study was the use of objective measures of physical activity i.e. 
pedometer, rather than subjective measures only, which are often overstated (327, 340, 341). Data are 
also presented on abdominal and MF muscle size at L2-L5 lumbar spine levels from 217 active 
older adults aged 50-79 (mean 63.3) years. This study also has some limitations. The participants 
were independent community-dwelling adults but with knee osteoarthritis and mild to moderate 
knee pain. Knee osteoarthritis is a common chronic joint disease (342) that is highly prevalent in 
older adults (343, 344), causes disability and pain and has the potential to influence physical activity 
and quality of life. However, the average knee pain levels for the participants in this study were 
relatively low, the participants were active (average steps per day >7300) and the average quality 
of life scores were in the high range. Consequently, the results from this study could, with 
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caution, be generalised to other older adults. It is important to note that the subscale of the 
WOMAC questionnaire used in this study is specifically designed for people with knee 
osteoarthritis to assess their perceptions of the effects of  their knee on physical functions , such 
as managing stairs, ambulating and some activities of daily living (ADLs).  Thus, while we can 
say that in people with moderately painful OA, size and activation of the trunk muscles 
measured are not associated with their perceptions of how their knee affects their physical 
function, further investigation is required before ruling out any association between trunk muscle 
size and activation and physical function more generally. It is possible that participants’ physical 
function would have been affected, but not related to knee pain, which could have caused 
underreporting of limitations and could have affected our results.  It may also be possible that the 
associations between muscles of the trunk and physical function could have differed if a tool 
specifically designed to assess physical function e.g. SPPB had been used. Finally, the 
participants in this study had low serum vitamin D levels which could affect physical function 
and may conceal any relationship between physical function and muscle size. 
The current study contributes to a limited body of knowledge on the associations between 
abdominal and MF muscle size and measures of physical activity, physical function and quality 
of life, specifically in active adults aged 50-79 years. Although our results indicate a lack of 
association between abdominal and MF muscle size and function and measures of physical 
activity, physical function and quality of life, these should be interpreted within the limitations of 
the measures used to assess muscle function and physical function. Future studies should 
examine what other factors affect trunk muscles of older adults, the long-term effects of declines 
in muscle size on physical activity, physical function and quality of life of older adults and 
potential intervention strategies that can be implemented to mitigate the effect of age-related 
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Table 1. Characteristics of participants   
 Males Females 
Sex % (n/N) 52.1 (113/217) 47.9 (104/217) 
Age (yrs.) 63.7 (7.3) 62.0 (7.2) 
Weight (kg) 90.8 (12.5) 77.5 (15.0) 
Height (cm)   176.3 (6.4) 161.2 (6.5) 
BMI (kg/m2) 29.2 (3.8) 30.0 (5.8) 
Vitamin D (nmol/L) 44.4 (11.5) 41.9 (12.5) 
Current back pain %(n/N) 31.0 (35/113) 29.0 (30/104) 
VAS score for current low back pain‡ 32.1 (18.6) 32.0 (25.1) 
WOMAC score for knee pain (0-500) 113.3 (81.5) 131.5 (90.4) 
Mean muscle thickness (cm)†     
RA (cm) 0.91 (0.17) 0.76 (0.18) 
TrA muscle thickness 0.44 (0.1) 0.34 (0.1) 
IO muscle thickness 0.91 (0.26) 0.71 (0.18) 
EO muscle thickness 0.46 (0.12) 0.42 (0.12) 
Multifidus muscle thickness (L2-L3) 2.86 (0.45) 2.41 (0.38) 
Multifidus muscle thickness (L3/L4) 2.53 (0.38) 2.11 (0.48) 
Multifidus muscle thickness (L4/L5) 3.06 (0.45) 2.69 (0.51) 
Multifidus muscle thickness (L5/S1) 2.95 (0.41) 2.52 (0.52) 
Mean multifidus CSA (cm2)†     
      L2 2.82 (0.48) 2.47 (0.52) 
      L3 3.64 (0.52) 3.26 (0.61) 
      L4 4.47 (0.58) 4.15 (0.72) 
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      L5 5.31 (0.74) 4.83 (0.88) 
MET-hour-week (IPAQ) 67.3 (68.5) 43.0 (62.0) 
Steps per day (Pedometer) 7542.6 (3049.6) 7300.4 (3320.2) 
     
Functional deficit score (WOMAC)  
(ranges 0-1700) 
370.7 (272.8) 424.4 (286.4) 
Quality of life (AQoL-4D utility score) 
(ranges -0.04*=worst to 1=best) 
0.780 (0.2) 0.715 (0.2) 
     
All results reported mean (standard deviation) or % (n/N) where indicated.  BMI: body mass 
index. ‡VAS: visual analogue scale (0-10 where 0=no pain and 10=very worst pain). † 
because there were no statistically significant differences between the two sides, the means of 
the right and left muscle sizes were used in the analysis. RA: rectus abdominis muscle, lateral 
abdominals: transversus abdominis, internal oblique and external oblique muscles, CSA: 
cross-sectional area, IPAQ: International Physical Activity Questionnaire, WOMAC Western 
Ontario and McMaster Universities Osteoarthritis Index. AQoL The Assessment of Quality 
of Life instrument; utility scores scale from 1.0 (best) to -0.04 (worst) 
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Table 2. Cross-sectional correlations between abdominal and multifidus muscles in the relaxed 
state and physical activity, ambulatory activity, physical function and quality of life of adults 50-79 
years of age.  
 










 Quality of 
life 
(AQoL) 
Abdominal muscles thickness in relaxed state 
RA 
 
0.099  0.01  -0.02  -0.075 
TrA -0.017  0.094  0.022  -0.056 
IO 0.035  0.026  0.088  -0.071 
EO -0.066  -0.005  0.029  0.033 
      
Multifidus muscle thickness in relaxed state  
L2/L3 0.012  -0.046  0.034  0.005 
L3/L4 -0.043  -0.129  0.101  0.014 
L4/L5 -0.05  -0.115  0.055  0.057 
L5/S1 -0.02  -0.087  0.054  0.07 
Multifidus muscle cross-sectional area in relaxed state 
L2 
 
 0.093  0.06  -0.039  -0.062 
L3 0.064  -0.015  -0.126  -0.072 
L4 0.007  0.000  -0.044  -0.115 
L5  -0.04  -0.021  0.041  -0.173 
         
 
Abbreviations: IPAQ, International Physical Activity Questionnaire; WOMAC, Western Ontario 
and McMaster Universities Osteoarthritis Index; AQoL, The Assessment of Quality of Life 
instrument; RA, rectus abdominis; Lateral abdominals, transversus abdominis, internal oblique 
and external oblique muscles; * indicates statistically significant p<0.05; muscle sizes used in the 
models were averages of sides. 
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Table 3. Cross-sectional correlations between change in thickness with sub-maximal contraction 
(muscle function) of abdominal and multifidus muscles and physical activity, ambulatory activity, 
physical function and quality of life of adults 50-79 years of age.  
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Abbreviations: IPAQ, International Physical Activity Questionnaire; WOMAC, Western Ontario 
and McMaster Universities Osteoarthritis Index; AQoL, The Assessment of Quality of Life 
instrument; RA, rectus abdominis; Lateral abdominals, transversus abdominis, internal oblique 
and external oblique muscles; * indicates statistically significant p<0.05; muscle sizes used in the 
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8.1 Background and aims of the thesis 
By 2050, the global population of people aged 60 years and over will double, and the number of 
people over 80 years will triple (1). This will have profound consequences on social-support 
systems and health budgets (2). As the number of people aged 50 years and older increases, the 
number of people in the workforce within this age bracket is likely to increase as well. (345). 
Therefore, it is important to identify factors that have the potential to affect healthy ageing and 
implement strategies that would increase the likelihood of maintaining the physical capacity for 
work and activities of daily living of people 50 years and over to enable this population to 
continue their participation in the workforce and enjoy a healthy ageing process. The muscles of 
the trunk have the potential to play a key role in maintaining older adults’ physical capacity due 
to the complex role these muscles play in load transfer from the upper limbs to the pelvis, force 
dissipation, control of balance and posture, and movement of the trunk and pelvis (6, 8, 9). 
Therefore, it is essential to have a good understanding of possible causes of decline in the size 
and function of the muscles of the trunk, and how such declines could potentially affect people’s 
physical capacity and limit their quality of life.  
8.1.1 Aims 
It is well known that upper and lower limb muscles decrease in size and strength with increasing 
age. Both have been shown to be associated with decreases in physical function and quality of 
life of older adults. Among young adults, it has been shown that decreased muscle size and 
changes in activation of the abdominal and MF muscles are associated with LBP. However, there 
is little information regarding the changes in size that muscles of the trunk undergo with age and 
the effect these changes may have on the physical functioning of older adults. Therefore, the 
overarching aim of this thesis was to improve knowledge and understanding of the muscles of 
the trunk in older adults.  
The specific aims of this thesis were: (1) to identify factors that affect the morphology, 
composition and function of the muscles of the trunk, (2) to ascertain whether a therapeutic 
intervention that has long been suggested for this population would have an effect on the size 
and function of these muscles, and (3) to ascertain whether age-related changes in the size of 
these muscles affect the physical activity levels, physical function and quality of life of older 
adults. In order to address the specific aims, a study was undertaken to investigate whether the 
reliability of USI as a tool to measure the size of these muscles in older adults was adequate for 
its use in clinical and epidemiology research addressing aims (2) and (3). 
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8.2 Key findings, limitations and future directions 
In order to ascertain what was known about muscles of the trunk in older adults, a systematic 
review was undertaken. Chapter 3 of this thesis provided a comprehensive and systematic 
assessment of the current literature investigating abdominal and multifidus muscle in adults aged 
50 years and older. The results from the systematic review in Chapter 3 confirmed that there was 
a paucity of information available on the therapeutic benefits of vitamin D supplementation on 
muscles of the trunk and that little was known about the role these muscles play in the physical 
functioning and quality of life of older adults. It also reinforced the need to undertake further 
reliability studies to ascertain the reliability and validity of USI as a tool to measure the size of 
abdominal and MF muscles. Chapters 5-7 addressed the second and third parts of the aims of this 
research project and filled important gaps in the literature identified in the systematic review. 
Studies in Chapters 5 - 7 used data from an ultrasound imaging sub-study (n=217) of the Vitamin 
D Effect on Osteoarthritis (VIDEO) clinical trial, conducted between June 2010 and December 
2013. The participants were community-dwelling adults aged 50-79 years with ongoing 
symptoms of knee osteoarthritis and serum 25(OH)D levels between 12.5 and 60 nmol/L.  
8.2.1 Key findings 
The systematic review in Chapter 3 showed that size, strength, activation and quality of the 
muscles of the trunk could be influenced by ageing, spinal conditions, LBP, stroke or decreased 
physical activity. In the remainder of this project, it was decided to focus attention on the size of 
the abdominal and MF muscles as important muscles of the trunk. This was an important 
consideration because it enabled focus on the specific characteristics of individual muscles. 
Other aspects of muscle function such as strength and power were not considered because the 
measurements cannot be made for individual muscles. Trunk muscle activation was also not 
investigated because the studies that used EMG to measure trunk muscles of older adults were 
conflicting. The assessment of muscle composition requires expensive equipment. 
One of the gaps in the literature identified in the systematic review was a lack of information 
about the test-retest of measurements of trunk muscle size using USI in older adults. This 
prompted undertaking of a test-retest reliability study of USI for the assessment of abdominal 
and MF muscle thickness and CSA in adults aged 50-79 years (Chapter 5). The results showed 
moderate to substantial reliability for the majority of muscles measured and confirmed the 
appropriateness of using these measures in longitudinal studies and as outcomes for RCTs.  
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Having established that USI was a reliable tool to measure abdominal and MF muscles size, USI 
was used to fill another gap in the literature identified in the systematic review by investigating a 
potential cost-effective intervention for the maintenance of abdominal and MF muscles. Vitamin 
D supplementation has long been mooted as a therapeutic intervention for skeletal muscle, but no 
studies were found on its efficacy for abdominal or MF muscles. Chapter 3 presented a study 
investigating the effect of vitamin D supplementation on abdominal and MF muscles in vitamin 
D deficient adults 50 - 79 years. This study provided robust evidence for a lack of effect of 
vitamin D supplementation on the size or function of the abdominal and MF muscles of older 
adults, hence informing clinicians treating patients affected by the effects of vitamin D 
deficiency that vitamin D supplementation alone is not an effective therapy to improve or 
preserve the size, or ability to contract of these postural muscles of the trunk. Future vitamin D 
trials need to focus instead on measures of trunk muscle strength and fat infiltrations. This is 
because the literature on the effect of vitamin D on skeletal muscle is conflicting (216, 311) and 
recent studies indicate that changes in trunk muscle strength and fat infiltrations appear to be an 
important determinant of physical function of older adults (7, 313, 338, 339).  
A further gap in the literature was the limited number of studies investigating associations 
between muscles of the trunk and measures of physical activity, physical function or quality of 
life, particularly in healthy older adults. This prompted the investigation of associations between 
abdominal and multifidus muscle size and function (assessed by changes in muscle thickness on 
contraction) and measures of physical activity, physical function and quality of life among 
healthy, community-dwelling adults aged 50-79 years with knee osteoarthritis (Chapter 7). This 
study revealed only weak cross-sectional correlations between abdominal or MF muscle size or 
function and measures of physical activity, functional deficit subscale of the WOMAC or quality 
of life. Despite the limitations, the findings in this study are consistent with current literature (145, 
279)  indicating that muscle size may not be an important determinant of physical activity, 
physical function or have an impact on older adult’s quality of life. Therefore, these findings 
inform both clinicians designing rehabilitation programs for older adults and future research in 
the area.  
Finally, the systematic review update (second part of Chapter 3) included several studies that 
filled some of the gaps identified in the systematic review. These included studies examining the 
validity and reliability for the assessment abdominal and MF muscles using imaging techniques 
and importantly, studies investigating associations between trunk muscle morphology and 
quality and measures of physical function. The latter studies suggest that abdominal and MF 
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muscle strength and muscle quality are important determinants of physical function in older 
adults. Therefore, these factors would appear to be promising directions for future research 
investigating the effect of age-related changes in abdominal and MF muscles on physical 
function and quality of life of older adults. 
8.2.2 Strengths and limitations 
Collectively, the findings within this thesis have contributed to the limited knowledge-base on 
the abdominal and MF muscles in older adults by identifying and addressing some critical gaps 
in the literature. This thesis followed a systematic approach to the collection of information and 
provided a summary of the current literature on abdominal and MF muscles. The double-blind 
RCT design of the study in Chapter 6 provided robust evidence regarding the efficacy of vitamin 
D supplementation for improving or maintain trunk muscle size. Lastly, the use of objective 
measures of physical activity and the use of a highly reliable and valid instrument to measure 
quality of life added strength to the findings in Chapter 7. However, the findings from the studies 
in this thesis should be interpreted within the context of their limitations.  
In relation to the systematic review, the focus was on studies that used EMG and imaging 
techniques to assess muscles individually. Therefore, studies that used other methods of 
assessing trunk muscle structure or function were not included. The study in Chapter 7 has 
several important limitations, including the cross-sectional design that does not allow inferences 
about causation to be drawn. The indicator of muscle function used, was change in muscle 
thickness with contraction, and hence it was not possible to tell if other aspects of muscle 
function may have been affected by vitamin D supplementation. The measure of physical 
function was part of a questionnaire tailored to assess the effects of knee OA on physical 
function and thus has an emphasis on activities that involve primarily the use of the lower limbs, 
and not specifically muscles of the trunk. 
8.2.3 Future directions 
In compiling this thesis, several directions for future research have become evident and are 
outlined below: 
 Longitudinal studies investigating the effect of potential age-related factors that can 
affect muscles of the trunk and the effect of pathological conditions. These studies will 
inform the development of strategies to counteract any detrimental effect of those factors 
on muscles of the trunk. 
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 Longitudinal studies investigating association between trunk muscle morphology, 
strength or fat infiltrations and measures of physical activity, physical function or quality 
of life.  
 Studies investigating cost-effective interventions that would help individuals mitigate the 
effects of ageing or pathology on muscles of the trunk.   
 Longitudinal studies investigating the effect of vitamin D supplementation on trunk 
muscle size, strength or fat infiltrations, for people with severe vitamin D deficiency or 
for people with restricted mobility. These studies would inform clinicians about potential 
cost-effective therapies for people affected by vitamin D deficiency. 
8.3 Conclusion 
In conclusion, the information presented in this thesis has shown that age and various spinal 
conditions, LBP and stroke have detrimental effects on abdominal and MF muscle size, strength, 
activation and muscle quality, reflected in an increase in intramuscular fat infiltrations. The 
analysis of data from a USI sub-study of a clinical trial demonstrated that in active, community-
dwelling adults aged 50 to 79 years with low serum vitamin D levels and knee osteoarthritis, 
abdominal or MF muscles size may not be an important determinant of physical capacity 
outcomes. The effect of strength and intramuscular fat infiltrations on muscles of the trunk 
appear to be promising directions for future research when investigating the effect of age-related 





Chapter 9 -References           139 
139 
 











1. United Nations: Department of Economic and Social Affairs. Population Division. 
(2017). World Population Prospects: The 2017 Revision, Methodology of the United 




2. Chatterji S, Byles J, Cutler D, Seeman T, Verdes E. (2015). Health, functioning, and 
disability in older adults—present status and future implications. Lancet. 385(9967):563-
75 
 
3. Australian Institute of Helath and welfare. (2015 - 2016). Government spending on Aged 
care. 'Retrieved from': https://www.gen-agedcaredata.gov.au/Topics/Government-
spending-on-aged-care. 
 
4. Australian Institute of Health and Welfare. (2017). Demographics and diseases: hospital 




5. Scott D, Blizzard L, Fell J, Jones G. (2011). The epidemiology of sarcopenia in 
community living older adults: what role does lifestyle play? J Cachexia Sarcopenia 
Muscle.1-10 
 
6. Granacher U, Gollhofer A, Hortobagyi T, Kressig RW, Muehlbauer T. (2013). The 
importance of trunk muscle strength for balance, functional performance, and fall 
prevention in seniors: a systematic review. Sports Med. 43(7):627-41 
 
7. Suri P, Kiely DK, Leveille SG, Frontera WR, Bean JF. (2009). Trunk muscle attributes 
are associated with balance and mobility in older adults: a pilot study. PM R. 1(10):916-
24 
 
8. Ekstrom RA, Donatelli RA, Carp KC. (2007). Electromyographic analysis of core trunk, 
hip, and thigh muscles during 9 rehabilitation exercises. J Orthop Sports Phys Ther. 
37(12):754-62 
 
9. Bergmark A. (1989). Stability of the lumbar spine. A study in mechanical engineering. 
Acta Orthop Scand Suppl. 230(sup230):1-54 
 
10. Anderson BD, Spector A. (2000). Introduction to Pilates-based rehabilitation. Orthop 
Chapter 9 -References           141 
141 
 
Phys Ther Clin N Am. 9(3):395-410 
 
11. Janssen I, Heymsfield SB, Wang ZM, Ross R. (2000). Skeletal muscle mass and 
distribution in 468 men and women aged 18–88 yr. J Appl Physiol. 89(1):81-8 
 
12. Trombetti A, Reid KF, Hars M, Herrmann FR, Pasha E, Phillips EM, et al. (2016). Age-
associated declines in muscle mass, strength, power, and physical performance: impact 
on fear of falling and quality of life. Osteoporos Int. 27(2):463-71 
 
13. Charlier R, Mertens E, Lefevre J, Thomis M. (2015). Muscle mass and muscle function 
over the adult life span: a cross-sectional study in Flemish adults. Arch Gerontol Geriatr. 
61(2):161-7 
 
14. Maden-Wilkinson TM, McPhee JS, Jones DA, Degens H. (2015). Age-related loss of 
muscle mass, strength, and power and their association with mobility in recreationally-
active older adults in the United Kingdom. J Aging Phys Act. 23(3):352-60 
 
15. Tyrovolas S, Koyanagi A, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, et al. (2015). 
The role of muscle mass and body fat on disability among older adults: a cross-national 
analysis. Exp Gerontol. 69:27-35 
 
16. Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. (1999). Predictors of 
skeletal muscle mass in elderly men and women. Mech Ageing Dev. 107(2):123-36 
 
17. Doherty TJ. (2003). Invited review: Aging and sarcopenia. J Appl Physiol (1985). 
95(4):1717-27 
 
18. Evans WJ. (2010). Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am J Clin 
Nutr. 91(4):1123S-7S 
 
19. Janssen I, Heymsfield SB, Ross R. (2002). Low relative skeletal muscle mass 
(sarcopenia) in older persons is associated with functional impairment and physical 
disability. J Am Geriatr Soc. 50(5):889-96 
 
20. Roubenoff R. (2000). Sarcopenia and its implications for the elderly. Eur J Clin Nutr. 54 
Suppl 3:S40-7 
 
21. Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, et 
al. (1994). Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying 
reduced body cell mass in chronic inflammation. J Clin Invest. 93(6):2379-86 
 
22. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. (2010). 
Chapter 9 -References           142 
142 
 
Sarcopenia: European consensus on definition and diagnosis: Report of the European 
Working Group on Sarcopenia in Older People. Age Ageing. 39(4):412-23 
 
23. Melton 3rd L, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM, Riggs BL. (2000). 
Epidemiology of sarcopenia. J Am Geriatr Soc. 48(6):625 
 
24. Hughes VA, Frontera WR, Wood M, Evans WJ, Dallal GE, Roubenoff R, et al. (2001). 
Longitudinal muscle strength changes in older adults: influence of muscle mass, physical 
activity, and health. J Gerontol A Biol Sci Med Sci. 56(5):B209-17 
 
25. Dominguez LJ, Barbagallo M, Lauretani F, Bandinelli S, Bos A, Corsi AM, et al. (2006). 
Magnesium and muscle performance in older persons: the InCHIANTI study. Am J Clin 
Nutr. 84(2):419-26 
 
26. Takahashi K, Takahashi H, Nakadaira H, Yamamoto M. (2006). Different changes of 
quantity due to aging in the psoas major and quadriceps femoris muscles in women. J 
Musculoskelet Neuronal Interact. 6(2):201 
 
27. Drey M. (2011). Sarcopenia–pathophysiology and clinical relevance. WMW Wiener 
Medizinische Wochenschrift.  
 
28. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. 
(1998). Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 
147(8):755-63 
 
29. Thomas DR. (2010). Sarcopenia. Clin Geriatr Med. 26(2):331-46 
 
30. Rosenberg IH. (1997). Sarcopenia: origins and clinical relevance. J Nutr. 127(5 
Suppl):990S-1S 
 
31. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB. (2010). Sarcopenia: 
etiology, clinical consequences, intervention, and assessment. Osteoporos Int. 21(4):543-
59 
 
32. Scherbakov N, Doehner W. Sarcopenia in stroke—facts and numbers on muscle loss 
accounting for disability after stroke. Springer; 2011. 
 
33. Aagaard P, Suetta C, Caserotti P, Magnusson SP, Kjær M. (2010). Role of the nervous 
system in sarcopenia and muscle atrophy with aging: strength training as a 
countermeasure. Scand J Med Sci Sports. 20(1):49-64 
 
34. Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y, et al. (2014). 
Chapter 9 -References           143 
143 
 
Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. 
Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 
43(6):748-59 
 
35. Dam TT, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R, et al. (2014). An 
evidence-based comparison of operational criteria for the presence of sarcopenia. J 
Gerontol A Biol Sci Med Sci. 69(5):584-90 
 
36. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. (2011). 
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: 
prevalence, etiology, and consequences. International working group on sarcopenia. J Am 
Med Dir Assoc. 12(4):249-56 
 
37. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, et al. (2011). 
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 
12(6):403-9 
 
38. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. (2018). 
Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 
48(1):16-31 
 
39. Zanker J, Scott D, Reijnierse E, Brennan-Olsen S, Daly R, Girgis C, et al. (2019). 
Establishing an operational definition of sarcopenia in Australia and New Zealand: delphi 
method based consensus statement. The journal of nutrition, health & aging. 23(1):105-
10 
 
40. Muscaritoli M, Anker S, Argilés J, Aversa Z, Bauer J, Biolo G, et al. (2010). Consensus 
definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special 
Interest Groups (SIG)“cachexia-anorexia in chronic wasting diseases” and “nutrition in 
geriatrics”. Clinical Nutrition. 29(2):154-9 
 
41. Narici MV, Maffulli N. (2010). Sarcopenia: characteristics, mechanisms and functional 
significance. Br Med Bull. 95(1):139-59 
 
42. Roubenoff R, Hughes VA. (2000). Sarcopenia. J Gerontol A Biol Sci Med Sci. 
55(12):M716 
 
43. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. (2001). Sarcopenia. J Lab 
Clin Med. 137(4):231-43 
 
44. Frontera WR, Hughes VA, Lutz KJ, Evans WJ. (1991). A cross-sectional study of muscle 
strength and mass in 45- to 78-yr-old men and women. J Appl Physiol (1985). 71(2):644-
50 




45. Campbell MJ, McComas AJ, Petito F. (1973). Physiological changes in ageing muscles. J 
Neurol Neurosurg Psychiatry. 36(2):174-82 
 
46. Goodpaster BH, Thaete FL, Kelley DE. (2000). Composition of skeletal muscle 
evaluated with computed tomography. Ann N Y Acad Sci. 904(1):18-24 
 
47. Heymsfield SB, Stevens V, Noel R, McManus C, Smith J, Nixon D. (1982). Biochemical 
composition of muscle in normal and semistarved human subjects: relevance to 
anthropometric measurements. Am J Clin Nutr. 36(1):131-42 
 
48. Frontera WR, Hughes VA, Fielding RA, Fiatarone MA, Evans WJ, Roubenoff R. (2000). 
Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol (1985). 88(4):1321-6 
 
49. Frontera WR, Reid KF, Phillips EM, Krivickas LS, Hughes VA, Roubenoff R, et al. 
(2008). Muscle fiber size and function in elderly humans: a longitudinal study. J Appl 
Physiol (1985). 105(2):637-42 
 
50. Atherton PJ, Smith K. (2012). Muscle protein synthesis in response to nutrition and 
exercise. J Physiol. 590(5):1049-57 
 
51. Morley JE. (1997). Anorexia of aging: physiologic and pathologic. Am J Clin Nutr. 
66(4):760-73 
 
52. Ding J, Kritchevsky SB, Newman AB, Taaffe DR, Nicklas BJ, Visser M, et al. (2007). 
Effects of birth cohort and age on body composition in a sample of community-based 
elderly. Am J Clin Nutr. 85(2):405-10 
 
53. Ritz E, Boland R, Kreusser W. (1980). Effects of vitamin D and parathyroid hormone on 
muscle: potential role in uremic myopathy. Am J Clin Nutr. 33(7):1522-9 
 
54. Simpson RU, Thomas GA, Arnold AJ. (1985). Identification of 1,25-dihydroxyvitamin 
D3 receptors and activities in muscle. J Biol Chem. 260(15):8882-91 
 
55. Gloth 3rd F, Smith CE, Hollis BW, Tobin JD. (1995). Functional improvement with 
vitamin D replenishment in a cohort of frail, vitamin D-deficient older people. J Am 
Geriatr Soc. 43(11):1269 
 
56. Verhaar HJ, Samson MM, Jansen PA, de Vreede PL, Manten JW, Duursma SA. (2000). 
Muscle strength, functional mobility and vitamin D in older women. Aging (Milano). 
12(6):455-60 
 
Chapter 9 -References           145 
145 
 
57. Dhesi JK, Bearne LM, Moniz C, Hurley MV, Jackson SH, Swift CG, et al. (2002). 
Neuromuscular and psychomotor function in elderly subjects who fall and the 
relationship with vitamin D status. J Bone Miner Res. 17(5):891-7 
 
58. Pfeifer M, Begerow B, Minne HW. (2002). Vitamin D and muscle function. Osteoporos 
Int. 13(3):187-94 
 
59. Ceglia L. (2009). Vitamin D and its role in skeletal muscle. Curr Opin Clin Nutr Metab 
Care. 12(6):628-33 
 
60. Bartoszewska M, Kamboj M, Patel DR. (2010). Vitamin D, muscle function, and 
exercise performance. Pediatr Clin North Am. 57(3):849-61 
 
61. Hamilton B. (2010). Vitamin D and human skeletal muscle. Scand J Med Sci Sports. 
20(2):182-90 
 
62. Melzer I, Benjuya N, Kaplanski J. (2004). Postural stability in the elderly: a comparison 
between fallers and non-fallers. Age Ageing. 33(6):602-7 
 
63. Scott D, Blizzard L, Fell J, Ding C, Winzenberg T, Jones G. (2010). A prospective study 
of the associations between 25‐hydroxy‐vitamin D, sarcopenia progression and physical 
activity in older adults. Clin Endocrinol (Oxf). 73(5):581-7 
 
64. Scott D, Blizzard L, Fell J, Jones G. (2010). Prospective associations between ambulatory 
activity, body composition and muscle function in older adults. Scand J Med Sci Sports.  
 
65. Kent-Braun JA, Ng AV, Young K. (2000). Skeletal muscle contractile and noncontractile 
components in young and older women and men. J Appl Physiol (1985). 88(2):662-8 
 
66. Scott D, Blizzard L, Fell J, Jones G. (2009). Ambulatory activity, body composition, and 
lower-limb muscle strength in older adults. Med Sci Sports Exerc. 41(2):383-9 
 
67. Klitgaard H, Mantoni M, Schiaffino S, Ausoni S, Gorza L, Laurent-Winter C, et al. 
(1990). Function, morphology and protein expression of ageing skeletal muscle: a cross-
sectional study of elderly men with different training backgrounds. Acta Physiol Scand. 
140(1):41-54 
 
68. Barnes J, Behrens TK, Benden ME, Biddle S, Bond D, Brassard P, et al. (2012). Letter to 
the Editor: Standardized use of the terms" sedentary" and" sedentary behaviours". Appl 
Physiol Nutr Metab. 37(3):540-2 
 
69. Gennuso KP, Gangnon RE, Matthews CE, Thraen-Borowski KM, Colbert LH. (2013). 
Chapter 9 -References           146 
146 
 
Sedentary behavior, physical activity, and markers of health in older adults. Med Sci 
Sports Exerc. 45(8):1493-500 
 
70. Gennuso KP, Thraen-Borowski KM, Gangnon RE, Colbert LH. (2016). Patterns of 
sedentary behavior and physical function in older adults. Aging Clin Exp Res. 28(5):943-
50 
 
71. Lee J, Chang RW, Ehrlich-Jones L, Kwoh CK, Nevitt M, Semanik PA, et al. (2015). 
Sedentary behavior and physical function: objective evidence from the Osteoarthritis 
Initiative. Arthritis Care Res (Hoboken). 67(3):366-73 
 
72. Semanik PA, Lee J, Song J, Chang RW, Sohn MW, Ehrlich-Jones LS, et al. (2015). 
Accelerometer-monitored sedentary behavior and observed physical function loss. Am J 
Public Health. 105(3):560-6 
 
73. Moore K, Dalley A, Agur AM.  XIII. 2018. Clinically Oriented Anatomy. Philadelphia: 
Lippincott Williams & Wilkins  
 
74. Kibler WB, Press J, Sciascia A. (2006). The role of core stability in athletic function. 
Sports Med. 36(3):189-98 
 
75. Cholewicki J, Juluru K, McGill SM. (1999). Intra-abdominal pressure mechanism for 
stabilizing the lumbar spine. J Biomech. 32(1):13-7 
 
76. Cresswell AG, Grundstrom H, Thorstensson A. (1992). Observations on intra-abdominal 
pressure and patterns of abdominal intra-muscular activity in man. Acta Physiol Scand. 
144(4):409-18 
 
77. Cresswell A, Oddsson L, Thorstensson A. (1994). The influence of sudden perturbations 
on trunk muscle activity and intra-abdominal pressure while standing. Exp Brain Res. 
98(2):336-41 
 
78. Comerford M, Mottram S. (2001). Movement and stability dysfunction-contemporary 
developments* 1. Man Ther. 6(1):15-26 
 
79. Kavcic N, Grenier S, McGill SM. (2004). Determining the stabilizing role of individual 
torso muscles during rehabilitation exercises. Spine (Phila Pa 1976). 29(11):1254-65 
 
80. Panjabi MM. (1992). The stabilizing system of the spine. Part I. Function, dysfunction, 
adaptation, and enhancement. J Spinal Disord. 5(4):383-9; discussion 97 
 
81. Richardson C, Jull G. (1995). Muscle control–pain control. What exercises would you 
Chapter 9 -References           147 
147 
 
prescribe? Man Ther. 1(1):2-10 
 
82. Standaert CJ, Weinstein SM, Rumpeltes J. (2008). Evidence-informed management of 
chronic low back pain with lumbar stabilization exercises. Spine J. 8(1):114-20 
 
83. Richardson C, Jull G, Hodges P, Hides J. (1999). Therapeutic exercise for spinal 
segmental stabilization in low back pain: scientific basis and clinical approach. 
Churchill Livingstone Edinburgh. 
 
84. Standring S. (2015). Gray's anatomy: the anatomical basis of clinical practice. 40th ed: 
London, UK: Churchill Livingston - Elsevier. 
 
85. Drake RL, Vogl W, Mitchell AWM. (2005). Gray's anatomy for students.  
 
86. Rosse C, Gaddum-Rosse P. (1997). Hollinshead's textbook of anatomy. Lippincott-Raven 
Philadelphia. 
 
87. Willson JD, Dougherty CP, Ireland ML, Davis IM. (2005). Core stability and its 
relationship to lower extremity function and injury. J Am Acad Orthop Surg. 13(5):316-
25 
 
88. de Looze MP, Groen H, Horemans H, Kingma I, van Dieen JH. (1999). Abdominal 
muscles contribute in a minor way to peak spinal compression in lifting. J Biomech. 
32(7):655-62 
 
89. Waters RL, Morris JM. (1972). Electrical activity of muscles of the trunk during walking. 
J Anat. 111(Pt 2):191-9 
 
90. Howarth SJ, Beach TA, Callaghan JP. (2008). Abdominal muscles dominate 
contributions to vertebral joint stiffness during the push-up. J Appl Biomech. 24(2):130-9 
 
91. Barker PJ, Briggs CA, Bogeski G. (2004). Tensile transmission across the lumbar fasciae 
in unembalmed cadavers: effects of tension to various muscular attachments. Spine. 
29(2):129 
 
92. Tesh KM, Dunn JS, Evans JH. (1987). The abdominal muscles and vertebral stability. 
Spine (Phila Pa 1976). 12(5):501-8 
 
93. De Troyer A, Estenne M, Ninane V, Van Gansbeke D, Gorini M. (1990). Transversus 
abdominis muscle function in humans. J Appl Physiol (1985). 68(3):1010-6 
 
Chapter 9 -References           148 
148 
 
94. hideAinscough-Potts AM, Morrissey MC, Critchley D. (2006). The response of the 
transverse abdominis and internal oblique muscles to different postures. Man Ther. 
11(1):54-60 
 
95. Gracovetsky S, Farfan H, Helleur C. (1985). The abdominal mechanism. Spine (Phila Pa 
1976). 10(4):317-24 
 
96. Urquhart DM, Barker PJ, Hodges PW, Story IH, Briggs CA. (2005). Regional 
morphology of the transversus abdominis and obliquus internus and externus abdominis 
muscles. Clin Biomech (Bristol, Avon). 20(3):233-41 
 
97. Richardson CA, Snijders CJ, Hides JA, Damen L, Pas MS, Storm J. (2002). The relation 
between the transversus abdominis muscles, sacroiliac joint mechanics, and low back 
pain. Spine. 27(4):399 
 
98. Bogduk N. (2005). Clinical anatomy of the lumbar spine and sacrum. Churchill 
Livingstone. 
 
99. Macintosh JE, Bogduk N. (1987). 1987 Volvo award in basic science. The morphology 
of the lumbar erector spinae. Spine (Phila Pa 1976). 12(7):658-68 
 
100. Bogduk N. (1980). A reappraisal of the anatomy of the human lumbar erector spinae. J 
Anat. 131(Pt 3):525-40 
 
101. Hansen L, de Zee M, Rasmussen J, Andersen TB, Wong C, Simonsen EB. (2006). 
Anatomy and biomechanics of the back muscles in the lumbar spine with reference to 
biomechanical modeling. Spine (Phila Pa 1976). 31(17):1888-99 
 
102. Mannion A, Dumas GA, Cooper R, Espinosa F, Faris M, Stevenson J. (1997). Muscle 
fibre size and type distribution in thoracic and lumbar regions of erector spinae in healthy 
subjects without low back pain: Normal values and sex differences. J Anat. 190(4):505-
13 
 
103. Kay AG. (2001). An extensive literature review of the lumbar multifidus: biomechanics. 
J Man Manip Ther. 9(1):17-39 
 
104. Akuthota V, Nadler SF. (2004). Core strengthening1. Arch Phys Med Rehabil. 85:86-92 
 
105. Macintosh JE, Valencia F, Bogduk N, Munro RR. (1986). The morphology of the human 
lumbar multifidus. Clin Biomech (Bristol, Avon). 1(4):196-204 
 
106. Rosatelli AL, Ravichandiran K, Agur AM. (2008). Three-dimensional study of the 
Chapter 9 -References           149 
149 
 
musculotendinous architecture of lumbar multifidus and its functional implications. Clin 
Anat. 21(6):539-46 
 
107. Macintosh JE, Bogduk N. (1986). The biomechanics of the lumbar multifidus. Clin 
Biomech (Bristol, Avon). 1(4):205-13 
 
108. Dickx N, Cagnie B, Achten E, Vandemaele P, Parlevliet T, Danneels L. (2010). 
Differentiation between deep and superficial fibers of the lumbar multifidus by magnetic 
resonance imaging. Eur Spine J. 19(1):122-8 
 
109. Moseley GL, Hodges PW, Gandevia SC. (2002). Deep and superficial fibers of the 
lumbar multifidus muscle are differentially active during voluntary arm movements. 
Spine (Phila Pa 1976). 27(2):E29-36 
 
110. Gibbons S, Comerford M, Emerson P. (2002). Rehabilitation of the stability function of 
psoas major. Orthopaedic Division Review Jan/Feb. 9 
 
111. Sajko S, Stuber K. (2009). Psoas Major: a case report and review of its anatomy, 
biomechanics, and clinical implications. J Can Chiropr Assoc. 53(4):311-8 
 
112. Jorgensson A. (1993). The iliopsoas muscle and the lumbar spine. Aust J Physiother. 
39(2):125-32 
 
113. Gracovetsky S, Farfan HF, Lamy C. (1981). The mechanism of the lumbar spine. Spine 
(Phila Pa 1976). 6(3):249-62 
 
114. Barker KL, Shamley DR, Jackson D. (2004). Changes in the cross-sectional area of 
multifidus and psoas in patients with unilateral back pain: the relationship to pain and 
disability. Spine (Phila Pa 1976). 29(22):E515-9 
 
115. Stokes IA, Gardner-Morse MG, Henry SM. (2010). Intra-abdominal pressure and 
abdominal wall muscular function: Spinal unloading mechanism. Clin Biomech (Bristol, 
Avon). 25(9):859-66 
 
116. Willard FH, Vleeming A, Schuenke MD, Danneels L, Schleip R. (2012). The 
thoracolumbar fascia: anatomy, function and clinical considerations. J Anat. 221(6):507-
36 
 
117. Barker PJ, Urquhart DM, Story IH, Fahrer M, Briggs CA. (2007). The middle layer of 
lumbar fascia and attachments to lumbar transverse processes: implications for segmental 
control and fracture. Eur Spine J. 16(12):2232-7 
 
Chapter 9 -References           150 
150 
 
118. Barker PJ, Briggs CA. (1999). Attachments of the posterior layer of lumbar fascia. Spine 
(Phila Pa 1976). 24(17):1757-64 
 
119. Peiper C, Junge K, Prescher A, Stumpf M, Schumpelick V. (2004). Abdominal 
musculature and the transversalis fascia: an anatomical viewpoint. Hernia. 8(4):376-80 
 
120. Netter FH. (. 2014). Atlas of Human Anatomy, Saunders Elsevier, 2014: Atlas of Human 
Anatomy. 6th ed. 
 
121. Rankin G, Stokes M, Newham DJ. (2006). Abdominal muscle size and symmetry in 
normal subjects. Muscle Nerve. 34(3):320-6 
 
122. Stokes M, Rankin G, Newham DJ. (2005). Ultrasound imaging of lumbar multifidus 
muscle: normal reference ranges for measurements and practical guidance on the 
technique. Man Ther. 10(2):116-26 
 
123. McGill S, Juker D, Kropf P. (1996). Quantitative intramuscular myoelectric activity of 
quadratus lumborum during a wide variety of tasks. Clin Biomech (Bristol, Avon). 
11(3):170-2 
 
124. McGill SM. (1998). Low back exercises: evidence for improving exercise regimens. Phys 
Ther. 78(7):754-65 
 
125. Stevens VK, Bouche KG, Mahieu NN, Coorevits PL, Vanderstraeten GG, Danneels LA. 
(2006). Trunk muscle activity in healthy subjects during bridging stabilization exercises. 
BMC Musculoskelet Disord. 7(1):75 
 
126. Phillips C. (2005). Stability in dance training. J Dance Med Sci. 9(1):24-8 
 
127. Pool-Goudzwaard A, Vleeming A, Stoeckart R, Snijders J, Mens J. (1998). Insufficient 
lumbopelvic stability: a clinical, anatomical and biomechanical approach to'a-
specific'low back pain. Man Ther. 3(1):12-20 
 
128. Sapsford RR, Hodges PW, Richardson CA, Cooper DH, Markwell SJ, Jull GA. (2001). 
Co-activation of the abdominal and pelvic floor muscles during voluntary exercises. 
Neurourol Urodyn. 20(1):31-42 
 
129. O'Sullivan PB, Twomey L, Allison GT. (1998). Altered abdominal muscle recruitment in 
patients with chronic back pain following a specific exercise intervention. J Orthop 
Sports Phys Ther. 27(2):114-24 
 
130. Danneels LA, Vanderstraeten GG, Cambier DC, Witvrouw EE, Stevens VK, De Cuyper 
Chapter 9 -References           151 
151 
 
HJ. (2001). A functional subdivision of hip, abdominal, and back muscles during 
asymmetric lifting. Spine (Phila Pa 1976). 26(6):E114-21 
 
131. Cholewicki J, Panjabi MM, Khachatryan A. (1997). Stabilizing function of trunk flexor-
extensor muscles around a neutral spine posture. Spine (Phila Pa 1976). 22(19):2207-12 
 
132. Cioni M, Pisasale M, Abela S, Belfiore T, Micale M. (2010). Physiological 
Electromyographic Activation Patterns of Trunk Muscles During Walking. Open Rehabil 
J. 3(1):136-42 
 
133. Gracovetsky S, Farfan H. (1986). The optimum spine. Spine (Phila Pa 1976). 11(6):543-
73 
 
134. Hicks GE, Fritz JM, Delitto A, McGill SM. (2005). Preliminary development of a clinical 
prediction rule for determining which patients with low back pain will respond to a 
stabilization exercise program. Arch Phys Med Rehabil. 86(9):1753-62 
 
135. Dickstein R, Shefi S, Marcovitz E, Villa Y. (2004). Anticipatory postural adjustment in 
selected trunk muscles in post stroke hemiparetic patients. Arch Phys Med Rehabil. 
85(2):261-7 
 
136. Brumagne S, Cordo P, Lysens R, Verschueren S, Swinnen S. (2000). The role of 
paraspinal muscle spindles in lumbosacral position sense in individuals with and without 
low back pain. Spine. 25(8):989 
 
137. Granacher U, Zahner L, Gollhofer A. (2008). Strength, power, and postural control in 
seniors: Considerations for functional adaptations and for fall prevention. Eur J Sport Sci. 
8(6):325-40 
 
138. Cuellar WA, Wilson A, Blizzard CL, Otahal P, Callisaya ML, Jones G, et al. (2017). The 
assessment of abdominal and multifidus muscles and their role in physical function in 
older adults: a systematic review. Physiotherapy. 103(1):21-39 
 
139. Deschenes MR. (2004). Effects of aging on muscle fibre type and size. Sports Med. 
34(12):809-24 
 
140. Johannesdottir F, Allaire B, Anderson DE, Samelson EJ, Kiel DP, Bouxsein ML. (2018). 
Population-based study of age- and sex-related differences in muscle density and size in 
thoracic and lumbar spine: the Framingham study. Osteoporos Int. 29(7):1569-80 
 
141. Kanekar N, Aruin AS. (2014). The effect of aging on anticipatory postural control. Exp 
Brain Res. 232(4):1127-36 




142. Kanekar N, Aruin AS. (2014). Aging and balance control in response to external 
perturbations: role of anticipatory and compensatory postural mechanisms. Age (Dordr). 
36(3):9621 
 
143. Abboud J, Nougarou F, Page I, Cantin V, Massicotte D, Descarreaux M. (2014). Trunk 
motor variability in patients with non-specific chronic low back pain. Eur J Appl Physiol. 
114(12):2645-54 
 
144. Neels JG, Olefsky JM. (2006). Inflamed fat: what starts the fire? J Clin Invest. 116(1):33-
5 
 
145. Hicks GE, Simonsick EM, Harris TB, Newman AB, Weiner DK, Nevitt MA, et al. 
(2005). Trunk muscle composition as a predictor of reduced functional capacity in the 
health, aging and body composition study: The moderating role of back pain. J Gerontol 
A Biol Sci Med Sci. 60:1420-4 
 
146. Sions JM, Coyle PC, Velasco TO, Elliott JM, Hicks GE. (2017). Multifidi muscle 
characteristics and physical function among older adults with and without chronic low 
back pain. Arch Phys Med Rehabil. 98(1):51-7 
 
147. Hu H, Meijer OG, Hodges PW, Bruijn SM, Strijers RL, Nanayakkara PW, et al. (2012). 
Control of the lateral abdominal muscles during walking. Hum Mov Sci. 31(4):880-96 
 
148. Maki BE. (1997). Gait changes in older adults: predictors of falls or indicators of fear. J 
Am Geriatr Soc. 45(3):313-20 
 
149. Crawford R, Gizzi L, Dieterich A, Ni Mhuiris A, Falla D. (2018). Age-related changes in 
trunk muscle activity and spinal and lower limb kinematics during gait. PLoS One. 
13(11):e0206514 
 
150. Masaki M, Ikezoe T, Fukumoto Y, Minami S, Tsukagoshi R, Sakuma K, et al. (2015). 
Association of sagittal spinal alignment with thickness and echo intensity of lumbar back 
muscles in middle-aged and elderly women. Arch Gerontol Geriatr. 61(2):197-201 
 
151. Jette AM, Branch LG. (1985). Impairment and disability in the aged. J Chronic Dis. 
38(1):59-65 
 
152. Foldvari M, Clark M, Laviolette LC, Bernstein MA, Kaliton D, Castaneda C, et al. 
(2000). Association of muscle power with functional status in community-dwelling 
elderly women. J Gerontol A Biol Sci Med Sci. 55(4):M192-9 
 
153. Verheyden G, Nieuwboer A, Van de Winckel A, De Weerdt W. (2007). Clinical tools to 
Chapter 9 -References           153 
153 
 
measure trunk performance after stroke: a systematic review of the literature. Clin 
Rehabil. 21(5):387-94 
 
154. Cholewicki J, McGill SM. (1996). Mechanical stability of the in vivo lumbar spine: 
implications for injury and chronic low back pain. Clin Biomech (Bristol, Avon). 11(1):1-
15 
 
155. Clarke Davidson KL, Hubley-Kozey CL. (2005). Trunk muscle responses to demands of 
an exercise progression to improve dynamic spinal stability1. Arch Phys Med Rehabil. 
86(2):216-23 
 
156. McGill SM. (1991). Electromyographic activity of the abdominal and low back 
musculature during the generation of isometric and dynamic axial trunk torque: 
implications for lumbar mechanics. J Orthop Res. 9(1):91-103 
 
157. Costa LO, Maher CG, Latimer J, Smeets RJ. (2009). Reproducibility of rehabilitative 
ultrasound imaging for the measurement of abdominal muscle activity: a systematic 
review. Phys Ther. 89(8):756-69 
 
158. Kiefer A, Shirazi-Adl A, Parnianpour M. (1998). Synergy of the human spine in neutral 
postures. Eur Spine J. 7(6):471-9 
 
159. Panjabi MM. (2003). Clinical spinal instability and low back pain. J Electromyogr 
Kinesiol. 13(4):371-9 
 
160. McGill S, Patt N, Norman R. (1988). Measurement of the trunk musculature of active 
males using CT scan radiography: implications for force and moment generating capacity 
about the L4/L5 joint. J Biomech. 21(4):329 
 
161. Danneels LA, Vanderstraeten GG, Cambier DC, Witvrouw EE, De Cuyper HJ. (2000). 
CT imaging of trunk muscles in chronic low back pain patients and healthy control 
subjects. Eur Spine J. 9(4):266-72 
 
162. Hides JA, Richardson CA, Jull GA. (1995). Magnetic resonance imaging and 
ultrasonography of the lumbar multifidus muscle. Comparison of two different 
modalities. Spine (Phila Pa 1976). 20(1):54-8 
 
163. Richardson CA, Hides JA, Wilson S, Stanton W, Snijders CJ. (2004). Lumbo-pelvic joint 
protection against antigravity forces: motor control and segmental stiffness assessed with 
magnetic resonance imaging. J Gravit Physiol. 11(2):P119-22 
 
164. Kader D, Wardlaw D, Smith F. (2000). Correlation between the MRI changes in the 
lumbar multifidus muscles and leg pain. Clinical radiology. 55(2):145-9 




165. Aubrey J, Esfandiari N, Baracos VE, Buteau FA, Frenette J, Putman CT, et al. (2014). 
Measurement of skeletal muscle radiation attenuation and basis of its biological variation. 
Acta Physiol (Oxf). 210(3):489-97 
 
166. Goodpaster BH, Carlson CL, Visser M, Kelley DE, Scherzinger A, Harris TB, et al. 
(2001). Attenuation of skeletal muscle and strength in the elderly: The Health ABC 
Study. J Appl Physiol (1985). 90(6):2157-65 
 
167. Azuma K, Sera Y, Shinjo T, Takayama M, Shiomi E, Momoshima S, et al. (2017). 
Maintenance of the paraspinal muscles may protect against radiographic knee 
osteoarthritis. Open Access Rheumatol. 9:151-8 
 
168. Cawthon PM, Fox KM, Gandra SR, Delmonico MJ, Chiou CF, Anthony MS, et al. 
(2009). Do muscle mass, muscle density, strength, and physical function similarly 
influence risk of hospitalization in older adults? J Am Geriatr Soc. 57(8):1411-9 
 
169. Hides JA, Stokes MJ, Saide M, Jull GA, Cooper DH. (1994). Evidence of lumbar 
multifidus muscle wasting ipsilateral to symptoms in patients with acute/subacute low 
back pain. Spine (Phila Pa 1976). 19(2):165-72 
 
170. Hodges PW, Pengel LH, Herbert RD, Gandevia SC. (2003). Measurement of muscle 
contraction with ultrasound imaging. Muscle Nerve. 27(6):682-92 
 
171. Stokes M, Hides J, Elliott J, Kiesel K, Hodges P. (2007). Rehabilitative ultrasound 
imaging of the posterior paraspinal muscles. J Orthop Sports Phys Ther. 37(10):581-95 
 
172. Herbert RD, Gabriel M. (2002). Effects of stretching before and after exercising on 
muscle soreness and risk of injury: systematic review. BMJ. 325(7362):468 
 
173. Gubler D, Mannion AF, Schenk P, Gorelick M, Helbling D, Gerber H, et al. (2010). 
Ultrasound tissue Doppler imaging reveals no delay in abdominal muscle feed-forward 
activity during rapid arm movements in patients with chronic low back pain. Spine. 
35(16):1506 
 
174. Hides JA, Stanton WR, McMahon S, Sims K, Richardson CA. (2008). Effect of 
stabilization training on multifidus muscle cross-sectional area among young elite 
cricketers with low back pain. J Orthop Sports Phys Ther. 38(3):101-8 
 
175. Hides JA, Richardson CA, Jull GA. (1998). Use of real-time ultrasound imaging for 
feedback in rehabilitation. Man Ther. 3(3):125-31 
 
176. Costa LO, Maher CG, Latimer J, Hodges PW, Shirley D. (2009). An investigation of the 
Chapter 9 -References           155 
155 
 
reproducibility of ultrasound measures of abdominal muscle activation in patients with 
chronic non-specific low back pain. Eur Spine J. 18(7):1059-65 
 
177. Hebert JJ, Koppenhaver SL, Parent EC, Fritz JM. (2009). A systematic review of the 
reliability of rehabilitative ultrasound imaging for the quantitative assessment of the 
abdominal and lumbar trunk muscles. Spine (Phila Pa 1976). 34(23):E848-56 
 
178. Golafshani N. (2003). Understanding reliability and validity in qualitative research. Qual 
Rep. 8(4):597-606 
 
179. Joppe M. The Research Process. Retrieved February 25, 2006. 2000. 
 
180. Larivière C, Gagnon D, Genest K. (2014). Controlling for out-of-plane lumbar moments 
during unidirectional trunk efforts: Learning and reliability issues related to trunk muscle 
activation estimates. J Electromyogr Kinesiol. 24(4):531-41 
 
181. Anderson DE, D'Agostino JM, Bruno AG, Demissie S, Kiel DP, Bouxsein ML. (2013). 
Variations of CT-based trunk muscle attenuation by age, sex, and specific muscle. J 
Gerontol A Biol Sci Med Sci. 68(3):317-23 
 
182. Kalichman L, Hodges P, Li L, Guermazi A, Hunter DJ. (2010). Changes in paraspinal 
muscles and their association with low back pain and spinal degeneration: CT study. Eur 
Spine J. 19(7):1136-44 
 
183. Kang CH, Shin MJ, Kim SM, Lee SH, Lee CS. (2007). MRI of paraspinal muscles in 
lumbar degenerative kyphosis patients and control patients with chronic low back pain. 
Clin Radiol. 62(5):479-86 
 
184. Shafaq N, Suzuki A, Matsumura A, Terai H, Toyoda H, Yasuda H, et al. (2012). 
Asymmetric degeneration of paravertebral muscles in patients with degenerative lumbar 
scoliosis. Spine (Phila Pa 1976). 37(16):1398-406 
 
185. Teyhen DS, Gill NW, Whittaker JL, Henry SM, Hides JA, Hodges P. (2007). 
Rehabilitative ultrasound imaging of the abdominal muscles. J Orthop Sports Phys Ther. 
37(8):450-66 
 
186. Ikezoe T, Mori N, Nakamura M, Ichihashi N. (2012). Effects of age and inactivity due to 
prolonged bed rest on atrophy of trunk muscles. Eur J Appl Physiol. 112(1):43-8 
 
187. Girgis CM, Clifton-Bligh RJ, Turner N, Lau SL, Gunton JE. (2014). Effects of vitamin D 
in skeletal muscle: falls, strength, athletic performance and insulin sensitivity. Clin 
Endocrinol (Oxf). 80(2):169-81 




188. Bischoff H, Stähelin H, Tyndall A, Theiler R. (2000). Relationship between muscle 
strength and vitamin D metabolites: are there therapeutic possibilities in the elderly? Z 
Rheumatol. 59(7):I39-I41 
 
189. Holick MF. (1994). McCollum Award Lecture, 1994: vitamin D--new horizons for the 
21st century. Am J Clin Nutr. 60(4):619-30 
 
190. MacLaughlin J, Holick MF. (1985). Aging decreases the capacity of human skin to 
produce vitamin D3. J Clin Invest. 76(4):1536-8 
 
191. van Schoor NM, Lips P. (2011). Worldwide vitamin D status. Best Pract Res Clin 
Endocrinol Metab. 25(4):671-80 
 
192. Holick MF. (2007). Vitamin D deficiency. N Engl J Med. 357(3):266-81 
 
193. Ross AC, Manson JAE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. (2011). 
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute 
of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 96(1):53-8 
 
194. Deeb KK, Trump DL, Johnson CS. (2007). Vitamin D signalling pathways in cancer: 
potential for anticancer therapeutics. Nat Rev Cancer. 7(9):684-700 
 
195. Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. (2013). The roles of 
vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 34(1):33-83 
 
196. Glendenning P. (2015). Abnormal laboratory results: Measuring vitamin D. Aust Prescr. 
38(1):12 
 
197. Sanders KM, Scott D, Ebeling PR. (2014). Vitamin D deficiency and its role in muscle-
bone interactions in the elderly. Curr Osteoporos Rep. 12(1):74-81 
 
198. Working Group of the A, New Zealand B, Mineral S, Endocrine Society of A, 
Osteoporosis A. (2005). Vitamin D and adult bone health in Australia and New Zealand: 
a position statement. Med J Aust. 182(6):281-5 
 
199. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et 
al. (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine 
Society clinical practice guideline. J Clin Endocrinol Metab. 96(7):1911-30 
 
200. Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, et al. 
(2012). Vitamin D and health in adults in Australia and New Zealand: a position 
Chapter 9 -References           157 
157 
 
statement. Med J Aust. 196(11):686-7 
 
201. Zhu K, Austin N, Devine A, Bruce D, Prince RL. (2010). A randomized controlled trial 
of the effects of vitamin D on muscle strength and mobility in older women with vitamin 
D insufficiency. J Am Geriatr Soc. 58(11):2063-8 
 
202. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C, et al. (2003). Effects of 
vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone 
Miner Res. 18(2):343-51 
 
203. Visser M, Deeg DJH, Lips P. (2003). Low vitamin D and high parathyroid hormone 
levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the 
Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 88(12):5766 
 
204. Venning G. (2005). Recent developments in vitamin D deficiency and muscle weakness 
among elderly people. BMJ. 330(7490):524-6 
 
205. Ding C, Cicuttini F, Parameswaran V, Burgess J, Quinn S, Jones G. (2009). Serum levels 
of vitamin D, sunlight exposure, and knee cartilage loss in older adults: the Tasmanian 
older adult cohort study. Arthritis Rheum. 60(5):1381-9 
 
206. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. (2011). Effect of 
vitamin D supplementation on muscle strength: a systematic review and meta-analysis. 
Osteoporos Int. 22(3):859-71 
 
207. Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE, et al. 
(2010). IOF position statement: vitamin D recommendations for older adults. Osteoporos 
Int. 21(7):1151-4 
 
208. Hamilton B, Grantham J, Racinais S, Chalabi H. (2010). Vitamin D deficiency is 
endemic in Middle Eastern sportsmen. Public Health Nutr. 13(10):1528-34 
 
209. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, et al. (2003). Deletion of 
vitamin D receptor gene in mice results in abnormal skeletal muscle development with 
deregulated expression of myoregulatory transcription factors. Endocrinology. 
144(12):5138-44 
 
210. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stahelin HB, et al. 
(2001). In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle 
tissue. Histochem J. 33(1):19-24 
 
211. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y, Karlson EW, et al. (2004). 
Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity 
Chapter 9 -References           158 
158 
 
function in both active and inactive persons aged≧ 60 y. Am J Clin Nutr. 80(3):752-8 
 
212. Stern P, Kagen LJ. (1984). Effect of vitamin D and its metabolites on developing 
myogenic cultures. Exp Cell Res. 154(2):485-91 
 
213. Boland R. (1986). Role of vitamin D in skeletal muscle function. Endocr Rev. 7(4):434-
48 
 
214. Toury R, Stelly N, Boisonneau E, Convert M, Dupuis Y. (1990). Relationship between 
vitamin D status and deposition of bound calcium in skeletal muscle of the rat. Biol Cell. 
69:179-89 
 
215. Bischoff-Ferrari HA, Borchers M, Gudat F, Durmuller U, Stahelin HB, Dick W. (2004). 
Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner 
Res. 19(2):265-9 
 
216. Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, et al. (2014). The 
effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a 
systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol 
Metab. 99(11):4336-45 
 
217. Muir SW, Montero-Odasso M. (2011). Effect of vitamin D supplementation on muscle 
strength, gait and balance in older adults: a systematic review and meta-analysis. J Am 
Geriatr Soc. 59(12):2291-300 
 
218. Podsiadlo D, Richardson S. (1991). The timed “Up & Go”: a test of basic functional 
mobility for frail elderly persons. J Am Geriatr Soc. 39(2):142-8 
 
219. Shumway-Cook A, Brauer S, Woollacott M. (2000). Predicting the probability for falls in 
community-dwelling older adults using the Timed Up & Go Test. Phys Ther. 80(9):896-
903 
 
220. Hyatt RH, Whitelaw MN, Bhat A, Scott S, Maxwell JD. (1990). Association of muscle 
strength with functional status of elderly people. Age Ageing. 19(5):330-6 
 
221. Cao Y, Jones G, Cicuttini F, Winzenberg T, Wluka A, Sharman J, et al. (2012). Vitamin 
D supplementation in the management of knee osteoarthritis: study protocol for a 
randomized controlled trial. Trials. 13:131 
 
222. Hides JA, Lambrecht G, Richardson CA, Stanton WR, Armbrecht G, Pruett C, et al. 
(2011). The effects of rehabilitation on the muscles of the trunk following prolonged bed 
rest. Eur Spine J. 20(5):808-18 




223. Pereira LM, Marcucci FC, de Oliveira Menacho M, Garanhani MR, Lavado EL, Cardoso 
JR. (2011). Electromyographic activity of selected trunk muscles in subjects with and 
without hemiparesis during therapeutic exercise. J Electromyogr Kinesiol. 21(2):327-32 
 
224. Rønnestad BR, Kojedal Ø, Losnegard T, Kvamme B, Raastad T. (2012). Effect of heavy 
strength training on muscle thickness, strength, jump performance, and endurance 
performance in well-trained Nordic Combined athletes. Eur J Applied Physiol. 
112(6):2341-52 
 
225. Lievense A, Bierma-Zeinstra S, Verhagen A, Verhaar J, Koes B. (2001). Influence of 
work on the development of osteoarthritis of the hip: a systematic review. J Rheumatol. 
28(11):2520-8 
 
226. Shrout PE. (1998). Measurement reliability and agreement in psychiatry. Stat Methods 
Med Res. 7(3):301-17 
 
227. Anderson DE, D'Agostino JM, Bruno AG, Manoharan RK, Bouxsein ML. (2012). 
Regressions for estimating muscle parameters in the thoracic and lumbar trunk for use in 
musculoskeletal modeling. J Biomech. 45(1):66-75 
 
228. Briggs AM, Greig AM, Bennell KL, Hodges PW. (2007). Paraspinal muscle control in 
people with osteoporotic vertebral fracture. Eur Spine J. 16(8):1137-44 
 
229. Caix M, Outrequin G, Descottes B, Kalfon M, Pouget X. (1984). The muscles of the 
abdominal wall: a new functional approach with anatomoclinical deductions. Anat Clin. 
6(2):101-8 
 
230. Dickstein R, Sheffi S, Ben Haim Z, Shabtai E, Markovici E. (2000). Activation of flexor 
and extensor trunk muscles in hemiparesis. Am J Phys Med Rehabil. 79(3):228-34 
 
231. Dickstein R, Shefi S, Marcovitz E, Villa Y. (2004). Electromyographic activity of 
voluntarily activated trunk flexor and extensor muscles in post-stroke hemiparetic 
subjects. Clin Neurophysiol. 115(4):790-6 
 
232. Fukumoto Y, Ikezoe T, Tateuchi H, Tsukagoshi R, Akiyama H, So K, et al. (2012). 
Muscle mass and composition of the hip, thigh and abdominal muscles in women with 
and without hip osteoarthritis. Ultrasound Med Biol. 38(9):1540-5 
 
233. Hanada EY, Hubley-Kozey CL, McKeon MD, Gordon SA. (2008). The feasibility of 
measuring the activation of the trunk muscles in healthy older adults during trunk 
stability exercises. BMC Geriatr. 8:33 
 
Chapter 9 -References           160 
160 
 
234. Hanada EY, Johnson M, Hubley-Kozey C. (2011). A comparison of trunk muscle 
activation amplitudes during gait in older adults with and without chronic low back pain. 
PM R. 3(10):920-8 
 
235. Hwang JH, Lee YT, Park DS, Kwon TK. (2008). Age affects the latency of the erector 
spinae response to sudden loading. Clin Biomech (Bristol, Avon). 23(1):23-9 
 
236. Kafri M, Dickstein R. (2005). Activation of selected frontal trunk and extremities 
muscles during rolling from supine to side lying in healthy subjects and in post-stroke 
hemiparetic patients. NeuroRehabilitation. 20(2):125-31 
 
237. Kai S, Yoshimoto R, Nakahara M, Murakami S, Watari K, Takahashi S. (2008). Trunk 
muscle activity in two-leg standing to one-leg standing in healthy elderly adults. J Phys 
Ther Sci. 20(2):77-80 
 
238. Kalichman L, Kim DH, Li L, Guermazi A, Hunter DJ. (2010). Computed tomography-
evaluated features of spinal degeneration: prevalence, intercorrelation, and association 
with self-reported low back pain. Spine J. 10(3):200-8 
 
239. Kalichman L, Li L, Hunter DJ, Been E. (2011). Association between computed 
tomography-evaluated lumbar lordosis and features of spinal degeneration, evaluated in 
supine position. Spine J. 11(4):308-15 
 
240. Kataoka H, Tonomura Y, Eura N, Terashima M, Kawahara M, Ueno S. (2012). Painful 
abdominal contractions in patients with Parkinson disease. J Clin Neurosci. 19(4):624-7 
 
241. Marcucci FC, Cardoso NS, Berteli Kde S, Garanhani MR, Cardoso JR. (2007). 
[Electromyographic alterations of trunk muscle of patients with post-stroke hemiparesis]. 
Arq Neuropsiquiatr. 65(3B):900-5 
 
242. McGill SM, Yingling VR, Peach JP. (1999). Three-dimensional kinematics and trunk 
muscle myoelectric activity in the elderly spine - a database compared to young people. 
Clin Biomech (Bristol, Avon). 14(6):389-95 
 
243. Oguri K, Zhao L, Du N, Kato Y, Miyamoto K, Hayakawa M, et al. (2004). Association 
of habitual long-distance running with the thickness of skeletal muscles and subcutaneous 
fat in the body extremities and trunk in middle-aged men. J Sports Med Phys Fitness. 
44(4):417-23 
 
244. Ota M, Ikezoe T, Kaneoka K, Ichihashi N. (2012). Age-related changes in the thickness 
of the deep and superficial abdominal muscles in women. Arch Gerontol Geriatr. 
55(2):e26-30 
 
Chapter 9 -References           161 
161 
 
245. Stetts DM, Freund JE, Allison SC, Carpenter G. (2009). A rehabilitative ultrasound 
imaging investigation of lateral abdominal muscle thickness in healthy aging adults. J 
Geriatr Phys Ther. 32(2):60-6 
 
246. Takahashi I, Kikuchi S, Sato K, Iwabuchi M. (2007). Effects of the mechanical load on 
forward bending motion of the trunk: comparison between patients with motion-induced 
intermittent low back pain and healthy subjects. Spine (Phila Pa 1976). 32(2):E73-8 
 
247. Sions JM, Velasco TO, Teyhen DS, Hicks GE. (2014). Ultrasound imaging: 
intraexaminer and interexaminer reliability for multifidus muscle thickness assessment in 
adults aged 60 to 85 years versus younger adults. J Orthop Sports Phys Ther. 44(6):425-
34 
 
248. Sions JM, Velasco TO, Teyhen DS, Hicks GE. (2014). Reliability of Ultrasound Imaging 
for the Assessment of Lumbar Multifidi Thickness in Older Adults with Chronic Low 
Back Pain. J Geriatr Phys Ther. 38:33-9 
 
249. Hides JA, Belavy DL, Stanton W, Wilson SJ, Rittweger J, Felsenberg D, et al. (2007). 
Magnetic resonance imaging assessment of trunk muscles during prolonged bed rest. 
Spine (Phila Pa 1976). 32(15):1687-92 
 
250. McGill SM. (2015). Low Back Disorders, 3E. Human Kinetics. 
 
251. Abbas J, Slon V, May H, Peled N, Hershkovitz I, Hamoud K. (2016). Paraspinal muscles 
density: a marker for degenerative lumbar spinal stenosis? BMC Musculoskelet Disord. 
17(1):422 
 
252. Banno T, Yamato Y, Hasegawa T, Kobayashi S, Togawa D, Oe S, et al. (2017). 
Assessment of the Cross-Sectional Areas of the Psoas Major and Multifidus Muscles in 
Patients With Adult Spinal Deformity: A Case-Control Study. Clin Spine Surg. 
30(7):E968-E73 
 
253. Hyun SJ, Bae CW, Lee SH, Rhim SC. (2016). Fatty Degeneration of the Paraspinal 
Muscle in Patients With Degenerative Lumbar Kyphosis: A New Evaluation Method of 
Quantitative Digital Analysis Using MRI and CT Scan. Clin Spine Surg. 29(10):441-7 
 
254. Kalichman L, Klindukhov A, Li L, Linov L. (2016). Indices of Paraspinal Muscles 
Degeneration: Reliability and Association With Facet Joint Osteoarthritis: Feasibility 
Study. Clin Spine Surg. 29(9):465-70 
 
255. Katzman WB, Miller-Martinez D, Marshall LM, Lane NE, Kado DM. (2014). Kyphosis 
and paraspinal muscle composition in older men: a cross-sectional study for the 
Osteoporotic Fractures in Men (MrOS) research group. BMC Musculoskelet Disord. 
15:19 




256. Kang EK, Park HW, Baek S, Lim JY. (2016). The Association between Trunk Body 
Composition and Spinal Bone Mineral Density in Korean Males versus Females: a 
Farmers' Cohort for Agricultural Work-Related Musculoskeletal Disorders (FARM) 
Study. J Korean Med Sci. 31(10):1595-603 
 
257. Fortin M, Omidyeganeh M, Battie MC, Ahmad O, Rivaz H. (2017). Evaluation of an 
automated thresholding algorithm for the quantification of paraspinal muscle composition 
from MRI images. Biomed Eng Online. 16(1):61 
 
258. Gellhorn AC, Suri P, Rundell SD, Olafsen N, Carlson MJ, Johnson S, et al. (2017). 
Lumbar Muscle Cross-Sectional Areas Do Not Predict Clinical Outcomes in Adults With 
Spinal Stenosis: A Longitudinal Study. PM R. 9(6):545-55 
 
259. Mhuiris AN, Volken T, Elliott JM, Hoggarth M, Samartzis D, Crawford RJ. (2016). 
Reliability of quantifying the spatial distribution of fatty infiltration in lumbar 
paravertebral muscles using a new segmentation method for T1-weighted MRI. BMC 
Musculoskelet Disord. 17:234 
 
260. Ropponen A, Videman T, Battié MC. (2008). The reliability of paraspinal muscles 
composition measurements using routine spine MRI and their association with back 
function. Man Ther. 13(4):349-56 
 
261. Sasaki T, Yoshimura N, Hashizume H, Yamada H, Oka H, Matsudaira K, et al. (2017). 
MRI-defined paraspinal muscle morphology in Japanese population: The Wakayama 
Spine Study. PLoS One. 12(11):e0187765 
 
262. Sions JM, Smith AC, Hicks GE, Elliott JM. (2016). Trunk Muscle Size and Composition 
Assessment in Older Adults with Chronic Low Back Pain: An Intra-Examiner and Inter-
Examiner Reliability Study. Pain Med. 17(8):1436-46 
 
263. Farshad M, Gerber C, Farshad-Amacker NA, Dietrich TJ, Laufer-Molnar V, Min K. 
(2014). Asymmetry of the multifidus muscle in lumbar radicular nerve compression. 
Skeletal Radiol. 43(1):49-53 
 
264. Cuellar WA, Blizzard L, Callisaya ML, Hides JA, Jones G, Ding C, et al. (2017). Test-
retest reliability of measurements of abdominal and multifidus muscles using ultrasound 
imaging in adults aged 50-79 years. Musculoskelet Sci Pract. 28(e1-e88):79-84 
 
265. Djordjevic O, Djordjevic A, Konstantinovic L. (2014). Interrater and Intrarater 
Reliability of Transverse Abdominal and Lumbar Multifidus Muscle Thickness in 
Subjects With and Without Low Back Pain. J Orthop Sports Phys Ther. 44(12):979-88 
 
266. Wilson A, Hides JA, Blizzard L, Callisaya M, Cooper A, Srikanth VK, et al. (2016). 
Chapter 9 -References           163 
163 
 
Measuring ultrasound images of abdominal and lumbar multifidus muscles in older 
adults: A reliability study. Man Ther. 23(e1-e18):114-9 
 
267. Sions JM, Teyhen DS, Hicks GE. (2017). Criterion validity of ultrasound imaging: 
assessment of multifidi cross-sectional area in older adults with and without chronic low 
back pain. J Geriatr Phys Ther. 40(2):74-9 
 
268. Fortin M, Videman T, Gibbons LE, Battie MC. (2014). Paraspinal muscle morphology 
and composition: a 15-yr longitudinal magnetic resonance imaging study. Med Sci Sports 
Exerc. 46(5):893-901 
 
269. Masaki M, Ikezoe T, Fukumoto Y, Minami S, Aoyama J, Ibuki S, et al. (2016). 
Association of walking speed with sagittal spinal alignment, muscle thickness, and echo 
intensity of lumbar back muscles in middle-aged and elderly women. Aging Clin Exp 
Res. 28(3):429-34 
 
270. Fortin M, Yuan Y, Battie MC. (2013). Factors associated with paraspinal muscle 
asymmetry in size and composition in a general population sample of men. Phys Ther. 
93(11):1540-50 
 
271. Anderson DE, Quinn E, Parker E, Allaire BT, Muir JW, Rubin CT, et al. (2016). 
Associations of Computed Tomography-Based Trunk Muscle Size and Density With 
Balance and Falls in Older Adults. J Gerontol A Biol Sci Med Sci. 71(6):811-6 
 
272. Anderson DE, Bean JF, Holt NE, Keel JC, Bouxsein ML. (2014). Computed 
tomography-based muscle attenuation and electrical impedance myography as indicators 
of trunk muscle strength independent of muscle size in older adults. Am J Phys Med 
Rehabil. 93(7):553-61 
 
273. Anderson GS, Deluigi F, Belli G, Tentoni C, Gaetz MB. (2016). Training for improved 
neuro-muscular control of balance in middle aged females. J Bodyw Mov Ther. 20(1):10-
8 
 
274. Chen YY, Pao JL, Liaw CK, Hsu WL, Yang RS. (2014). Image changes of paraspinal 
muscles and clinical correlations in patients with unilateral lumbar spinal stenosis. Eur 
Spine J. 23(5):999-1006 
 
275. Fortin M, Dobrescu O, Courtemanche M, Sparrey CJ, Santaguida C, Fehlings MG, et al. 
(2017). Association Between Paraspinal Muscle Morphology, Clinical Symptoms, and 
Functional Status in Patients With Degenerative Cervical Myelopathy. Spine (Phila Pa 
1976). 42(4):232-9 
 
276. Kim H, Lee CK, Yeom JS, Lee JH, Cho JH, Shin SI, et al. (2013). Asymmetry of the 
cross-sectional area of paravertebral and psoas muscle in patients with degenerative 
Chapter 9 -References           164 
164 
 
scoliosis. Eur Spine J. 22(6):1332-8 
 
277. Nava-Bringas TI, Ramirez-Mora I, Coronado-Zarco R, Macias-Hernandez SI, Cruz-
Medina E, Arellano-Hernandez A, et al. (2014). Association of strength, muscle balance, 
and atrophy with pain and function in patients with degenerative spondylolisthesis. J 
Back Musculoskelet Rehabil. 27(3):371-6 
 
278. Ekin EE, Kurtul Yildiz H, Mutlu H. (2016). Age and sex-based distribution of lumbar 
multifidus muscle atrophy and coexistence of disc hernia: an MRI study of 2028 patients. 
Diagn Interv Radiol. 22(3):273-6 
 
279. Sions JM, Elliott JM, Pohlig RT, Hicks GE. (2017). Trunk Muscle Characteristics of the 
Multifidi, Erector Spinae, Psoas, and Quadratus Lumborum in Older Adults With and 
Without Chronic Low Back Pain. J Orthop Sports Phys Ther. 47(3):173-9 
 
280. Le Cara EC, Marcus RL, Dempsey AR, Hoffman MD, Hebert JJ. (2014). Morphology 
versus function: the relationship between lumbar multifidus intramuscular adipose tissue 
and muscle function among patients with low back pain. Arch Phys Med Rehabil. 
95(10):1846-52 
 
281. Fortin M, Lazary A, Varga PP, McCall I, Battie MC. (2016). Paraspinal muscle 
asymmetry and fat infiltration in patients with symptomatic disc herniation. Eur Spine J. 
25(5):1452-9 
 
282. Fortin M, Gibbons LE, Videman T, Battie MC. (2015). Do variations in paraspinal 
muscle morphology and composition predict low back pain in men? Scand J Med Sci 
Sports. 25(6):880-7 
 
283. Altinkaya N, Cekinmez M. (2016). Lumbar multifidus muscle changes in unilateral 
lumbar disc herniation using magnetic resonance imaging. Skeletal Radiol. 45(1):73-7 
 
284. Margraf NG, Rohr A, Granert O, Hampel J, Drews A, Deuschl G. (2015). MRI of lumbar 
trunk muscles in patients with Parkinson's disease and camptocormia. J Neurol. 
262(7):1655-64 
 
285. Ondo WG, Haykal HA. (2014). Paraspinal muscle asymmetry in Parkinson's disease. Int 
J Neurosci. 124(2):93-6 
 
286. Margraf NG, Rogalski M, Deuschl G, Kuhtz-Buschbeck JP. (2017). Trunk muscle 
activation pattern in parkinsonian camptocormia as revealed with surface 
electromyography. Parkinsonism Relat Disord. 44:44-50 
 
287. Cole MH, Naughton GA, Silburn PA. (2017). Neuromuscular Impairments Are 
Chapter 9 -References           165 
165 
 
Associated With Impaired Head and Trunk Stability During Gait in Parkinson Fallers. 
Neurorehabil Neural Repair. 31(1):34-47 
 
288. Rijken NH, van Engelen BG, de Rooy JW, Geurts AC, Weerdesteyn V. (2014). Trunk 
muscle involvement is most critical for the loss of balance control in patients with 
facioscapulohumeral muscular dystrophy. Clin Biomech (Bristol, Avon). 29(8):855-60 
 
289. Freund JE, Stetts DM, Vallabhajosula S. (2016). Relationships between trunk 
performance, gait and postural control in persons with multiple sclerosis. 
NeuroRehabilitation. 39(2):305-17 
 
290. Gaffney BMM, Christiansen CL, Murray AM, Davidson BS. (2018). Trunk movement 
compensations and corresponding core muscle demand during step ambulation in people 
with unilateral transtibial amputation. J Electromyogr Kinesiol. 39:16-25 
 
291. Altman RD, Hochberg M, Murphy WA, Jr., Wolfe F, Lequesne M. (1995). Atlas of 
individual radiographic features in osteoarthritis. Osteoarthritis Cartilage. 3 Suppl A:3-
70 
 
292. Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, et al. (2016). Effect of Vitamin D 
Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With 
Symptomatic Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 315(10):1005-13 
 
293. IPAQ Research Committee. Guidelines for data processing and analysis of the 
International Physical Activity Questionnaire (IPAQ)–short and long forms 2005 
[Available from: http://www.ipaq.ki.se. 
 
294. Bellamy N. (2000). WOMAC Osteoarthritis Index: User Guide IV.  
 
295. Hawthorne G, Richardson J, Osborne R, McNeil H. (1997). The assessment of quality of 
life (AQoL) instrument construction, initial validation & utility scaling.  
 
296. Scott D, Blizzard L, Fell J, Jones G. (2009). Statin therapy, muscle function and falls risk 
in community-dwelling older adults. QJM. 102(9):625-33 
 
297. Rousson V, Gasser T, Seifert B. (2002). Assessing intrarater, interrater and test–retest 
reliability of continuous measurements. Stat Med. 21(22):3431-46 
 
298. Hides JA, Miokovic T, Belavy DL, Stanton WR, Richardson CA. (2007). Ultrasound 
imaging assessment of abdominal muscle function during drawing-in of the abdominal 
wall: an intrarater reliability study. J Orthop Sports Phys Ther. 37(8):480-6 
 
Chapter 9 -References           166 
166 
 
299. Wallwork TL, Stanton WR, Freke M, Hides JA. (2009). The effect of chronic low back 
pain on size and contraction of the lumbar multifidus muscle. Man Ther. 14(5):496-500 
 
300. Hides J, Gilmore C, Stanton W, Bohlscheid E. (2008). Multifidus size and symmetry 
among chronic LBP and healthy asymptomatic subjects. Man Ther. 13(1):43-9 
 
301. Wallwork TL, Hides JA, Stanton WR. (2007). Intrarater and interrater reliability of 
assessment of lumbar multifidus muscle thickness using rehabilitative ultrasound 
imaging. J Orthop Sports Phys Ther. 37(10):608-12 
 
302. Bland JM, Altman D. (1986). Statistical methods for assessing agreement between two 
methods of clinical measurement. Lancet. 327:307-10 
 
303. Shrout PE, Fleiss JL. (1979). Intraclass correlations: uses in assessing rater reliability. 
Psychol Bull. 86(2):420-8 
 
304. de Vet HC, Terwee CB, Knol DL, Bouter LM. (2006). When to use agreement versus 
reliability measures. J Clin Epidemiol. 59:1033-9 
 
305. Frantz Pressler J, Givens Heiss D, Buford JA, Chidley JV. (2006). Between-day 
repeatability and symmetry of multifidus cross-sectional area measured using ultrasound 
imaging. J Ortho Sports Phys Ther. 36:10-8 
 
306. Koppenhaver SL, Parent EC, Teyhen DS, Hebert JJ, Fritz JM. (2009). The effect of 
averaging multiple trials on measurement error during ultrasound imaging of transversus 
abdominis and lumbar multifidus muscles in individuals with low back pain. J Orthop 
Sports Phys Ther. 39(8):604-11 
 
307. Whittaker JL, Stokes M. (2011). Ultrasound imaging and muscle function. J Orthop 
Sports Phys Ther. 41(8):572-80 
 
308. Cuellar WA, Blizzard L, Hides JA, Callisaya ML, Jones G, Cicuttini F, et al. (2019). 
Vitamin D supplements for trunk muscle morphology in older adults: secondary analysis 
of a randomized controlled trial. J Cachexia Sarcopenia Muscle. 10(1):177-87 
 
309. Gordon PL, Doyle JW, Johansen KL. (2012). Association of 1,25-dihydroxyvitamin D 
levels with physical performance and thigh muscle cross-sectional area in chronic kidney 
disease stage 3 and 4. J Ren Nutr. 22(4):423-33 
 
310. Gordon PL, Sakkas GK, Doyle JW, Shubert T, Johansen KL. (2007). Relationship 
between vitamin D and muscle size and strength in patients on hemodialysis. J Ren Nutr. 
17(6):397-407 




311. Rejnmark L. (2011). Effects of vitamin d on muscle function and performance: a review 
of evidence from randomized controlled trials. Ther Adv Chronic Dis. 2(1):25-37 
 
312. Gupta R, Sharma U, Gupta N, Kalaivani M, Singh U, Guleria R, et al. (2010). Effect of 
cholecalciferol and calcium supplementation on muscle strength and energy metabolism 
in vitamin D-deficient Asian Indians: a randomized, controlled trial. Clin Endocrinol 
(Oxf). 73(4):445-51 
 
313. Shahtahmassebi B, Hebert JJ, Hecimovich MD, Fairchild TJ. (2017). Associations 
between trunk muscle morphology, strength and function in older adults. Sci Rep. 7:1-10 
 
314. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee 
RY, et al. (2004). Effect of Vitamin D on falls: a meta-analysis. JAMA. 291(16):1999-
2006 
 
315. Hides JA, Cooper DH, Stokes MJ. (1992). Diagnostic ultrasound imaging for 
measurement of the lumbar multifidus muscle in normal young adults. Physiother Theory 
Pract. 8(1):19-26 
 
316. Koppenhaver SL, Hebert JJ, Fritz JM, Parent EC, Teyhen DS, Magel JS. (2009). 
Reliability of rehabilitative ultrasound imaging of the transversus abdominis and lumbar 
multifidus muscles. Arch Phys Med Rehabil. 90(1):87-94 
 
317. Teyhen DS, George SZ, Dugan JL, Williamson J, Neilson BD, Childs JD. (2011). Inter-
rater reliability of ultrasound imaging of the trunk musculature among novice raters. J 
Ultrasound Med. 30(3):347-56 
 
318. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. 
(2003). International physical activity questionnaire: 12-country reliability and validity. 
Med Sci Sports Exerc. 35(8):1381-95 
 
319. Holm S. (1979). A simple sequentially rejective multiple test procedure. Scand J Statist. 
6(2):65-70 
 
320. Hosseinifar M, Akbari M, Behtash H, Amiri M, Sarrafzadeh J. (2013). The Effects of 
Stabilization and Mckenzie Exercises on Transverse Abdominis and Multifidus Muscle 
Thickness, Pain, and Disability: A Randomized Controlled Trial in NonSpecific Chronic 
Low Back Pain. J Phys Ther Sci. 25(12):1541-5 
 
321. Vasseljen O, Fladmark AM. (2010). Abdominal muscle contraction thickness and 
function after specific and general exercises: a randomized controlled trial in chronic low 
back pain patients. Man Ther. 15(5):482-9 




322. Hides JA, Stanton WR, Wilson SJ, Freke M, McMahon S, Sims K. (2010). Retraining 
motor control of abdominal muscles among elite cricketers with low back pain. Scand J 
Med Sci Sports. 20(6):834-42 
 
323. Freeman J, Wilson K, Spears R, Shalhoub V, Sibley P. (2015). Performance evaluation of 
four 25-hydroxyvitamin D assays to measure 25-hydroxyvitamin D2. Clin Biochem. 
48(16-17):1097-104 
 
324. von Haehling S, Morley JE, Coats AJ, Anker SD. (2010). Ethical guidelines for 
authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia 
Sarcopenia Muscle. 1(1):7-8 
 
325. Hicks GE, Simonsick EM, Harris TB, Newman AB, Weiner DK, Nevitt MA, et al. 
(2005). Cross-sectional associations between trunk muscle composition, back pain, and 
physical function in the health, aging and body composition study. J Gerontol A Biol Sci 
Med Sci. 60(7):882-7 
 
326. Lee PH, Macfarlane DJ, Lam TH, Stewart SM. (2011). Validity of the International 
Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav 
Nutr Phys Act. 8(1):115 
 
327. Cleland VJ, Schmidt MD, Salmon J, Dwyer T, Venn A. (2011). Correlates of pedometer-
measured and self-reported physical activity among young Australian adults. J Sci Med 
Sport. 14(6):496-503 
 
328. Tudor-Locke C, Bassett DR, Shipe MF, McClain JJ. (2011). Pedometry methods for 
assessing free-living adults. J Phys Act Health. 8(3):445-53 
 
329. Basaran S, Guzel R, Seydaoglu G, Guler-Uysal F. (2010). Validity, reliability, and 
comparison of the WOMAC osteoarthritis index and Lequesne algofunctional index in 
Turkish patients with hip or knee osteoarthritis. Clin Rheumatol. 29(7):749-56 
 
330. Bellamy N. (2002). WOMAC: a 20-year experiential review of a patient-centered self-
reported health status questionnaire. J Rheumatol. 29(12):2473-6 
 
331. Salaffi F, Leardini G, Canesi B, Mannoni A, Fioravanti A, Caporali R, et al. (2003). 
Reliability and validity of the Western Ontario and McMaster Universities (WOMAC) 
Osteoarthritis Index in Italian patients with osteoarthritis of the knee. Osteoarthritis 
Cartilage. 11(8):551-60 
 
332. Hawthorne G, Osborne R. (2005). Population norms and meaningful differences for the 
Assessment of Quality of Life (AQoL) measure. Aust N Z J Public Health. 29(2):136-42 




333. Osborne RH, Hawthorne G, Lew EA, Gray LC. (2003). Quality of life assessment in the 
community-dwelling elderly: validation of the Assessment of Quality of Life (AQoL) 
Instrument and comparison with the SF-36. J Clin Epidemiol. 56(2):138-47 
 
334. Richardson J, Hawthorne G, Day N, Osborne R, McNeil H. (1998). Difficulty with Life 
and Death: Methodological Issues and Results from the Utility Scaling of the Assessment 
of Quality of Life (AQoL) Instrument. Economics and Health 1988.121-38 
 
335. Cuellar W, Blizzard L, Callisaya M, Hides J, Jones G, Ding C, et al. (2017). Test-retest 
reliability of measurements of abdominal and multifidus muscles using ultrasound 
imaging in adults aged 50–79 years. Musculoskel Sci Pract. 28:79-84 
 
336. Richardson J, Chen G, Iezzi A, Khan MA. (2011). Transformations between the 
Assessment of Quality of Life AQoL Instruments and Test-Retest Reliability. Melbourne, 
Australia: Centre for Health Economics, Monash University.  
 
337. Lee I-M, Rexrode KM, Cook NR, Manson JE, Buring JE. (2001). Physical activity and 
coronary heart disease in women: Is no pain, no gain passé? JAMA. 285(11):1447-54 
 
338. Granacher U, Lacroix A, Muehlbauer T, Roettger K, Gollhofer A. (2013). Effects of core 
instability strength training on trunk muscle strength, spinal mobility, dynamic balance 
and functional mobility in older adults. Gerontology. 59(2):105-13 
 
339. Suri P, Kiely DK, Leveille SG, Frontera WR, Bean JF. (2011). Increased trunk extension 
endurance is associated with meaningful improvement in balance among older adults 
with mobility problems. Arch Phys Med Rehabil. 92(7):1038-43 
 
340. Bermúdez VJ, Rojas JJ, Córdova EB, Añez R, Toledo A, Aguirre MA, et al. (2013). 
International physical activity questionnaire overestimation is ameliorated by individual 
analysis of the scores. Am J Ther. 20(4):448-58 
 
341. Hallal PC, Gomez LF, Parra DC, Lobelo F, Mosquera J, Florindo AA, et al. (2010). 
Lessons learned after 10 years of IPAQ use in Brazil and Colombia. J Phys Act Health. 
7(s2):S259-S64 
 
342. Australian Institute of Helath and Welfare. (2007). Arthritis series no 5. Cat no. PHE93. 
Canberra. 'Retrieved from': http://www.aihw.gov.au. 
 
343.  Cooper C, Javaid MK, Arden N. Epidemiology of osteoarthritis.  Atlas of osteoarthritis: 
Springer; 2014. p. 21-36. 
 
344. Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. (1987). The 
Chapter 9 -References           170 
170 
 
prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. 
Arthritis Rheum. 30(8):914-8 
 
345. Australian Bureau of Statistics. (2016). Census of Population, Employment in Australia. 
Canberra; Australian Government. 'Retrieved from': http://www.abs.gov.au. 
 
   
Appendices            171 
171 
 







Appendix 1: VIDEO study protocol         172 
172 
 
Appendix 1: Vitamin D supplementation in the management of knee osteoarthritis: 
study protocol for a randomized controlled trial 
 
 


































Appendix 2: International Physical Activity Questionnaire (PAQ)     180 
180 
 
Appendix 2: International Physical Activity Questionnaire (PAQ) 
 
                     International Physical Activity Questionnaire (IPAQ) 
                                   Short version 
 
PLEASE ANSWER EACH QUESTION EVEN IF YOU DO NOT CONSIDER YOURSELF TO BE     
AN ACTIVE PERSON.  THINK ABOUT THE ACTIVITIES YOU DO AT WORK, AS PART OF 
YOUR HOUSE AND YARD WORK, TO GET FROM PLACE TO PLACE, AND IN YOUR SPARE 
TIME FOR RECREATION, EXERCISE OR SPORT. 
 
Think about all the vigorous activities which take hard physical effort that you did in the 
last 7 days.  Vigorous activities make you breathe much harder than normal and may 
include heavy lifting, digging, aerobics, or fast bicycling.  Think only about those physical 
activities that you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical activities? 
 _____  Days per week         
   Don't Know/Not Sure  
     Refused 
 
 [Interviewer clarification: Think only about those physical activities that you do for at least 
10 minutes at a time.] 
[Interviewer note: If respondent answers zero, refuses or does not know, skip to Question 16] 
 
2.  How much time did you usually spend doing vigorous physical activities on one of those 
days?  
 
 __ __     Hours per day    
      
 __ __ __ Minutes per day  
        
    Don't Know/Not Sure   
       
                                     Refused   
 
[Interviewer clarification: Think only about those physical activities you do for at least 
10 minutes at a time.] 
 
[Interviewer probe: An average time for one of the days on which you do vigorous 
activity is being sought. If the respondent can't answer because the pattern of time spent 
varies widely from day to day, ask: "How much time in total would you spend over the 
last 7 days doing vigorous physical activities?”  
 
__ __     Hours per week    
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 __ __ __ Minutes per week 
        
    Don't Know/Not Sure   
       
                                     Refused   
    
 
Think about all the moderate activities which take hard physical effort that you did in the 
last 7 days.  Vigorous Moderate physical activities make you breathe somewhat harder 
than normal and may include carrying light loads, bicycling at a regular pace, or doubles 
tennis.  Do not include walking.  Again, think about only those physical activities that you 
did for at least 10 minutes at a time. 
 
3. During the last 7 days, on how many days did you do moderate physical activities? 
 _____  Days per week         
             Don't Know/Not Sure   
     Refused 
 
[Interviewer clarification: Think only about those physical activities that you do for at least 
10 minutes at a time] 
[Interviewer Note: If respondent answers zero, refuses or does not know, skip to Question 18] 
4. How much time did you usually spend doing moderate physical activities on one of those 
days? 
 
 __ __     Hours per day    
      
 __ __ __ Minutes per day  
        
    Don't Know/Not Sure   
       
                                     Refused   
 
[Interviewer clarification: Think only about those physical activities that you do for at 
least 10 minutes at a time.] 
 
[Interviewer probe: An average time for one of the days on which you do moderate 
activity is being sought. If the respondent can't answer because the pattern of time spent 
varies widely from day to day, or includes time spent in multiple jobs, ask: “What is the 
total amount of time you spent over the last 7 days doing moderate physical activities?” 
            __ __     Hours per week    
      
 __ __ __ Minutes per week  
        
    Don't Know/Not Sure   
       
                                     Refused   
 
THINK ABOUT THE TIME YOU SPENT WALKING IN THE LAST 7 DAYS.  THIS INCLUDES AT 
WORK AND AT HOME, WALKING TO TRAVEL FROM PLACE TO PLACE, AND ANY OTHER 
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WALKING THAT YOU MIGHT DO SOLELY FOR RECREATION, SPORT, EXERCISE, OR LEISURE. 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a time? 
            _____ Days per week         
             Don't Know/Not Sure   
  Refused 
  
[Interviewer clarification: Think only about the walking that you do for at least 10 
minutes at a time.] 
 
[Interviewer Note: If respondent answers zero, refuses or does not know, skip to 
Question 20] 
 
 6. How much time did you usually spend walking on one of those days? 
 __ __     Hours per day    
      
 __ __ __ Minutes per day  
        
    Don't Know/Not Sure   
       
                                     Refused   
 
  
[Interviewer probe: An average time for one of the days on which you walk is being 
sought.  If the respondent can't answer because the pattern of time spent varies widely 
from day to day, ask: “What is the total amount of time you spent walking over the last 7 
days?” 
 
             __ __    Hours per week    
      
 __ __ __ Minutes per week  
        
    Don't Know/Not Sure   
       
                                     Refused   
 
THINK ABOUT THE TIME YOU SPENT SITTING ON WEEK DAYS DURING THE LAST 7 DAYS.  
INCLUDE TIME SPENT AT WORK, AT HOME, WHILE DOING COURSE WORK, AND DURING 
LEISURE TIME.  THIS MAY INCLUDE TIME SPENT SITTING AT A DESK, VISITING FRIENDS, 
READING OR SITTING OR LYING DOWN TO WATCH TELEVISION. 
7.  During the last 7 days, how much time did you usually spend sitting on a week day?  
            __ __    Hours per weekday   
      
 __ __ __ Minutes per weekday  
        
    Don't Know/Not Sure   
       
                                     Refused   
 
                                                                                           
[Interviewer clarification: Include time spent lying down (awake) as well as 
sitting] 




[Interviewer probe: An average time per day spent sitting is being sought.  If the 
respondent can't answer because the pattern of time spent varies widely from day to day, 
ask: “What is the total amount of time you spent sitting last Wednesday?” 
             __ __    Hours on Wednesday    
      
 __ __ __ Minutes on Wednesday  
        
    Don't Know/Not Sure   
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Appendix 3: Western Ontario and McMaster Universities Arthritis Index 
(WOMAC) 
 
Rate the following today.  Place a mark on the line: 
Referring to your knee, Do you have (This is not in questionnaire but is implicit) 
PAIN      none                 severe 
Walking on a flat surface  
Going Up and down stairs  
At night while in bed  
Sitting or lying  
Standing upright  
STIFFNESS   
After first awakening  
Later in the day  
FUNCTIONAL DEFICIT 
Descending stairs  
Ascending stairs  
Rising from bed  
Rising from sitting  
Putting on socks  
Taking off socks  
Bending to the floor  
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Lying in bed  
Walking on flat  
Getting in/out of bath  
Standing  
Sitting   
Getting in/out of the car  
Getting on/off toilet  
Heavy domestic chores  
Light domestic chores  
Shopping 
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Appendix 4: Assessment of Quality of Life instrument (AQoL) 




Please circle the alternative that best describes you during the last week.  
 
ILLNESS 
1. Concerning my use of prescribed medicines:  
 
A. I do not or rarely use any medicines at all.  
B. I use one or two medicinal drugs regularly.  
C. I need to use three or four medicinal drugs regularly.  
D. I use five or more medicinal drugs regularly.  
 
 
2. To what extent do I rely on medicines or a medical aid? (NOT glasses or a hearing 
aid.) (For example: walking frame, wheelchair, prosthesis etc.)  
 
A. I do not use any medicines and/or medical aids.  
B. I occasionally use medicines and/or medical aids.  
C. I regularly use medicines and/or medical aids.  
D. I have to constantly take medicines or use a medical aid.  
 
 
3. Do I need regular medical treatment from a doctor or other health professional? 
  
A. I do not need regular medical treatment.  
B. Although I have some regular medical treatment, I am not dependent on this.  
C. I am dependent on having regular medical treatment.  




4. Do I need any help looking after myself?  
 
A. I need no help at all 
B. Occasionally I need some help with personal care tasks.  
C. I need help with the more difficult personal care tasks.  
D. I need daily help with most or all personal care tasks.  
 
 
5. When doing household tasks: (For example, preparing food, gardening, using the 
video recorder, radio, telephone or washing the car)  
 
A. I need no help at all.  
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B. Occasionally I need some help with household tasks.  
C. I need help with the more difficult household tasks.  
D. I need daily help with most or all household tasks.  
 
 
6. Thinking about how easily I can get around my home and community: 
  
A. I get around my home and community by myself without any difficulty.  
B. I find it difficult to get around my home and community by myself.  
C. I cannot get around the community by myself, but I can get around my home with 
some difficulty.  




7. Because of my health, my relationships (for example: with my friends, partner or 
parents) generally:  
 
A. Are very close and warm.  
B. Are sometimes close and warm.  
C. Are seldom close and warm.  
D. I have no close and warm relationships.  
 
 
8. Thinking about my relationship with other people:  
 
A. I have plenty of friends, and am never lonely.  
B. Although I have friends, I am occasionally lonely.  
C. I have some friends, but am often lonely for company.  
D. I am socially isolated and feel lonely.  
 
 
9. Thinking about my health and my relationship with my family:  
 
A. My role in the family is unaffected by my health.  
B. There are some parts of my family role I cannot carry out.  
C. There are many parts of my family role I cannot carry out.  




10. Thinking about my vision, including when using my glasses or contact lenses if 
needed:  
 
A. I see normally.  
B. I have some difficulty focusing on things, or I do not see them sharply. 
   For example: small print, a newspaper, or seeing objects in the distance.  
C. I have a lot of difficulty seeing things. My vision is blurred.  
   For example: I can see just enough to get by with.  
D. I only see general shapes, or am blind. For example: I need a guide to move around.  





11. Thinking about my hearing, including using my hearing aid if needed:  
 
A. I hear normally.  
B. I have some difficulty hearing or I do not hear clearly. 
   For example: I ask people to speak up, or turn up the TV or radio volume.  
C. I have difficulty hearing things clearly. For example: Often I do not    understand what 
is said. I usually do not take part in conversations because I 
cannot hear what is said.  
D. I hear very little indeed. For example: I cannot fully understand loud voices speaking 
directly to me.  
 
 
12. When I communicate with others: (For example: by talking, listening, writing or 
signing)  
 
A. I have no trouble speaking to them or understanding what they are saying.  
B. I have some difficulty being understood by people who do not know me. I have no 
trouble understanding what others are saying to me.  
C. I am only understood by people who know me well. I have great trouble 
understanding what others are saying to me.  




13. If I think about how I sleep:  
 
A. I am able to sleep without difficulty most of the time.  
B. My sleep is interrupted some of the time, but I am usually able to go back to sleep 
without difficulty.  
C. My sleep is interrupted most nights, but I am usually able to go back to sleep without 
difficulty.  
D. I sleep in short bursts only. I am awake most of the night.  
 
 
14. Thinking about how I generally feel:  
 
A. I do not feel anxious, worried or depressed.  
B. I am slightly anxious, worried or depressed.  
C. I feel moderately anxious, worried or depressed.  
D. I am extremely anxious, worried or depressed.  
 
 
15. How much pain or discomfort do I experience?  
 
A. None at all.  
B. I have moderate pain.  
C. I suffer from severe pain.  
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D. I suffer unbearable pain.  
 
 
Hawthorne & Richardson (1996) All rights reserved.  
Assessment of Quality of Life (AQoL) instrument. Melbourne, Centre for Health Program 
Evaluation. 
The AQoL may not be copied or used without permission.
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Appendix 5: Core muscle questionnaire 
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Appendix 6: Case Report Form 
 
 




                                                                                    DD  /  MM  /  YYYY 
 
RANDOMISATION CODE 
A randomisation code will be assigned to the participant  if the inclusion and 
exclusion criteria have been met                                                R  
 
ANALGESIC USE 
YES     NO  
Has the subject withheld taking anti-inflammatory and 
analgesic medications prior to appointment 
If YES, continue with questionnaires.  
 
If NO, allow the subject to complete all BUT the 
WOMAC Questionnaire.  Ask subject to withhold 
analgesic and inflammatory medications from today and 
complete the WOMAC questionnaire at home.  The 
questionnaire is then to be returned in pre-addressed, pre-
paid envelopes.  








          




















Please fill in the medical and medication history: 
SURGICAL HISTORY 























If the subject is currently taking any medications for any of the above procedures, ensure that 





Have you ever been told by your Dr. or a nurse that 
you have any of the following conditions? 
If yes, do you currently 
have these conditions? 
     YES        NO YES                   NO 
Diabetes                                  
Osteoporosis                                  
High Blood Pressure                                  
Asthma                                  
Bronchitis                                  
Emphysema                                  
Heart Attack                                  
Stroke                                  
Angina                                  
High Cholesterol                                  















CURRENT MEDICAL CONDITIONS Date of Onset 
(DD/MM/YYYY) 
  






If the subject is currently taking any medications for any of the above procedures, ensure that details 
are recorded in the Concomitant Medications record. 
 
CONCOMITANT MEDICATIONS 
Is the subject currently taking cholesterol lowering agents?                   YES   NO 
                                                             
If YES please specify below 











Lipitor      
cholestyramine 
Questran      
colestipol  
Colestid granules      
ezetimibe  
Ezetrol, Vytorin      
fenofibrate  
Lipidil      
fluvastatin  
Lescol, Vastin      










     


















Is the subject regularly taking NSAIDS?                                               YES   NO 
 









Diclohexal, Dinac, Fenac, 
Genrx  Diclofenac, Hexal 
Diclac, Imflac, Voltaren 
     
Diflunisal  
      
Ibruprofen  
Advil, Brufen, Bugesic, 
Butalgin, Herron Blue, 
Iprofen, Nurofen, 
Nurolasts, Panafen, 
Profen, Rafen, Tri-Profen 
     
Indomethacin  
Arthrexin, Indocid,      
Ketoprofen  
Orudis, Oruvail,      
Ketorolac  
Toradol      
Mefenamic Acid  






     




      
Piroxicam  
Feldene, Genrx Piroxicam, 
Mobilis, Pirohexal-D 
     
Sulindac  
Aclin      
Tiaprofenic Acid  
Surgam      
Tenoxicam      
Celecoxib  
Celebrex      
Parecoxib  
Dynastat      
Meloxicam  
Mefic. Mobic, Movalis 
     
Lumiracoxib  
Prexige 









     
 
What is the subject’s daily intake of NSAIDs?  .  mg 
 







Is the subject regularly taking analgesic medications?                              YES   NO                                                      
                                                                  





Dosage Frequency Route Start date Duration 
(years, 
months) 
Aspirin      
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Alka-Seltzer, Aspro Clear, 
Disprin, Ecotrin, Solprin 
Paracetamol 














Codis, Dispirin Forte, 
Veganin 
     
Codeine; Paracetamol 
Codalgin, Codapane, 
Codral, Dymadon Co, 
Painstop, Panadeine, 
Panamax Co 
     
Codeine, Paracetamol, 
Doxylamine Succinate 
Codalgin Plus, Fiorinal, 
Mersyndol, Panalgesic 
     
Aspirin; Dihydrocodeine 









Actiq      
Morphine Anamorph, 
Kapanol, MS Contin, MS 
Mono, Ordine, Sevredol 




     
Destropropoxyphene 
Doloxene  




     
Tramadol 
 Genrx Tramadol, Tramal, 
Tremedo, Zydol 
     




 Physeptone      
Buprenorphine  
Temgesic      












     
Codeine phosphate; 
paracetamol  
Codalgin Forte, Codapane 
Forte, Dymadon Forte, 
Panadeine Forte, Prodeine, 




Is the subject regularly taking osteoporosis medications?                      YES   NO                                      
                                                                 









     
Alendronate +  
Vitamin D 
 Fosamax Plus 
     
Calcium  
Caltrate, Citrocal 
     
calcitriol  
Calcijex, Calcitriol, 
Kosteo, Rocaltrol, Sitriol 
     
etidronate  
Didrocal, Didronel 
     
risedronate  
Actonel 
     
Risedronate + calcium 
Actonel combi 
     
raloxifene Evista      





     
teriparatide Forteo      




Is the subject taking low dose aspirin each day (≤150mg/day)?                  YES   NO 
                                                               
If Yes, provide details below 
 












Does the subject take any other medications? (Ask to see ALL medications used)? 
 
                                                                                                                  YES   NO                                                     
 If Yes, provide details below                                                                           
 





     
Chondroitin      
Glucosamine + 
Chondroitin 
     
Fish oil      
Other      
      
 





Height (without shoes) 
 
Stadiometer type  
Leicester     Other.................................. 
Stadiometer Number  
 
cms 
Weight (without shoes but clothed) 
 
Scale type 
Heine                 Other.................................. 




Girth measurement: hip  
Measurement  1  .cm  
Measurement  2  .cm 
Measurement  3  . cm 
 
Girth measurement: waist  
Measurement  1 .cm 
Measurement  2 . cm 
Measurement  3 .cm 
 
Leg muscle strength  
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Measurement  1  Kg 
Measurement  2  Kg 
Measurement  3  Kg 
 
Hand grip strength 
Which is your dominant hand?            Right      Left 
 
 Left  
Measurement  1  Kg 
Measurement  2  Kg 
Measurement  3  Kg 
 
Right  
Measurement  1  Kg 
Measurement  2  Kg 
Measurement  3  Kg 
 
   
Upper Arm Blood Pressure 
 
OMRON HEM907 Digital Automatic Blood Pressure Monitor  number   
Room Temperature .degrees celcius  
Time participant lying: 





Arm circumference .cm 
 
Cuff size Small (17-22 cm) 
               Regular (22-32 cm) 
               Large (32-42cm) 
 
Arm used  R (Please use right arm)  L  
                                                                       If left arm used, please specify why 
                                                                       Right arm injured 
                                                                       Right arm amputated 
                                                                       Recent surgery to right arm  
                                                                        Other (please specify)  
 
Time first reading taken: 
Please allow interval of at least 30 seconds between each reading 
 
Measurement  1  / mmHg 
Measurement  2  / mmHg 
 
 
Central Blood Pressure  
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Measurement  1  / mmHg 
Measurement  2  / mmHg 
 
Aortic pulse wave velocity 
Measurement 1  .m/s 




Body fat BIA analyser 
YES     NO 
Has body fat BIA analyser been performed?  
 
                                          If no state reason  a. refusal 
                                                b. physical restrictions  
                                                                        c. other…………........ 
 
 Date taken………………… 
 Time taken............................    
                                
 
Right Side     Left Side Please specify reason...............................    
(Right side preferred)                         
 
 Measurement 1 Measurement 2 Average 
Resistance 













*Resistance values must be within 1% of each other, otherwise repeat 
 
Fat-free mass (FFM) (kg) . 
 
% Fat-free mass (FFM) . 
























Fat mass (kg) . 
 
% Fat mass . 
 
Body Frame Size: 
Height (cm) .    
Wrist circumference (cm) .    
 
Height/wrist circumference .    
Less than 10.4                 Small frame       
Between  9.6 and 10.4    Medium frame   
Less than 9.6                   Large frame       
 
Daily Activity Level 
The “Daily Activity Level” describes the amount of physical work associated with the 
individual’s typical daily routine. It is important to select an activity level that is appropriate 
to the amount of activity that the person sees on an average daily basis.  
 
• Very Light (No Exercise) 
Seated and standing activities, painting, driving, laboratory work, typing, sewing, 
ironing, cooking, playing cards, playing a musical instrument 
 
• Light (Some Exercise) 
Walking on a level surface at 2.5 to 3 mph ( 4 - 4.8 kph ), garage work, carpentry, 
restaurant trades, house-cleaning, child care, golf, sailing, table tennis 
 
• Moderate (Moderate Exercise) 
Walking 3.5 to 4 mph ( 5.6 - 6.5 kph ), weeding and hoeing, carrying a load, cycling, 
skiing, tennis, dancing 
 
• Heavy (Athletic) 
Walking with a load uphill, tree felling, heavy manual digging, basketball, climbing, 
football, soccer 
 
• Exceptional (Elite Athlete) 
Extremely strenuous physical activity 











        













        
 
       
        
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YES     NO 
Does the subject experience symptomatic knee osteoarthritis for in 
most days of the last month 
a) Knee pain [with a pain visual analogue scale      (VAS, 0-100 
mm) of at least 20 mm] 
Actual knee pain score(s) ---------------------------------------(L) 




      
 
………. 







YES     NO 
Completed 
YES    NO 
WOMAC                                                                                         
AQoL                                                                                   
Low back pain questionnaire                                               
Foot pain questionnaire                                                        
Diet                                                                                               
CCV Barcode   
     
 
International Physical Activity Questionnaire  
(IPAQ, short form)                                                          
                   
     
Patient Heath Questionnaire-9 (PHQ-9)                                  
 
KNEE OSTEOARTHRITIS HISTORY 
With regard to the pain in your study-selected knee; 
 
How long have you experienced pain in that knee? 
  
Have you had previous surgery to this knee? 
 






















Have you had a previous injury to this knee, requiring 
use of walking stick, frame or wheelchair?  
   
 
If so, how many years ago    
 
 









JOINT OSTEOARTHRITIS HISTORY 
Over the past month have you had pain on 
most days in any of the following joints? 
 
 Other knee.  Not the one being 
investigated  in this study 




 Other (details)…………………. 
 No others 
 
EDUCATION 
What is highest level of education? 
 
 Didn’t finish high school 
 Finished high school 
 Trade/Apprenticeship 
 Certificate/Diploma 
 Bachelor degree or higher 
 Didn’t answer 
 
EMPLOYMENT HISTORY 






















What kind of work have you done for 



















1. Have you ever been a “regular smoker”? 
      If “NO” go to next section  
 
 
Note: A “regular smoker” is someone who has 
smoked at least 7 cigarettes, cigars or pipes every 
week for at least 3 months. 
 
 2. At what age did you first become a 
“regular smoker”? 
 
3. Are you currently a “regular smoker”? 
If no, go to question4 
If yes, skip to question 5 
 
 
4. How old were you when you last gave up 
being a “regular smoker”? 
 
5. How many cigarettes, pipes, or cigars 
DO/DID you smoke daily on week days?  
 
6. How many cigarettes, pipes, or cigars 
DO/DID you smoke daily on weekends? 
 




……………Years of age. 
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In summer, during weekends and holidays, how much 






In winter, during weekends and holidays, how much 








In summer, how much did your activities (playing, day 
sports, spectator sports, gardening, walking, working 
activities, etc.) take you outside in the last year?  
 
 
In winter, how much did your activities (playing, day 
sports, spectator sports, gardening, walking, working 
activities, etc.) take you outside in the last year?  




When outside in summer, how often did you use a 
sunscreen or make sure you were ‘covered up’ for the 
last year? 
   
< 1 hr a day………. 1 
1 to 2 hrs per day….2 
2 to 3 hrs per day….3 
3 to 4 hrs per day….4 
 4 hrs a day………5 
 
< 1 hr a day………. 1 
1 to 2 hrs per day….2 
2 to 3 hrs per day….3 
3 to 4 hrs per day….4 
 4 hrs a day………5 
 
Not that often………1 
A moderate amount …2 
Quite a lot…………   3 
Virtually all the time. .4 
 
Not that often………. 1 
A moderate amount …2 
Quite a lot…………..  3 
Virtually all the time. .4 
 
 
Never / rarely………1 
Occasionally……….2 
Most of the time……3 







YES     NO 
Blood samples from the first visit can be used?  




If no, please answer the following: 
Has a blood sample been taken for 25-(OH) D?  
 




Time samples taken: _________________________ 
Signature: _________________________________Date________                   
 
 
      
 
      
      





YES     NO 
Have affected knee MRI been booked? 
                                Date taken…………………    
                                 If no state reason   a. refusal 
                                                  b. physical restrictions 
                                                  c. claustophobic 
                                        d. not to have MRI 
                                                  e. other…………………… 
      
 
 
Real Time Ultrasound 
YES     NO 
Has Real Time Abdominal Ultrasound been performed (in 
Hobart)? 
                                Date taken…………………    
                                 If no state reason    a. refusal 
                                                  b. physical restrictions                                   
                                                               c. other…………………… 
      
(INSERT U/S INTERVIEW FORM ) 
 
 
VISIT 2 TEST RESULT SUMMARIES 
 

























Other marker  
 
 
Other marker  
 
 





VISIT 2 TEST RESULT SUMMARIES 
Comments if Applicable 
MRI REPORT  
 
KNEE X-RAY REPORT  
 
REAL TIME ULTRASOUND 
REPORT 
 





 YES      NO 








      
Number of Vitamin D or placebo capsule issued today for the 
subject to take home: ....................................... 
           
Has the subject been informed to take their monthly capsule and 
that they will receive a reminder? 
 
Has the subject been informed of the storage and administration 






         
 
         
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I agree to comply with taking my monthly placebo or Vitamin D 
capsule. If for any reason I do not, I will notify the research 
officer as soon as possible. I will also notify the research officer 
should I experience any side effects. 
 
Signature of participant: ............................................... 
 
Date: ............................................................................. 
   
 
         
  
 
Signature of research officer: ........................................... 
 








PREPARATION FOR NEXT APPOINTMENT 
YES     NO 
Has an appointment been made for the Subject’s visit 3 at month 
3? 
   
  
      
Has the subject been issued with a pedometer, had its use 
explained and been asked to use it over a 7 day consecutive 
period? 
Please record details in Pedometer Record 
Pedometer number_____________ 
 
If pedometer not issued state reason why: 
Refusal                                                
Physical restrictions                          
Unable to comprehend instructions  




If Yes, Please answer the following questions: 
 
      
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Appendix 7: MEDLINE, CINAHL, EMBASE AND THE COCHRANE LIBRARY Electronic search strategies for muscles of the 
trunk and assessment modalities 
DATABASE MEDLINE via PUBMED  
DATE (January 1966 – May 2013) 
FILTERS “Middle Aged + Aged: 45+ years”, Middle Aged: 45-64 years” and “Aged: 65+ years” 
RESTRICTIONS None 
STRATEGY  
#1 “abdominal muscle*” OR “trunk muscle*” OR “rectus abdominis” OR “internal oblique” OR “external oblique” OR 
“transversus abdominis” OR “multifidus” OR “core stabil*” OR “core strength*” 
#2 “electromyography*”, “emg”, “real time ultrasound imaging”, “rtusi”, “real time ultrasound”, “rtu”, “computerised 
tomography”, “ct”, “ct scan*”, “magnetic resonance imaging”, and “mri”. 
#3 #1 AND #2 
DATABASE CINAHL (1982 – May 2013) 
DATE (1982 – May 2013) 
FILTERS “45-65 years” and “65+ years”, 




STRATEGY   
#1 “abdominal muscle*” OR “trunk muscle*” OR “rectus abdominis” OR “internal oblique” OR “external oblique” OR 
“transversus abdominis” OR “multifidus” OR “core stabil*” OR “core strength*” 
#2 “electromyography*”, “emg”, “real time ultrasound imaging”, “rtusi”, “real time ultrasound”, “rtu”, “computerised 
tomography”, “ct”, “ct scan*”, “magnetic resonance imaging”, and “mri”. 
#3 #1 AND #2 
DATABASE EMBASE 




#1 “abdominal muscle*” OR “trunk muscle*” OR “rectus abdominis” OR “internal oblique” OR “external oblique” OR 
“transversus abdominis” OR “multifidus” OR “core stabil*” OR “core strength*” 
#2 “electromyography*”, “emg”, “real time ultrasound imaging”, “rtusi”, “real time ultrasound”, “rtu”, “computerised 
tomography”, “ct”, “ct scan*”, “magnetic resonance imaging”, and “mri”. 
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#3 #1 AND #2 
DATABASE THE COCHRANE LIBRARY 




#1 “abdominal muscle*” OR “trunk muscle*” OR “rectus abdominis” OR “internal oblique” OR “external oblique” OR 
“transversus abdominis” OR “multifidus” OR “core stabil*” OR “core strength*” 
#2 “electromyography*”, “emg”, “real time ultrasound imaging”, “rtusi”, “real time ultrasound”, “rtu”, “computerised 
tomography”, “ct”, “ct scan*”, “magnetic resonance imaging”, and “mri”. 
#3 #1 AND #2 
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Appendix 8: Criteria for the assessment of methodological quality – Part A 
List of criteria for the assessment of the methodological quality for cohort, cross-sectional and 
case control studies. Specifications of these criteria are shown in Appendix II. 
All items are assessed scoring: + / - / ?/NA 
 
+ positive (design or conduct adequate); - negative (design or conduct inadequate);  
? unclear (item insufficiently described); NA (Not Applicable to this study) 
 
Criteria           V/I 
STUDY DESIGN 
a) Prospective design was used        V 
b)  Withdrawals ≤ 20%         V 
c) Information on completers versus withdrawals      I 
STUDY POPULATION 
d) Selection before disease was known to be present or at uniform point  V 
e) Nonbiased selection of participants and with exclusion criteria applied equally 
 to all            V 
f) Description of relevant inclusion and exclusion criteria source population  I 
g) Sufficient description of baseline characteristics study population    I 
h) Participation rate ≥ 80% or participation rate > 50% and <80%, and a clear 
 description of methods of recruitment and information describing how  
representative those who agree to participate are in comparison to those  
who do not agree.          V/I 
 
ASSESSMENT OF TRUNK MUSCLES (MF, RA, TRA, IO AND EO) 
i) Trunk Muscles were assessed identically in the studied population  
according to a standardized protocol.       V 
j) Protocol described an appropriate method of muscle measurement.   V 
k) Individual muscles measured are specified.       V 
 
(I) WHERE TRUNK MUSCLES WERE THE OUTCOME THEN: 
 (l) to (o) not applicable if trunk muscles are not the outcome factor. 
l) Information on how determinants were measured     V 
m) Method used to measure determinants is valid     V/I 
n) Determinants were measured in an identical way for the whole studied  
population.          V 
o) Trunk muscles were measured at least two time points (applicable only 
 for longitudinal design)        V/I 
 
 
(II) WHERE TRUNK MUSCLES WERE THE DETERMINANTS THEN: 
 (p) to (u) not applicable if trunk muscles are not the determinant  
p) Information on how outcomes were measured is given    V/I 
q) Assessor blinded to any outcome measure.      V 
r) The outcome measure is valid.       V 
s) Reliability study on the outcome measure was conducted (reliability)  V 
t) The outcome can be used to measure change over time (responsiveness)  
u) The outcome is measured independently of the trunk muscles.   V 
ANALYSIS AND DATA PRESENTATION 
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v) Data presentation of most important outcomes     I 
w) Adjusted for most important confounders      V 
 
 
V = criterion on validity/ precision; I = criterion on informativeness 
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Appendix 9: Criteria for the assessment of methodological quality – Part B 
 




a) Positive if a prospective design was used. Also positive in case of a historical （
retrospective) cohort when the determinants were measured before the outcome was determined.  
‘Don’t know’ if a historical cohort is used, considering determinants at baseline which are not 
related to the primary research question for which the cohort is created or in case of 
ambispective design  
b) Positive if the total number of withdrawals was ≤ 20%; not applicable if design was not 
prospective cohort 




- Health status (healthy, independent, hospitalized or medical condition) 
- Presence or absence of low back pain 
not applicable if design was not prospective cohort 
STUDY POPULATION 
d) Positive if the study population was selected before the outcomes of the measurements 
were known. 
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Also positive if (sub-) groups were selected at a uniform point in the study. 
e) Positive if participants were drawn from the same source population (primary study base) 
and exclusion criteria are applied equally to all. 
f) Positive if relevant inclusion and exclusion criteria were formulated. 
g) Positive if trunk muscles and at least 5 of the following 9 items were reported: 
- Number of participants 
- Age (mean and measure of variance or confidential interval)  
- Sex 
- Body Mass Index (BMI) (mean and measure of variance) 
- Ethnicity 
- Place of recruitment 
- Sampling frame of source population (e.g. hospital, primary care, general population etc.)  
- Health status (healthy, independent, hospitalized or medical condition) 
- Presence or absence of low back pain 
h) Positive if the participation rate at baseline was at least 80%, or is between 50 and 80%,  
and a clear description of methods of recruitment and information describing how representative 
those who agree to participate are in comparison to those who do not agree is given .  
ASSESSMENT OF TRUNK MUSCLES (MULTIFIDUS, RA, TRA, IO AND EO) 
i) Positive if there is a description of a standardized method of trunk muscle measurement 
for the entire studied population 
j) Positive if trunk muscle activation, thickness or CSA were measured by RTUS, CT, 
EMG or MRI in accordance with the criteria set in the study. 
k) Positive if individual muscles measured are specified. 
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(I) WHERE TRUNK MUSCLES WERE THE OUTCOME THEN: 
 (l) to (o) not applicable if trunk muscles are not the outcome factor. 
l) Positive if information on how the determinants were measured is given 
m) Positive if the method used to measure the determinants is a valid measure 
n) Positive if determinants were measured in an identical way for the whole studied 
population. 
o) Positive if determinants were measured at least two time points. Not applicable if not 
longitudinal design. 
  
(II) WHERE TRUNK MUSCLES WERE THE DETERMINANT THEN: 
 (p) to (u) not applicable if trunk muscles are not the determinant 
p) Positive if information on how outcomes were measured is given 
q) Positive if assessor was blind to any outcome measure. 
r) Positive if the outcome measure is valid. 
s) Positive if the outcome measure is reliable. 
t) Positive if the outcome can be used to measure change over time (longitudinal studies 
only) 
u) Positive if the outcome is measured independently of the trunk muscles. 
 
ANALYSIS AND DATA PRESENTATION 
v) Positive if frequency or percentage, mean and standard deviation for a group is given or 
(or β) or RR with CI or P-value of the outcome(s) were reported. For reliability studies; positive 
if ICC or agreement scores are reported. 
w) Positive if there was at least correction for age, sex, back pain and BMI by means of 
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matching, restriction or adjustment in the analysis. No applicable in purely descriptive studies or 
reliability/ validity studies. 
 
 
 Morton SM, Bandara DK, Robinson EM, Carr PE. In the 21st Century, what is an acceptable response 
rate? Aust N Z J. Public Health.2012 ;36(2):106-8. 
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Appendix 10: Methodology quality assessment 
 Study design Study population 
Assessment of 
trunk ,muscles 
Trunk muscles - outcomes Trunk muscles - determinants Analysis Score Reliability % 
Author Year a b c d e f g h i j k l m n o p q r s t u v w   
Anderson 2012 − N/A N/A + + + + + + + + + + + N/A       + + 13/14 93% 
Anderson 2013 − N/A N/A + + + + + + + + + + + N/A + − + + + − + + 17/20 85% 
Briggs 2007 − N/A N/A + + + − − + + + + + + N/A       + − 10/14 71% 
Caix 1984 − N/A N/A + − − − − + + + − − − N/A       − − 4/14 29% 
Dickstein 2000 − N/A N/A + + + + − + + + + − + N/A       + − 10/14 71% 
Dickstein 2004a − N/A N/A + + + + − + + + + − + N/A       + − 10/14 71% 
Dickstein 2004 b − N/A N/A + − + + − + + + + − + N/A       + − 9/14 64% 
Fukumoto 2012 − N/A N/A + + + + + + + + + + + N/A       + − 12/14 86% 
Hanada 2008 − N/A N/A + + + + + + + + + − + N/A       + − 11/14 79% 
Hanada 2011 − N/A N/A + − + + − + + + + + + N/A       + − 10/14 71% 
Hicks 2005 + + + + + + + + + + +     + − − − + + + + 16/19 84% 
Hwang 2008 − N/A N/A + − + + − + + + + − + N/A       + − 9/14 64% 
Ikezoe 2012 − N/A N/A + − + + − + + + + + + N/A       + − 10/14 71% 
Kafri 2005 − N/A N/A + + + + − + + + + + + N/A       − − 10/14 71% 
Kai 2008 − N/A N/A + − + + − + + + + − + N/A       − − 8/14 57% 
Kalichman 2010 − N/A N/A + − + + + + + + + + + N/A       + + 12/14 86% 
Kalichman 2011 − N/A N/A + − + + + + + + + + + N/A       + + 12/14 86% 
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Kang 2007 + + + + + + + + + + + + + + N/A       + − 15/16 94% 
Kataoka 2012 − N/A N/A − − + − − − + +     − − − − − − − − 3/17 18% 
Marcucci 2007 − N/A N/A + + + + − + + + + − − N/A       + − 9/14 64% 
McGill 1999 − N/A N/A + − + + − + + + + − + N/A       − − 8/14 57% 
Oguri 2004 − N/A N/A + − + + − + + + + + + N/A       + − 10/14 71% 
Ota 2012 − N/A N/A + − + + − + + + + + + N/A       + − 10/14 71% 
Pereira 2011 − N/A N/A + − + + − + + + + − + N/A       + − 9/14 64% 
Shafaq 2012 + + + + + + + − + + + + + + N/A       + − 14/16 88% 
Stetts 2009 − N/A N/A + − + + − + + + + + + N/A       + − 10/14 71% 
Stokes 2005 − N/A N/A + − + + − + + + + + + N/A       + − 10/14 71% 
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Appendix 11: The assessment of abdominal and multifidus muscles and their role in 
physical function in older adults: a systematic review 
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Appendix 12: Test-retest reliability of measurements of abdominal and multifidus 
muscles using ultrasound imaging in adults aged 50-79 years 
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Appendix 13: Vitamin D supplements for trunk muscle morphology in older adults: 
secondary analysis of a randomized controlled trial 
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Vitamin D supplements for trunk muscle morphology 
in older adults: secondary analysis of a randomized 
controlled trial 
William A. Cuellar1,2* , Leigh Blizzard1, Julie A. Hides4,5, Michele L. Callisaya1,3, Graeme Jones1, Flavia Cicuttini7, Anita 
E. Wluka7, Changhai Ding1,7,8  & Tania M.   Winzenberg1,6 
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Background The effect of vitamin D supplementation on postural muscles of the trunk is of particular interest because low 25-
hydroxyvitamin D [25(OH) D] levels are associated with decreased postural balance and increased risk of falls. Understanding the 
role of vitamin D supplementation plays in trunk muscle function of older adults is necessary, as this is a potentially modifiable 
factor to improve postural muscle function and decrease the risk of falling of older adults. The objective of this randomized 
controlled trial was to evaluate the effect of 12 months of vitamin D supplementation compared with placebo, on morphology 
and function of the trunk muscles of adults aged 50 to 79 years with low serum 25(OH) D levels. 
Methods This was a secondary analysis of a randomized, placebo-controlled, and double-blind clinical trial conducted be- tween 
June 2010 and December 2013 in Tasmania, Australia. The clinical trial was registered with the Australian New Zealand clinical 
trial registration agency, ClinicalTrials.gov identifier: NCT01176344; Australian New Zealand Clinical Trials Registry: ACTRN 
12610000495022. Participants were aged 50–79 years with ongoing symptoms of knee osteoarthritis and with low serum 
[25(OH) D] (12.5 to 60 nmol/L, 5.2 to 24 ng/mL). Participants were randomly assigned to either monthly 50 000 IU oral vitamin 
D3 (n = 104) or an identical placebo (n = 113) for 24 months as per clinical trial protocol. The primary outcomes in this pre-
specified secondary analysis were between-group differences in change in size of rectus abdominis, transversus abdominis, 
internal oblique, external oblique, and lumbar multifidus muscles and function (assessed by change in thickness on contraction) 
of these muscles (excepting rectus abdominis) from baseline to 12 months. Muscle size was assessed using ultrasound imaging. 
Results Of 217 participants (mean age 63 years, 48% women), 186 (85.7%) completed the study. There were no significant 
between-group differences in change in size or function of the abdominal or multifidus muscles after 12 months of vitamin D 
supplementation. 
Conclusions A monthly dose of 50 000 IU of vitamin D3 alone for 12 months does not affect the size or ability to contract trunk 
muscles of independent community-dwelling older adults with symptomatic knee osteoarthritis and low serum 25(OH) D levels 
regardless of body mass index status or degree of vitamin D deficiency. An effect of vitamin D supplementation on other aspects 
of trunk muscle function such as strength, power, or physical function cannot be ruled out. 
Keywords Randomized controlled trial; Vitamin D supplementation; Postural trunk muscles; Muscle size and function; Older adults; 
Ultrasound imaging 
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Population levels of serum 25-hydroxyvitamin D [25(OH) D] are 
variable around the world, but deficiency is common in older 
adults due to decreased sun exposure, decreased pro- duction 
of vitamin D in the skin, insufficient intake of vitamin D in their 
diet, and institutionalization.1–4 Mean population 25(OH) D 
levels commonly fall below 50 nmol/L (20 ng/mL), which is 
considered to be the minimum target level for adequate bone 
health, mineral homeostasis, and muscle function.4–6 
Common clinical presentations of severe vitamin D deficiency 
include bone pain, gait disturbances, and muscle weakness, 
especially of proximal muscles of the upper and lower limbs 
and muscles of the  trunk.7  Previous  research has found that 
vitamin D plays a vital role in muscle development and growth.8 
The mechanism may be through 1,25(OH)2  binding to  a specific 
vitamin D receptor found in skeletal muscle9,10  leading to de 
novo protein synthesis and thus muscle cell proliferation and 
growth.11,12  Furthermore,  a review of randomized controlled 
trials (RCTs) has examined the effect of vitamin D 
supplementation on several aspects of muscle function 
including lower limb strength, handgrip, postural balance, gait 
speed, and physical performance (timed- up-and-go test).13 
Even though evidence in this review was conflicting, 7 of 11 
studies demonstrated beneficial effects, as has another 
published RCT.14 A more recent systematic review and meta-
analysis of 30 RCTs by Beaudart et al.15 found small but 
significant positive effects of vitamin D supplementation on 
lower limb muscle strength, although there were no effects on 
muscle mass or power. Thus, there is both a biological basis and 
clinical trial evidence for considering that correcting vitamin D 
deficiency may improve muscle strength and function. 
Muscles of the trunk, particularly the abdominal and lumbar 
multifidus muscles (MF), are postural muscles tonically active 
during daily upright activities16 and essential for the stability of 
the spine, balance, and posture.17–19 Trunk muscle size is 
correlated with strength,20,21 and among older adults, trunk 
muscle strength has been found to be associated with mobility 
and falls.22,23 The effect of vitamin D supplementation on 
muscles of the trunk is of particular interest because low 
25(OH) D levels are associated with decreased postural 
balance13 and increased risk of falls in older adults.24 
Consequently, vitamin D supplementation has the potential to 
be a relatively cheap intervention to improve postural muscle 
function and decrease the risk of falling among older adults. 
Despite this, to our knowledge, the effects of vitamin D 
supplementation on trunk muscles have not been assessed 
previously. Therefore, the objective of this RCT was to evaluate 
the effect of 12 months of vitamin D supplementation 
compared with placebo, on morphology and function of the 
trunk muscles of adults aged 50 to 79 years with low serum 
25(OH) D levels. 
Methods 
Trial design 
The Vitamin D Effect on Osteoarthritis (VIDEO) study was a 
randomized, placebo-controlled, and double-blind clinical trial 
conducted between June 2010 and December 2013, with the 
main objectives of determining if vitamin D supplementation 
could reduce knee cartilage volume loss, prevent progression of 
knee structural abnormalities, improve lower limb muscle 
strength, and alter the progression of knee pain.25,26 The 
protocol for VIDEO and its  pre-specified analyses have been 
published.25 This pre-specified secondary analysis investigating 
the effects of vitamin D supplementation on the size of 
abdominal and lumbar MF muscles over 12 months was 
undertaken in one of the two VIDEO sites, namely, Hobart, 
Tasmania, Australia. VIDEO was registered with the Australian 
New Zealand clinical trial registration agency, ClinicalTrials.gov 
identifier: NCT01176344; Australian New Zealand Clinical Trials 
Registry: ACTRN 12610000495022.25 The clinical trial and sub-
studies were conducted following the Note for Guidance on 
Good Clinical Practice (CPMP/ICH/135/95) and the 2007 




Participants were recruited through advertisements in the local 
media and community groups, and referrals from general 
practitioners, specialist rheumatologists, and orthopaedic 
surgeons. Inclusion and exclusion criteria are described in detail 
in the published clinical trial protocol.25     In brief, participants 
were people aged 50–79 years, with on- going symptoms of 
knee osteoarthritis for at least 6 months with pain levels 
between 20 and 80 mm on a 100 mm visual analogue scale and 
serum 25(OH) D levels between 12.5 and 
60 nmol/L (5.2 to 24 ng/mL). Exclusion criteria included severe 
radiographic knee osteoarthritis, severe pain on standing, 
hypersensitivity to vitamin D, any condition affecting oral drug 
absorption, and anticipated need for knee or hip surgery within 
the next 2 years. Ethics approval was received from The 
Tasmania Health and Human Ethics Committee (reference 




Randomization and blinding 
Participants were randomly assigned to a vitamin D or a placebo 
group using computer-generated allocation with a 1:1 ratio. 
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Allocation concealment was ensured by using a central 
automated process independent of the investigators. 
Participants,  investigators, and research coordinators were 
all blinded to the treatment allocation. Blinding both for the 
main study and for the trunk muscle outcomes was 
maintained until all data were collected, cleaned, and 




Participants in the treatment group were given one 50 000 IU 
(1.25 mg) vitamin D3 (cholecalciferol) capsule per month, for 
24 months. Participants in the control group were given an 
identical inert placebo. The vitamin D3 compound and inert 
placebo were acquired from Nationwide Compounding 
Pharmacy, Melbourne, Australia.25 
 
Outcomes 
Primary outcome measures in this pre-specified secondary 
analysis were between-group differences in change in muscle 
morphology: (i) changes in muscle thickness of the abdominal 
muscles [rectus abdominis (RA), transversus abdominis (TrA), 
internal oblique, and external oblique] and the lumbar MF 
muscles; (ii) changes in cross sectional area (CSA) of the MF 
muscles; and (iii) changes in muscle thickness with contraction 
of the abdominal muscles (except RA) and the MF muscles from 
baseline to 12 months. 
 
Image capture and measurement 
Ultrasound muscle images were taken using a Phillips HDI 5000 
ultrasound machine (Bothwell, WA, USA) in brightness mode 
(B-mode) with a handheld 4–7 MHz broadband curved array 
transducer. Image capture and measurement of the abdominal 
wall and MF muscles were undertaken following previously 
published protocols.27–36 The ultrasound imaging (USI) 
assessments were conducted by a physical therapist who 
undertook 36 h of practical training in USI at the beginning of 
the project. 
Muscles of the abdominal wall were imaged in transverse 
section. Participants were positioned in supine lying, with a 
pillow under their knees.30,28 To elicit a voluntary contraction of 
the abdominal wall, participants were asked to ‘take a re- laxed 
breath in and out, hold your breath out, and then draw in your 
lower abdomen without moving your spine’.28 The RA muscles 
were only imaged at rest, and the transversus abdominis, 
internal oblique, and external oblique muscles were imaged at 
rest and on  contraction.30 
Imaging of the lumbar MF muscles was performed with 
participants positioned in prone lying, with a pillow placed under 
their abdomen to reduce lumbar lordosis.31,32,34 Image of the 
lumbar MF muscles were captured both at rest (in the transverse 
plane) and during contraction (in the parasagittal plane). 
Instructions for the isometric contraction were ‘take a relaxed 
breath in and out, hold your breath out and try to slowly “swell” 
and contract the muscle without moving the spine’.37 
Ultrasound images were stored and later analysed offline by a 
single examiner using a software package (Image J Image 
Processing and Analysis, version IJ 1.46r, http://imagej.nih. 
gov/ij/). The thickness of the abdominal muscles was measured 
as the perpendicular distance between the superior and inferior 
hyperechoic muscle fascias at  approximately  the middle of the 
image identified using the software’s Cartesian coordinates.28 
The CSA of the MF muscle was measured by tracing around the 
inner edge of the fascial boundaries of the muscle,27,31 and the 
thickness of the MF muscle was measured from the tip of the 
zygapophyseal joint to the inferior fascial edge of the superior 
border of the muscle.34 Intraclass correlation coefficients (ICC) 
for abdominal and  MF  muscle  measurements  were  ICC = > 
0.85 for interrater USI image measurement reliability35  and ICC 
= 0.74–0.98 for test–retest reliability.36 
 
Other factors 
Height was measured by stadiometer to the nearest 0.1 cm 
(Leicester Height Measure, Invicta Plastics Ltd, Leicester,  UK). 
Weight was measured by calibrated scales (Heine S-7307, 
Heine, New Hampshire, USA) and body mass index (BMI) was 
calculated [weight (kg)/height (m2)]. Knee pain scores were 
obtained using a visual analogue pain scale in 
100 mm, assessing pain during walking, using stairs, in bed, 
sitting or lying, and standing. The total pain score was calculated 
as the sum of the five items (range 0–500).38 Total Western 
Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC) score was calculated as the sum of the scores in each 
of its subscales that included pain, stiffness, and physical 
function. Missing data were managed according to the WOMAC 
user guide.38 Physical activity was measured using the short 
version of the International Physical Activity Questionnaire 
(IPAQ) instrument. Data were collected on vigorous and 
moderate activity as well as walking and sitting, but data on 
sitting were not used in the analysis. Total IPAQ scores were 
calculated according to published guidelines.39,40 Current low 
back pain status was assessed by a questionnaire asking ‘do you 
currently have any pain in your back?’, and pain scores were 
obtained using a Visual Analogue Scale (0–100 mm). History of 
back surgery, abdominal surgery, and medications were 
obtained by questionnaire. Leg strength measures to the 
nearest kilogram were obtained for both legs simultaneously 
using    a dynamometer (TTM Muscular Meter, Tokyo, Japan) as 
described by Scott et al.41 This is an isometric strength muscle 




test, predominantly for the quadriceps and hip extensor 




Serum 25(OH) D was assayed at screening, 3 and 24 months. 
Blood samples were centrifuged after standing for 10 min at 
room temperature and the resultant serum frozen at 80°C until 
assayed using direct competitive chemiluminescent 
immunoassays (DiaSorin Inc.). The intraassay and interassay 
coefficients of variation were 3.2% and 6.0%.26 
 
Sample size 
Calculations were based on the standard deviations reported 
by Rankin et al.30 for the thickness of the abdominal muscles 
and by Wallwork et al.42 for thickness and CSA of the lumbar 
multifidus. Correlations between measurements and 
remeasurement of r = 0.9 for abdominal muscle thickness, r = 
0.5 for multifidus thickness, and r = 0.7 for multifidus CSA were 
observed in our reliability study.36 On that basis, this study of 
projected size 200 subjects (100 in each arm) would have 80% 
power to detect between-group differences of 0.02 to 0.05 cm 
for change in abdominal muscle thickness, 0.20 to 0.21 cm for 
change in multifidus thickness, and 0.28 to 0.40 cm2 for 
change in multifidus CSA. 
Statistical analysis 
As summary measures of their distributions, means and  
standard deviations were used for continuous measures, and 
percentages and frequencies were used for categorical factors. 
Random intercept linear mixed models were used to estimate 
the change between baseline and follow-up in both treatment 
arms, and the difference in change for the treatment groups, in 
this intention-to-treat analysis. The models included binary terms 
for side (left or right) in measurements of muscle thickness and 
CSA and for state (relaxed or contracted) of muscle thickness. 
Changes in muscle morphology, that is thickness and CSA in the 
relaxed state, and change in function (assessed by changes in 
muscle thickness on contraction) were compared for each group 
of participants. Because there was no statistically significant 
differences between the two sides for either group, the means of 
the right and left muscle sizes were used in the analysis. In 
additional analyses, adjustments were made for age, sex, and 
BMI (pre-specified in the proto- col) and for additional factors that 
were potential confounders and for which there was an 
imbalance between the treatment arms. Only the adjustment for 
lower limb strength resulted in a marked change in the estimated 
effect of the intervention (Table 1). To test for interaction by 
serum 25(OH) D status at baseline, a binary term generated using 
a serum 25(OH) D cut-point of 25 nmol/L (10 ng/mL) was included 
as a covariate and as a component of a product term in the 
regression model.  Similarly, testing for interaction by BMI 
category [normal (≤25 kg/m2), overweight (>25 to <30 kg/m2), 
and obese (≥30 kg/m2)] was performed. The step-down 
procedure of Holm43  was used  to control the family-wise  error  
rate  (Table 3). Statistical analyses were performed using Stata 
(Version 14.0, Stata Corporation, TX, USA), and a two-sided P-
value of 0.05 was deemed statistical significance. 
Table 1  Baseline characteristics of vitamin D and placebo  groups 
 
Vitamin D (N = 104) Placebo (N = 113) 





BMI ≤25 kg/m2: % (n/N) 
BMI >25 to <30 kg/m2: % (n/N) 
BMI ≥30 kg/m2: % (n/N) 
25-hydroxyvitamin D (nmol/L) 




Physical activity—IPAQ score 
Current low back pain: % (n/N) 
Current low back pain—VAS score 
History of low back surgery: % (n/N) 
History of abdominal surgery: % (n/N) 
Medication: Statins; % (n/N) 
Lower limb strength (kg) 
Grip strength: right (kg) 














































All results reported mean (standard deviation) or % (n/N) where indicated. BMI, body mass index; IPAQ, International Physical Activity 
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Questionnaire (MET-min/week); VAS, visual analogue scale (0–100 where 0 = no pain and 100 = very worst pain); WOMAC, Western On- 
tario and McMaster Universities Osteoarthritis Index. 
Results 
Of the 422 potential VIDEO participants screened at the Hobart 
site, 265 were randomized and assigned to the treatment or 
placebo groups. Of these, 104 participants in the treatment 
group (39.3%) and 113 participants in the placebo group 
(42.6%) had images of their trunk muscles taken at baseline for 
this sub-study.  Ninety-five and 91 
participants had trunk muscle images taken at follow-up 1 year 
later in the treatment and placebo groups, respectively (Figure 
1). 
Table 1 summarizes the baseline characteristics of participants 
in the treatment and placebo groups in this sub-study. The 
groups were reasonably well matched, with some difference in 
proportions for gender, low back pain, history of abdominal 
surgery, statins use, and lower limb strength. 
Figure 1  Flowchart of  participation.  
 
 





Overall knee pain scores measured by the WOMAC were in the 
low ranges (122/500), while physical activity levels measured  
by the IPAQ were in the higher ranges (>3000 MET-
min/week).40 Mean serum 25(OH) D levels in the vitamin D 
group increased by 39.3 nmol/L (15.6 ng/ mL) and 44.5 nmol/L 
(18.0 ng/mL) at 3 and 24 months respectively, compared with 
an initial increase of 17.6 nmol/L (7.2 ng/mL) at 3 months and 
a total increase of 6.8 nmol/L (2.8 ng/mL) at 24 months in the 
placebo  group. There were no baseline differences between 
the participants in this sub-study and the entire VIDEO cohort    
(n = 413).26 The BMI of the study population was relatively high 
(over 85% were overweight or obese). In the 172 participants 
of this USI sub-study who had serum 25(OH) D measured at 24 
months, increase in serum 25(OH) D levels from baseline to 24  
months in overweight (>25 to <30 kg/m2) and obese 
participants (≥30 kg/m2) was 8.7 nmol/L (3.6 ng/mL) and 5.2 
nmol/L (2.0 ng/mL) lower, than those participants with normal 
BMI (≤25 kg/m2).  In fact, 76% of the treatment group achieved 
serum 25(OH) D levels ≥75 nmol/L (≥30 ng/mL) by 24 months 
compared with only 7% of the placebo group, the former 
including 25/33 (76%) of obese and 22/33 (67%) of overweight 
treatment arm participants. 
The between-group treatment effects for trunk muscle size 
and change in thickness with contraction were small (less than 
4% in each muscle), inconsistent in direction, and not 
statistically significant (Tables 2 and 3). Adjusting for age, sex, 
and BMI did not change these results (Tables 4 and 5). While 
additional adjustment for leg strength increased the effect size 
for multifidus thickness at the L2/L3, L3/L4, and L4/L5 vertebral 
levels, the only between-group difference that was statistically 
significant after controlling for family- wise error was at the 
L2/L3 vertebral level and the effect size (3.5%) remained small 
(Table 5). Results were similar after further adjustments for 
statin use, current low back pain, and history of abdominal or 
back surgery. There were not significant within-group 
differences in trunk muscle size or function over 12 months in 
either group. There were no interactions between treatment 
effect and either baseline 25(OH) D status or BMI in adjusted 
analyses for any muscle measure (all P < 0.05). 
 
Adverse events 
A description of adverse events for the full clinical trial has been 
reported previously.26 In this sub-study, 44 (42%) out 
 












































































All measures are in cm and are reported as mean (standard error). EO, external oblique; IO, internal oblique; RA, rectus abdominis; TrA, 
transversus abdominis. 
aAbsolute change in muscle thickness with contraction, calculated as (thickness when contracted – thickness when relaxed). 
*Statistically significant P < 0.05 
 
Table 3 Between-group differences in changes in relaxed abdominal muscle thickness (cm) and in change in muscle thickness with contraction from 










EOa 0.007 (-0.019, 0.034) 0.006 (-0.021, 0.034) 0.011 (-0.017, 0.040) 














0.007 (-0.015, 0.029) 
-0.007 (-0.027, 0.013) 
-0.005 (-0.028, 0.019) 
-0.017 (-0.058, 0.024) 
-0.024 (-0.068, 0.020) 
-0.010 (-0.032, 0.126) 
0.010 (-0.012, 0.032) 
-0.004 (-0.024, 0.016) 
-0.004 (-0.028, 0.019) 
-0.013 (-0.054, 0.028) 
-0.022 (-0.066, 0.022) 
-0.008 (-0.030, 0.015) 
0.009 (-0.015, 0.032) 
-0.007 (-0.029, 0.014) 
-0.004 (-0.030, 0.021) 
-0.010 (-0.054, 0.034) 
-0.021 (-0.069, 0.026) 
-0.010 (-0.034, 0.013) 
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aAbsolute change in muscle thickness with contraction calculated as (thickness when contracted – thickness when relaxed). 
*Statistically significant P < 0.05.
Appendix 13: RCT study - published paper        257 
257 
 
- - - - 
- - - 
- - - - - -
- - 
- 
- - - 
-
- - - 
- - 
- - 
- - - 
- - - - - -
- - - -
- - - 
Table 4 Changes in relaxed multifidus muscle thickness (cm), changes in muscle thickness with contraction, and in changes cross sectional area (cm2) 
from baseline to follow-up by intervention group 
 
Vitamin D group Placebo group Between-group 
differences 
Muscle Baseline Follow-up Change Baseline Follow-up Change 
Muscle thickness 
in change 
L2/L3_MF (relaxed)  2.646 (0.046)  2.649 (0.047) 0.003 (0.043) 2.670 (0.044)  2.580 (0.047) 0.090 (0.043) 0.092 (0.060) 
L2/L3_MFa 0.140 (0.018)  0.115 (0.018) 0.025 (0.019) 0.167 (0.017)  0.142 (0.018) 0.025 (0.019) 0.000 (0.026) 
L3/L4_MF (relaxed)  2.331 (0.043)  2.428 (0.044) 0.097 (0.036)*  2.339 (0.041)  2.409 (0.043) 0.070 (0.036) 0.027 (0.051) 
L3/L4_a 0.134 (0.018)  0.129 (0.018) 0.005 (0.021) 0.145 (0.017)  0.124 (0.018) 0.020 (0.021) 0.015 (0.029) 
L4/L5_MF (relaxed)  2.864 (0.048)  2.817 (0.049) 0.047 (0.045) 2.913 (0.046)  2.842 (0.049) 0.071 (0.046) 0.024 (0.064) 
L4/L5_MFa 0.168 (0.018)  0.160 (0.019) 0.008 (0.019) 0.184 (0.018)  0.180 (0.019) 0.005 (0.019) 0.003 (0.027) 
L5/S1_MF (relaxed)  2.744 (0.049)  2.863 (0.051) 0.119 (0.044)*  2.758 (0.047)  2.925 (0.050) 0.167 (0.045)* 0.048 (0.063) 
L5/S1_MFa 0.138 (0.019)  0.153 (0.020) 0.015 (0.021) 0.170 (0.018)  0.178 (0.020) 0.008 (0.021) 0.007 (0.030) 
Cross sectional area 
L2_MF_CSA 2.670 (0.054)  2.858 (0.055) 0.188 (0.027) 2.654 (0.052)  2.908 (0.053) 0.254 (0.027) -0.066 (0.038) 
L3_MF_CSA 3.500 (0.061)  3.830 (0.062) 0.330 (0.037) 3.423 (0.058)  3.774 (0.060) 0.350 (0.038) -0.021 (0.053) 
L4_MF_CSA 4.416 (0.068)  4.831 (0.069) 0.415 (0.038) 4.230 (0.065)  4.708 (0.067) 0.478 (0.039) -0.063 (0.054) 
L5_MF_CSA 5.211 (0.081)  5.519 (0.082) 0.307 (0.048) 4.979 (0.077)  5.399 (0.080) 0.420 (0.049) -0.112 (0.068) 
All measures are in cm and are reported as mean (standard error). CSA, cross sectional area; MF, multifidus muscle. 
aAbsolute change in muscle thickness with contraction calculated as (thickness when contracted – thickness when relaxed). 
*Statistically significant P < 0.05. 
 
Table 5 Between-group differences in change in relaxed multifidus muscle thickness (cm) and in change in muscle thickness with contraction and cross 
sectional area (cm2) from baseline to follow-up with and without adjustment for relevant  factors 
 
 
Muscle Unadjusted model 
Adjusted for 
Age + Sex + BMI Age + Sex + BMI + Leg strength 
Muscle thickness 
L2/L3_MF (relaxed) 0.092 (  0.026, 0.211) 0.115 (  0.004, 0.234) 0.172 (0.048, 0.296)* 
L2/L3_MFa 0.000 (  0.052, 0.051) 0.115 (  0.054, 0.051) 0.176 (   0.073, 0.037) 
L3/L4_MF (relaxed) 0.027 (  0.073, 0.127) 0.038 (  0.063, 0.139) 0.054 (   0.052, 0.161) 
L3/L4_MFa 0.015 (  0.042, 0.072) 0.017 (  0.041, 0.074) 0.001 (   0.062, 0.060) 
L4/L5_MF (relaxed) 0.024 (  0.102, 0.150) 0.050 (  0.076, 0.176) 0.089 (   0.045, 0.222) 
L4/L5_MFa 0.003 (  0.056, 0.050) 0.003 (  0.049, 0.056) 0.025 (   0.054, 0.059) 
L5/S1_MF (relaxed) 0.048 (  0.172, 0.076) 0.028 (  0.152, 0.096) 0.015 (   0.146, 0.117) 
L5/S1_MFa 0.007 (  0.052, 0.066) 0.015 (  0.043, 0.073) 0.017 (   0.044, 0.078) 
Cross sectional area 
L2_MF_CSA -0.066 (-0.142, 0.009) -0.059 (-0.135, 0.017) -0.060 (-0.140, 0.020) 
L3_MF_CSA -0.021 (-0.125, 0.083) -0.016 (-0.120, 0.089) 0.039 (-0.069, 0.147) 
L4_MF_CSA -0.063 (-0.169, 0.043) -0.062 (-0.168, 0.045) -0.041 (-0.148, 0.067) 
L5_MF_CSA -0.112 (-0.246, 0.022) -0.129 (-0.260, 0.003) -0.120 (-0.259, 0.019) 
All measures are in cm, and are reported as mean (standard error). CSA, cross sectional area; MF, multifidus muscle. 
aAbsolute change in muscle thickness with contraction calculated as (thickness when contracted – thickness when relaxed). 
*Statistically significant P < 0.05. 
 
of 104 participants in the vitamin D group reported adverse 
events compared with 30 (27%) out of 113 participants in the 
placebo group (Table 6). Two cases of hypercalcemia were 
reported in each group. One instance of hyperthyroid- ism and 




To our knowledge, this is the first RCT investigating the effect 
of vitamin D supplementation on the morphology of key 
postural trunk muscles of older adults. Apart from the 
thickness of the MF muscles at the L2–L3 vertebral level, there 
were no statistically significant differences in change in muscle 
thickness or CSA between the vitamin D and placebo groups, and 
all effect sizes were small and not clinically significant. The results 
suggest that vitamin D supplementation alone is not an effective 
means to improve or maintain trunk muscle size over time for 
adults aged 50–79 years, even for those individuals with 
moderate to severe deficiency. 
The purpose of this study was to determine whether vitamin D 
supplementation alone had beneficial effects in maintaining or 
improving trunk muscle size and function. In the present study, 
the within-group changes in trunk muscle size and function 
over time were all very small. Despite there 















aIncluding headache, lethargy, flu symptoms, and other events. 
 
 
being plausible reasons to hypothesize that vitamin D 
supplementation could improve trunk muscle size, our results 
suggest that increases or maintenance of muscle size or 
function of older adults cannot be expected from vitamin D 
supplementation alone, at least over the limited timeframe of 
1 year. In peripheral muscles, two systematic reviews reported 
positive effects of vitamin D supplementation on muscle   
strength in older adults with baseline 25(OH) D < 30 nmol/L 
(<12 ng/mL).15,44 However, in our study of trunk muscles, the 
response to supplementation did not vary between people with 
moderate to severe deficiency 25(OH) D (<25 nmol/L, <10 
ng/mL) at baseline and those with 25(OH) D levels above this  
level.  Thus, even in people with this degree of deficiency, 
vitamin D supplementation does not improve trunk muscle size 
or muscle function as assessed by change in muscle thickness 
during submaximal contraction. 
While there is no consensus on the amount of variation in trunk 
muscle size required to ascertain clinically meaningful changes 
in these muscles,30 previous studies  investigating the effect of 
exercise programmes on trunk muscles in people with low back 
pain have found interventions that increased muscle size were 
associated with decreases in pain.37,45,46 The changes in muscle 
sizes observed in those studies were larger than those seen in 
our study, for example, being over 5% for measures of the 
multifidus and transversus abdominis muscles at rest.37,45 Thus, 
exercise programmes or a combination of exercise and 
functional activities that target trunk muscles may be more 
effective in improving these muscles than vitamin D 
supplementation alone. 
The effects of vitamin D supplementation on peripheral muscle 
strength, mass, and power have been examined in a systematic 
review and meta-analysis.15 The studies in this review 
administered a wide range of vitamin D doses (as low 300 
IU/day, up to intermittent doses equivalent to around 8600 
IU/day). For muscle strength, there was a small but statistically 
significant positive effect of vitamin D supplementation on 
lower limb muscle strength [19 studies in 2349 people; vitamin 
D dose range 400–8600 IU; standard mean difference = 0.19 
(95% CI 0.05–0.34)]. However, there was no statistically 
significant effect of vitamin D supplementation neither on grip 
strength (16 studies, doses 400–8600 IU/day) nor on muscle 
mass (six studies, n = 538, doses 300–4000 IU/day) or power 
(five studies, n = 245, doses 400–4000 IU/day). The latter is 
consistent with the lack of effect on muscle size observed in the 
current study, but as trunk muscle strength and power were not 
measured in our study it remains to be determined whether 
vitamin D supplements affect strength or power in trunk 
muscles. 
Previous studies have reported improvements in measures of 
functional mobility (walking test and ‘timed up and go’ test) and 
reduced risk of falls with vitamin D supplementation of older 
adults.47,24 Although the present study did not investigate the 
effect of vitamin D supplementation on falls or functional 
Table 6   Adverse events  
 Vitamin D (N = 104) Placebo (N = 113) 
 No. of participants (%) No. of participants (%) 
Serious adverse events     
Death 1 (1.0) 0 (0.0) 
Malignancy 2 (1.9) 2 (1.8) 
Coronary artery disease 1 (1.0) 1 (0.9) 
Severe infection 0 (0.0) 1 (0.9) 
Major depression 1 (1.0) 0 (0.0) 
Nephrolithiasis 1 (1.0) 1 (0.9) 
Hospitalization 1 (1.0) 0 (0.0) 
Adverse events     
Hypercalcaemia 2 (1.9) 2 (1.8) 
Hyperparathyroidism 1 (1.0) 0 (0.0) 
Renal 2 (1.9) 0 (0.0) 
Falls 2 (1.9) 0 (0.0) 
Musculoskeletal 1 (1.0) 1 (0.9) 
Neurological 1 (1.0) 1 (0.9) 
Gastrointestinal 1 (1.0) 3 (2.7) 
Respiratory 2 (1.9) 1 (0.9) 
Ocular 1 (1.0) 1 (0.9) 
Infection 4 (3.9) 2 (1.8) 
Cardiac arrhythmia 1 (1.0) 0 (0.0) 
Chest pain 4 (3.9) 4 (3.5) 
Pain 6 (5.8) 2 (1.8) 
Allergy/immunology 0 (0.0) 2 (1.8) 
Other eventsa 9 (8.7) 6 (5.3) 
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mobility, our results suggest that changes to these outcomes 
are not mediated by trunk muscle size.   The effect of vitamin 
D supplementation on other aspects of trunk muscle function 
such as strength cannot be ruled out and should be the focus 
of future research. 
 
 
Strengths and limitations 
The strength of the current investigation is its design. It is a 
double-blind RCT, which provides robust evidence regarding 
the efficacy of vitamin D supplementation for improving trunk 
muscle size. Participants in this study were community-
dwelling adults with low serum 25(OH) D. This is the sub-
population most likely to benefit from vitamin D 
supplementation. 
It has limitations nevertheless. While the use of random 
allocation helps to reduce the possibility of imbalance be- 
tween the treatment arms, in this case randomization did not 
produce exact balance. However, we collected information that 
made it possible to adjust for these factors, and   the results of 
the adjusted analyses did not alter the overall conclusions of 
the study. While the study sample was on average only mildly 
deficient, there was no interaction between treatment 
response and vitamin D status at baseline, suggesting that the 
results are generalizable to both mildly and moderately 
deficient people. While our sample size was modest, we 
powered the study appropriately to detect treatment effects 
that were likely to be clinically meaningful based on existing 
literature.37,45,48 We are therefore unlikely to have failed to 
detect any clinically important treatment effects. The majority 
of participants were either overweight or obese, which could 
have influenced their serum 25(OH) D response to 
supplementation. However, participants with high BMI still 
achieved large increases in 25(OH) D and a much higher pro- 
portion of these participants reached levels ≥75 nmol/L (≥30 
ng/mL) than in the placebo group. Furthermore, there was no 
interaction between treatment response and BMI, so the 
impact of being an obese population on our results was 
minimal. The lack of any interaction also suggests that our 
results are generalizable to people with osteoarthritis who are 
of normal weight. It is possible that mobility restrictions from 
knee osteoarthritis may have affected participants’ ability to 
improve trunk muscle size. Nevertheless, levels of knee pain in 
the study were relatively low, functional limitations were 
modest, and physical activity levels were reasonable, which 
makes this scenario unlikely. We used a DiaSorin immunoassay 
method to measure serum 25(OH) D, rather than mass 
spectrometry which is considered the gold standard. However, 
mass spectrometry is not readily avail- able in clinical practice, 
which would affect translation into practice, and a recent study 
found that the DiaSorin immuno- assay achieved acceptable 
performance when compared with mass spectrometry.49 Our 
only measure of muscle function was change in muscle 
thickness with contraction, so we cannot rule out effects of  
vitamin  D  supplementation  on other aspects of muscle function 




There is no evidence that a monthly dose of 50 000 IU of 
vitamin D3 alone has an effect on the size or ability to contract 
trunk muscles of independent community-dwelling older adults 
with symptomatic knee osteoarthritis and low serum 25(OH) D 
levels regardless of BMI status or degree of vitamin D 
deficiency. An effect of vitamin D supplementation on other 
aspects of trunk muscle function such as strength, power, or 
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Appendix 14: Body Bequest Program – Registration form
BODY BEQUEST PROGRAM 
University of Tasmania     
Private Bag 34, Hobart, TAS  7001 






Body Bequest Program Registration 
The following personal information is required by the Registrar of Births, Deaths and Marriages. It is not used 
to contact any person except the nominated next of kin or Executor (back of form). 
 
NOTE: If you wish to withdraw your bequest or if any of the following information changes please advise the 
Body Bequest Program at the College of Health and Medicine. 
 
 
Mr  Mrs      ……………………………………………………………………………………………………….. 
Ms  Miss     SURNAME    GIVEN NAMES 
 
Present address  ……………………………………………………………………………………………….. 
                           ……………………………………..…  Phone number 
 
Date of Birth              Place of birth 
 
If born overseas, year of entry into Australia    Religion 
 
 
Retired?       Yes / No       Occupation (before retirement / current) 
 
Father’s full name 
Mother’s full maiden name 
 
Details of marriage/s (even if divorced. If married more than once, please give details for each) 
Where married (town / country) full date of marriage Age Partner’s full name (before marriage) 
1. …../…./…..   
2. …../…./…..   
3. …../…./…..   
4. …../…./…..   
 
Children from all relationships (including legally adopted* and deceased children) 
Given Names        *If adopted write 
                                   (A) after name 
Date of Birth  Given Names        *If adopted write 
                                   (A) after name 
Date of Birth  
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or ‘Deceased’ or ‘Deceased’ 
1. …../…./….. 5. …../…./….. 
2. …../…./….. 6. …../…./….. 
3. …../…./….. 7. …../…./….. 
4. …../…./….. 8. …../…./….. 
 
Name and address of your 
Regular doctor 
 
THE BACK OF THIS FORM MUST BE READ AND SIGNED 
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Please provide details of your next of kin (or executor) who will be able to give any additional information at 
the time of death for registration purposes and who will be notified after the cremation has been completed. 
Name:  ……………………………………………………….  Relationship:  ………………………………….. 
Address:  ………………………………………………………………………………………………………… 
……………………………………………………………….  Telephone:  …………………………………….. 
 
I give permission for any of my remains to be retained by the University of Tasmania: 
(Please tick ONE (1) box only) 
Indefinitely   5 years   other (not less than 3 years) 
 
I consent to the use of images of my body or parts of my body for education, training or research  
purposes.  
I understand that these images will not be identifiable. 
 
PLEASE READ CAREFULLY BEFORE YOU SIGN 
1. It is important that you discuss your intentions with your family so that your wishes may be followed. If 
the next of kin of the deceased are unhappy regarding the bequest to the University, the College of Health 
and Medicine may be unable to accept your bequest. 
 
2. If hospitalised, please ensure that the doctor and medical staff are aware of your wish to bequest your body 
to the University so that in the event of your death they can contact the Body Bequest Program without 
delay. 
 
3. Unless the circumstances at the time of death compel the University to decline your offer, the College of 
Health and Medicine will make arrangements and meet expenses in connection with the removal and 
transport and eventual cremation of your body. The College may retain your body for 5 years unless 
otherwise specified above. 
 
4. The University reserves the right to decline acceptance, for any reason, of your body after death*. If 
the University declines to accept your body, it will not be responsible in any way for your funeral 
arrangements or associated costs. Consequently, you and your family are strongly advised to agree on 
alternative arrangements in the event that your body is unable to be accepted at your time of death. 
 
*   Some reasons why the University is unable to accept a body are: body subjected to a post mortem 
examination, the possible existence of a contagious disease, or any other medical grounds, or non-medical 
grounds, e.g. if the body is not received within four days of the death or if the storage facility is full. 
 
This is to acknowledge that I have read the above information and, having done so, confirm that it is 
my wish that my body, after death, be made available to the College of Health and Medicine, 
University of Tasmania, under the provision of the Anatomical Examinations Act 2006, to be used in 
whatever way shall be deemed most beneficial for the advancement of medical studies and education. 
I also hereby authorise the University of Tasmania to have full access to my medical records and to 
make copies of these records when necessary. I understand that the University reserves the right to 
decline acceptance of my bequest. 
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Donor’s signature:  ……………………………..……………….…..…..  Date:  ………………………. 
Senior Next of Kin / Executor signature:  …………..…………………..  Date:  ………………………. 
Witness’ signature:  …………………………………….….………..…..  Date:  ………………………. 
 
NOTES FOR PERSON IN ATTENDANCE AT TIME OF DEATH 
Before making any other arrangements please contact the University’s Body Bequest Program as soon as 
possible, but definitely within 4 days of the death on 1800 792 661 (9 am – 7 pm, 7 days a week). 
In the event of acceptance of the body the Coordinator will make all the necessary arrangements for removal 
and transportation of the deceased to the College of Health and Medicine and for the registration of the death. 
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Appendix 16: PROSPERO – email correspondence regarding systematic review 
registration 
From: jimmy.christie@york.ac.uk [mailto:jimmy.christie@york.ac.uk] On Behalf Of CRD 
Register 
Sent: Wednesday, 4 March 2015 8:41 PM 
To: William Cuellar 




I'm afraid that it would not be possible for me to accept a completed review retrospectively as to 
do so would be to leave myself open to appeals from the many authors who have had reviews 
rejected for similar reasons. 
 
However, if you were to submit the review you would receive an e-mail from me saying that it 
had been rejected and giving the reason. We have found that publishers are usually quite happy 
to accept this e-mail as proof of your intent to register the review. 
 




 From: CRD-REGISTER [mailto:crd-register@york.ac.uk]  
Sent: Wednesday, 13 May 2015 5:29 PM 
To: William Cuellar 
Subject: PROSPERO Registration message [20511] 
 
Dear Mr Cuellar 
Thank you for submitting details of your systematic review Abdominal and 
multifidus muscles and their role in physical function in older adults: a 
systematic review to the PROSPERO register. 
We regret that from the information you have provided, we have assessed 
that your review does not meet the current inclusion criteria for 
PROSPERO. Reviews that have progressed beyond the point of completing 
data extraction are not eligible for inclusion in PROSPERO. The aim of the 
register is to capture information at the protocol stage of a review. Full 
details of the scope of the register can be found in the About pages at 
http://www.crd.york.ac.uk/PROSPERO. 
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We hope that this will not discourage you from registering your next 
systematic review at the protocol stage, with PROSPERO. 
Comments and feedback on your experience of registering with PROSPERO 
are welcome at crd-register@york.ac.uk 
Yours sincerely  
James Christie 
PROSPERO Administrator 
Centre for Reviews and Dissemination 
University of York 
York YO10 5DD 
t: +44 (0) 1904 321040 
f: +44 (0) 1904 321041 
e: CRD-register@york.ac.uk 
www.york.ac.uk/inst/crd 
CRD is part of the National Institute for Health Research and is a 
department of the University of York. 
Email disclaimer: http://www.york.ac.uk/docs/disclaimer/email.htm 
  
